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Members of the Major Facilitator Superfamily (MFS) make up the largest family of secondary 
active transporters, they mediate a diverse set of functions by controlling the movement of 
ions and small molecules across cell membranes. Members of the MFS share a set of common 
structural motifs consisting of transmembrane ɑ-helical segments.  The glycerol-3-phosphate 
transporter (GlpT), is an example of an MFS transporter with 12 α-helices ordered into two 
domains. Recent study on MFS transporter LacY, has implied an increased stability localized to 
the vicinity of the first helices of the protein. If this observation is found in other MFS proteins 
it could suggest a folding principle for other MFS transporters, whereby the first helix of the 
protein is acting as a stable unit that supports the process of folding. The inherent magnified 
stability of the helix 1 may also aid in other cellular events, where transporters or receptors 
are integrated into the membrane by anchoring to the membrane as well as becoming part of 
the unit that first penetrates the membrane leaflet. This work is focused on the stability 
analysis via alanine substitutions along the first alpha helix of the first domain of GlpT, 
compared to similar and corresponding mutations along the first helix of its second domain. 
The transporters stability is estimated by unfolding assays coupled with the decrease of 
secondary structure as measured by circular dichroism spectroscopy. Additional methods such 
as fluorescence spectroscopy, temperature denaturation and ligand binding assays have also 
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Approximately 20-80 % of the membrane weight is composed out of membrane proteins 
(1). In total 20-30 % of all proteins in a cell reside in a membrane (2). As such, membrane 
proteins are responsible for the majority of plasma membrane functions. These proteins 
can either be directly associated with lipid tails, with the protein structure traversing the 
bilayer, or be anchored with the lipid heads on the surface of the membrane. 
 
Many of the most fundamental functions required for cell function are carried out by 
membrane proteins. These proteins are responsible for processes such as: selective 
transport of molecules; resulting in a formation of a concentration gradient or electric 
potential; cell signalling; and receptor responding to extracellular stimuli by relaying the 
message into the cell. Other functions such as photosynthesis or generation of the cell’s 
main source of energy, ATP, are accomplished by large protein complexes. These 
complexes are assembled from several proteins and polypeptide chains into complex 
molecular machinery. 
 
Both the substrate transporters and the receptors are a major target for the 
pharmaceutical industry. A variety of disorders’ pathologies are linked to malfunctions 
arising from membrane proteins. The origin of these disorders is through either the direct 
effect of infections or harmful mutations impacting the protein function through protein 
misfolding. Approximately 60 % of all drugs target membrane proteins (3), underlying the 
necessity of understanding the processes involving membrane proteins, including the 
relationship between the protein structure and function.  
 
1.2 Protein folding studies 
The process in which proteins assume their correct fold and therefore functionality is of 
great importance to the viability of cells. The first breakthrough in protein folding was 
made by Anfinsen in 1972, stating that all the information needed for correct folding of 
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the protein is contained within its own polypeptide sequence (4). Since then, the 
understanding of protein folding was expanded by multiple crystal structures and 
mechanisms of protein action, such as actions of chaperones and translocons in driving 
the protein folding in vivo. The technical difficulties associated with membrane protein 
purification and stability during experimentation have resulted in only a handful of them 
being studied (5). Bacteriorhodopsin is one of the most well studied membrane proteins 
to date. It is present in membrane patches, called the purple membrane of the 
Halobacterium salinaria organism (6). Its natural high expression and relative ease of 
purification, leading to high yield of pure protein, has led it to be one of the well-
characterised proteins of its type. Most membrane proteins are poorly expressed and 
difficult to stabilise in vitro, resulting in complications during their study. Unstable proteins 
would show a tendency to protein degradation and misfolding, leading to formation of 
aggregates that are non-functional. 
 
The expansion of membrane protein research would bridge the gap between the two-
dimensional polypeptide and the functioning three-dimensional protein. This would result 
in advanced predictions of protein structure from the DNA code as well as the rational 
design of therapeutic compounds targeting newly discovered pathways. Moreover, the 
design of new enzymes and nanostructures would contribute to the expansion of the 
agricultural and chemical industries. Current work is focused on determining the 
stabilising factors of small and simple membrane proteins, so that this can later be 
translated to bigger and physiologically important proteins. The research in membrane 
protein folding is also focused on translocon-mediated folding and insertion; the role of 







1.2.1 Structure of membrane proteins 
The protein folding process is studied in a number of ways. The majority of them involve 
first obtaining and then analysing the folded protein structure. However, the ability to 
synthesize and obtain structures of membrane proteins is imperfect. In recent years, 
there was an increase in the number of solved structures of membrane proteins (7). Two 
prevailing structural motifs were identified; the α-helix and the β-barrels. The examples 
of two motifs can be seen in figure 1.1. 
 
Figure 1.1 Examples of α-helical and β-barrel motifs in membrane proteins 
The α-helical motif on the left is presented on bacteriorhodopsin (PDB: 4HWL, 8, Uniprot: 
P02945), on the right OmpF (PDB: 3HWB, 9, Uniprot: P02931) is showing a β-barrel motif. The 
hydrophobic core is made out of acyl chains and is approximately 30 Å in thickness. The interface, 
made mostly out of phospholipid head groups, is 15 Å thick. Structures were rendered in PyMOL 
software. 
 
The α-helical bundles represent the dominant motif of membrane proteins, while β-
barrels are mostly seen in toxins, porins and translocases. The majority of amino acids 
found in the membrane core are hydrophobic and are packed tightly to limit any water 
interactions. Salt-bridges are less common in membrane proteins than in their water-
soluble counterparts. They are replaced by stabilising hydrophobic forces acting 
between different motifs (10). The 30 Å thickness of the hydrophobic section of 
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membrane dictates the average size of the secondary structure observed in the 
membrane. In order to accommodate the thickness of the hydrophobic proportion of the 
membrane the length of the α-helix or β-structure is often extended. Furthermore, α-
helices can often be found to be orientated at an angle in respect to the surface plane of 
the membrane, with the aromatic residues such as tryptophan, located in the so-called 
aromatic belt, stabilising the protein through the interactions with the polar head groups 
(11). Other stabilising forces in the membrane proteins include: hydrogen bonds, charge-
charge interactions and disulphide bonds (12). However, both the protein and the lipid 
membrane are constantly in motion, changing their alignment and size, resulting in a 
dynamic environment where the membrane protein structure constantly adapts itself 
(13). Through favourable interactions with lipid chains and diverse range of lipid head 
groups, membrane protein is able to retain both, its structure and function (14). 
 
The protein fold and structure can also be defined by its positioning relative to the 
direction of the membrane. The observation that the membrane proteins tend to be found 
in a specific orientation to the membrane is called the positive-inside rule (15). According 
to the rule, certain amino acids show preference to where they are located, for example 
lysine and arginine tend to be found on the periplasmic side of the bacterial membranes 
(12, 16). It is thought that this preference helps to orientate the protein in the correct 
direction as well as to stabilise it during the folding process. The rule became a useful 
tool in predicating orientation and fold (17) of membrane proteins in the membrane. 
 
The work described in this thesis focuses on the study of a member of the major facilitator 
superfamily of transporters. Thus far, all identified members of MFS were found to be 
composed of alpha helical bundles. 
 
1.2.2 Alpha helical transporters 
Alpha-helical bundles make up structures that facilitate multiple functions, primarily 
transport of substrates across the membrane. Transport is achieved by α-helices working 
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together in subunits to achieve substrate selectivity and via conformational change 
transit of the molecule across the membrane barrier. The substrate transport often 
requires a presence of the polar binding pocket, in order to induce an affinity to a 
substrate that is usually charged. When the transporter’s channel is open, its binding 
pocket is exposed to an aqueous solvent. The channel structure has many requirements 
to satisfy in order to become functional. 
 
The energy penalty of maintaining polar residues within the hydrophobic core of the 
protein needs is balanced by opposing forces in order to maintain stability and 
appropriate protein fold (18). At the same time the folded structure cannot be overly 
stable, as the transporter needs to remain flexible in order to be able to respond with the 
conformational change during ligand binding. The energy of transporting a molecule can 
be produced either from the electrochemical gradient or from hydrolysis of a molecule 
with high energy potential, like ATP. 
 
Depending on the transporter, substrate transport can be facilitated in either direction. 
The uniporter transporters will move one substrate at a time along its concentration 
gradient. Symporters are able to transport different types of molecules in the same 
direction. An antiporter, will transport a substrate across the membrane in one direction 
and consequently a different molecule is ferried across the membrane in the opposite 
direction (19). Transporters partake in many essential physiological functions. The cell, 
such as neurone, will use a series of transporters with different selectivities, working in 
unison to provide concentration gradients of ions that then are used to drive the transport 
of other ions and substrates in a process referred to as action potential (20). Nearly a 
third of all described drug targets are thought to be transporters (21).  
 
The structural knowledge of cell’s proteome is mostly limited to soluble proteins, leaving 
transporters and the action of drugs acting upon them mostly unidentified. Mutations 
affecting the channel function or folding often lead to a disease. In the case of cystic 
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fibrosis, where the mutation of the cystic fibrosis gene causes misfolding of the CFTR 
protein, resulting in a faulty transport of chloride and in consequence thicker mucous 
associated with the disorder (22). The example of cystic fibrosis shows that mutations 
do not have to affect the binding site of the transporter in order to cause symptoms of 
the disease. Most often, the mutation will affect the stability of the protein through an 
unknown mechanism, that later would results in a disease. Understanding the processes 
leading to protein synthesis and stability may help to gain better understanding of 
possible treatment methods through identifying the relationship between the protein 
structure and function. 
 
1.3 Entropy and enthalpy of folding 
Multiple studies of water soluble proteins have resulted in the notion that protein folding 
can be described as a search of continuously more stable conformational states. As 
more stable contacts are favoured over non-native contacts, protein is guided towards a 
low energy state. The folding reaction is often depicted as a folding funnel with many 









Figure 1.2 Folding energy funnel 
In folding funnel hypothesis protein folding starts at the top of the funnel, with an unfolded 
polypeptide chain, which contains a high degree of conformational freedom and energy. The 
folding reaction drives polypeptide chain lower, towards protein’s native state at the “bottom” of 
the funnel, also called the lowest energy state. 
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The further the folding reaction progresses towards an energy minimum the more 
ordered and stable conformational states are established, with the native state present 
at the “bottom” of the folding funnel. The shape of the folding funnel is different for all 
proteins. Small proteins may have a single energy barrier to pass between folded and 
unfolded state. More complex proteins may have multiple intermediate states, each 
inhabiting its own energy minima.   
 
The hydrophobic effect is often described as the main force thought to drive protein 
folding. This effect is a net force, made up of multiple interactions between the 
polypeptide chain and surrounding environment, leading to a burial of hydrophobic side 
chains caused by an increase in entropy of water molecules. 
 
For a water molecule it is more favourable to form hydrogen bonds with other molecules 
like itself rather than to interact with a non-polar, hydrophobic surface of a polypeptide 
chain. To balance for disrupting hydrogen bonds from avoiding unfavourable interactions 
with non-polar surfaces, water molecules form highly ordered hydration shell around 
hydrophobic surfaces of the protein (24). As a consequence of increasing favourable 
water interactions, the order of the system is increased significantly.   
 
1.3.1 Difference between α-helical membrane protein and soluble 
protein folding 
The folding funnel hypothesis is also used to describe membrane protein folding (7). 
However, unlike folding of soluble proteins, membrane protein folding is directly 
influenced by the properties of the lipid bilayer. During the first phases of α-helical 
membrane protein folding, translocon complex guides partially folded secondary 
structure into bilayer, where the final folding steps occur (25). Therefore, membrane 
protein folding starts further down the folding funnel than in soluble proteins, and is 
coupled with the process of membrane insertion. The final energy landscape of 
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membrane protein’s folding funnel, and therefore the energy minima and folding rate, are 
dependent on interactions with the translocon and mechanical properties of the lipid 
bilayer. 
 
1.3.2 The translocon mediated alpha helices insertion 
Before being functional the polypeptide chain must first fold itself by forming local 
secondary structures and long-distance tertiary structures. The formation of structure, 
either in the form of α-helix or β-barrel aids in lowering of the thermodynamic cost of 
membrane insertion. The cost is lowered by concealing unfavourable polar interactions 
in the centre of the protein, thus making the protein ever more stable, by keeping these 
interactions away from the hydrophobic tails of the membrane’s lipids (26). The initial 
folding steps occur within the channel of the translocon. It is thought that containing the 
peptide in a restricted space of the channel forces the hydrogen bonds to form 
interhelical connections before the newly formed helix is inserted into the membrane 
(27). The studies by Hessa et al. (28) with the in vitro expression systems provided much 
insight into the relationship between the character of the helix and the behaviour of the 
translocon. Specifically the idea of protein-lipid interactions driving the insertion of helix 
by the translocon. In the study, the efficiency of translocation was measured as the model 
helix was mutated to present a range of different amino acids. The study found that the 
insertion efficiency correlated with the Wimley–White whole residue hydrophobicity 
scale, where the hydrophobic residues were favoured by the membrane (29). Moreover, 
it was found that the efficiency of translocation is dependent on the position of the residue 
as well as its hydrophobicity. For example, the tryptophan containing helix was more 
likely to be inserted if the tryptophan residue was located at the end of the helix, where 
it would interact with the phospholipid head-groups. 
 
The Wimley–White model describes the likelihood of observing protein residues 
embedded in the membrane, based on the whole residue hydrophobicity scale, which 
correlates well with the experimental data (30). The scale was calculated by measuring 
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transfer of unfolded chains from water to the POPC interface and transfer of unfolded 
chains into octanol. This scale can be useful in predicting the membrane spanning helix 
structures. However, it does not take into account other factors, such as when the helix 
is inserted laterally into the membrane it avoids interactions with the membrane interface 
(31). Moreover, different lipid compositions or stabilising effects of the tertiary structure 
are also not taken into the account (32).  
 
Although, the Wimley–White model correlates well with the probability of finding residues 
in the membrane, protein insertion is not governed by the hydrophobicity scale alone. 
These scales are useful in predicting the helix structures, however they do not take into 
account other factors such as when the helix is inserted laterally into the membrane, 
where it avoids interactions with the membrane interface (33). Moreover, different lipid 
compositions or the stabilising effects of the tertiary structure are also not taken into the 
account (34). 
 
1.3.3 Membrane protein synthesis in vivo 
Alpha-helical membrane protein synthesis and membrane integration are thought to be 
primarily executed by a partnership between the translating ribosome and the translocon 
complex (35). These complexes are therefore linked with the in vivo folding steps that 
assist the protein to assume the correct fold and localization within the crowded and 
complex cell environment.  
 
The organisation of the protein into the membrane is believed to be mediated by the 
degree of hydrophobicity of the peptide and the attached signal peptide (36). In 
eukaryotes, the process is located near the endoplasmic reticulum and executed by the 
heterotrimeric Sec61 complex (37). Alternatively, the bacteria possess the homologous 
SecYEG and accessory proteins that make up the bacterial holo-translocon 
supercomplex (38). Both the high resolution x-ray crystal structures and electron 
cryomicroscopy show much of the translocon structure at different times of the 
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translocation process (39, 40). The results show that to partake in the translocation 
process both eukaryotic and bacterial translocons undergo a tetramer formation, 
arranged as two dimers coupled together. However, disulphide cross-linking 
experiments (41) suggest that only one translocon complex facilitates the peptide 
translocation at one time.  
 
During membrane protein synthesis the cell uses two pathways of the insertion by the 
translocon. In a co-translational pathway the ribosome with the nascent peptide chain 
complex displays its hydrophobic signal recognition particle (SRP) recognition sequence, 
spanning the length of approximately 20 amino acids at the N-terminus of the peptide 
(42). Once the SRP recognises the recognition sequence, the process of translation is 
halted until the ribosome is docked with the translocon. At the site of the translocon, the 
SRP receptor binds to the SRP molecule removing it from the ribosome-peptide complex 
and subsequently transfers the peptide into the translocon to resume peptide translation 
within the complex. The secretory proteins pass through the translocon to cross the 
membrane (43). The sequence that identifies the proteins as membrane bound is 
unknown, but it is thought to be associated with the degree of hydrophobicity.  
 
An alternative post-translational process starts with already translated protein. In 
bacteria, newly translated proteins are coupled to SecB and delivered to SecA 
chaperone. Using ATP hydrolysis, SecA transfers the protein through the translocon 
using ATP-mediated conformational changes (44). The majority of secreted proteins are 
directed through the post-translational pathway. In eukaryotes the Sec62/63 complex is 
used to couple the protein with the translocon. Before being functional the polypeptide 
chain must first become folded by forming local secondary structures and long-distance 
tertiary structures that are arranged in the membrane and are described as the protein’s 




1.3.4 Membrane protein topology 
Before the protein assumes its final structure the helices need to arrange themselves in 
the correct orientation in relation to the membrane. The translocon is thought to take part 
in determining protein topology, when the peptide interacts with the lateral gate of the 
translocon complex. Subsequently, when the membrane helices are inserted into the 
membrane the final folding step occurs, and the protein assumes its native tertiary 
contacts. 
 
The information that decides the membrane protein topology is coded in the amino acid 
sequences and depends on a number of factors (45, 46). Amino acid residues bearing a 
positive charge, according to observations of the positive-inside rule (15), are more 
frequently found on the cytoplasmic side of the membrane. It is possible that these 
residues are not only guided by the proton gradient across the membrane, but also 
interact with the translocon itself (47). The scale of residue hydrophobicity is also a key 
factor in determining the topology. The hydrophobic residues will find their suitable 
positions within the segments of the membrane so that the net thermodynamic cost of 
inserting helices is satisfied. Moreover, the lipid structure and membrane composition 
will act as key determinants, which fine tune the protein structure during and after the 
insertion (48, 49). Post or co-translational modifications, such as glycosylation, may also 
influence protein topology (50). 
 
In the end, the structure of the helices may depend on interactions with other 
neighbouring helices (51). The general belief that transmembrane helices are inserted 
into the membrane in the same sequential order as they are translated by the ribosome 
could only be applicable to few proteins. The cross-linking studies of aquaporin 4 
insertion (52) have shown that some helices would be first integrated into the membrane 





1.3.5 Models of protein folding 
The problem of biological macromolecule folding is thought to be one of the most difficult 
challenges of modern biophysical research. Among thousands of possible conformations 
proteins are able to assume a unique stable structure in a shorter time than that which 
is required to test all possible orientations by trial and error (53). Therefore, it is likely 
that protein folding is governed by a set of rules and restrictions that guide the entire 
process. Many models were proposed to describe the process of folding α-helices within 
the membrane.  
 
The two step model, developed by Popot and Engleman in 1990 (54), states that first, 
helices are formed as independent, self-assembling units across the lipid membrane, 
followed by inter-helical interactions that form the tertiary structure. The observations of 
bacteriorhodopsin being able to refold from the independently stable units seem to 
confirm the properties of a single helix acting as an independent unit (55, 56). Although 
the model does not include additional phenomena such as cooperative folding in large 
multi-domain proteins, it does provide a fundamental principle that can be used to 
develop other more complex models, which take additional phenomena into account. 
 
The third stage to a two-step model was introduced by Jacobs and White in 2003, to 
incorporate additional events occurring after the helices self-associate. The folding of 
certain proteins may involve extra steps such as: binding of cofactors, folding of loops 
and insertion of extra polypeptides into the membrane (57). The extra events add 
complexity to the three stage model, however structural studies have observed the 
presence of many folds that cannot be explained by a two or three stage model. In order 
to address these observations, the four stage thermodynamic model (26) was 
introduced. It represents the combined arguments of Popot-Engelman’s two stage and 
Jacobs-White three step models to describe protein folding in terms of: 
-Insertion of the unfolded peptide into the membrane interface; 
-Folding of the helix at the interface; 
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-Insertion of the pre-folded helix; 
-The association of multiple helices into tertiary structure. 
Like other models, the four step model does not account for cascades of smaller steps 
that make up the folding process nor the final collapse, which finalises the folding of the 
secondary and tertiary structures (58, 59). 
 
1.3.6 Common motifs in membrane protein structure 
Common motifs and peptide sequences have been identified in order to compose a set 
of features that aid in maintaining protein stability. Many of these motifs are only 
applicable to few proteins, while others are more wide spread, such as the stretches of 
subsequent hydrophobic residues that were proven to be good indicators of 
transmembrane domains. Other motifs like, the GxxxG motif, were identified by Russ 
and Engelman (60) as the most common arrangement of residues in transmembrane 
helices. The motif describes spacings of glycine (GxxxG) and alanine (the AxxxA motif), 
resulting in an arrangement of small residues on a single side of the helix. Over 50% of 
α-helices displaying the GxxxG motif participate in helix-helix interactions (61). The small 
residues create cavities into which the larger residues can fit, increasing the 
compactness of the protein as well as increasing protein stability through the exclusion 
of water and promoting the Van der Waal interactions. This ‘’knobs-into-holes’’ concept 
encourages strong helix-helix interactions, but has also been implicated in the function 
and targeting of transmembrane proteins (62, 63).  
 
The membrane spanning sequences are dominantly hydrophobic. However, the 
occurrence of polar resides, such as asparagine, through which strong intermolecular 
bonding can be used to drive inter-helical formations (64), as well as to participate in 
water interactions. Aromatic compounds, such as tryptophan and tyrosine, can also be 
used to a similar extent to elicit helix oligomerisation, as well as promote interactions with 




Although the recognition of common motifs, such as amino acid sequence, may be used 
in prediction of the secondary and tertiary structures, the lipid membrane also needs to 
be taken into account as a major factor which influences protein structures. The property 
of the lipids within the membrane could be used to locally favour one conformation over 
another. For example, the short chain lipids may force the helix to tilt in order to bury its 
hydrophobic residues in the centre of membrane. 
 
1.4 Membrane composition 
The two basic components of biological cell membranes are lipids and proteins. The 
lipids maintain one of the most basic functions, which is to act as a barrier between the 
environment surrounding the cell and the cell’s organelles. The difference between the 
two environments allows for the formation of electric and chemical concentration 
gradients that drive many of the functions of the cell. Furthermore, membranes are 
involved in cell communication. They facilitate cell motility as well as provide surface for 
adhesion of other protein structural components, like cytoskeleton and extracellular 














Figure 1.3 Schematic of biological membrane 
The fluid mosaic model of a cell membrane presents lipids self-assembling into two leaflets with 
hydrophobic lipid tails facing inwards. Proteins can be found either within the membrane (integral 
proteins) or associated with the membrane surface (peripheral proteins). The cytoskeleton links 
the membrane to other cell organelles. Cholesterol is found in the centre of the membrane, 
contributing to the membranes physical properties. Carbohydrates are found bound to lipids 
(glycolipids) or proteins (glycoproteins) participating in cell adhesion and tagging. The figure is 
adapted from (68). 
 
1.4.1 Membrane lipids 
The diversity of membrane function is mirrored by the diversity of its constituents. A 
number of lipids make up the bilayer. The three major types of lipids are phospholipids, 
glycolipids and sterols (69). Phospholipids form the majority of all cell membranes. Their 
structure varies by their head groups as well as length and saturation of their acyl chains. 
The composition and the structural variety of lipids confer the membrane properties such 
as the degree of elasticity, fluidity and lateral pressure (70). The phospholipids can be 
found with one or more carbohydrate groups attached to the head group in the outer 
leaflet of the bilayer. Cholesterol, present in only eukaryotic cell membranes, maintains 
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the structure and fluidity of the membrane and is present to a varying degree in tissues 
of all animal cells (71). The function of lipids is not limited to providing structure to the 
cell membrane, but they also may act as an energy storage and act in cell signalling (72). 
 
The lipid bilayer is a very dynamic part of the cell that constantly adapts itself in response 
to the outside environment and the presence of membrane proteins (73). The most 
common types of lipids found in eukaryotic cell membranes are phosphatidylserine (PS), 
phosphatidylcholine (PC), phosphatidylethanolamines (PE) and sphingomyelin (SM), as 
well cholesterol. The chemical structures of various membrane constituents can be seen 
in figure 1.4. In comparison, the cholesterol is present in only small amounts in the 
membranes of mitochondria and endoplasmic reticulum organelles (71). More primordial 
cell membranes, such as in gram negative bacteria E.coli, are rich with PE, but lack 
cholesterol. Furthermore, the inner membrane of gram negative bacteria is mostly made 
out of PE with the addition of phosphatidylglycerol (PG) and cardiolipin, whereas the 
outer membrane is composed mainly of lipopolysaccharides. 
 
Lipid self-assembly in an aqueous environment is driven by the amphipathic character 
of the lipid molecules. The hydrophobic effect compels the acyl chains of lipids to come 
together, while exposing the hydrophilic head groups. The structures that satisfy the 
hydrophobic effect reduce their unfavourable contacts between the acyl chains and water 
by assuming one of the different mesophases, such as: lamellar, cubic, hexagonal, and 
micellar. Both the environment and the chemical structure of the lipids dictate into what 
phase they will self-assemble. The state of the lamellar phase or its fluidity depends on 
the temperature and is influenced by the acyl chain saturation and length as well as the 
type of the polar head group. As the temperature decreases the fluid phase changes first 
to a gel phase and then to a liquid crystalline phase (71). As the hydrophobic forces keep 
both layers flat in the bilayer, the curvature-increasing lipids tend to increase the lateral 





Figure 1.4 Structures of phospholipids and cholesterol 
The structure of an un-saturated phospholipid, PE, is seen in panel A. The alternative lipid without 
a kink with saturated acyl chain is shown in B. The four common phospholipid headgroups are 
listed as C – phosphatidylglycerol (PG), D – phosphatidylserine (PS) E – phosphatidylinositol (PI) 
and F – phosphatidylcholine (PC). The component of the lipid bilayer, cholesterol can be seen in 
panel G. Figures were created in Chemdraw software PerkinElmer Informatics 
(http://www.cambridesoft.com). 
 
1.4.2 Studying membrane proteins in vitro 
A growing number of in vitro studies concerned with membrane proteins seek to mimic 
the in vivo processes and report the key influence of the lipid composition on the protein 
behaviour and structure (75 - 77). For example, examination of PE-deficient E.coli strains 
have shown that the orientation of lactose permease transporter (LacY) is PE dependent. 
When PE is absent, the N-terminal part of the protein was found inverted. Re-introduction 
of PE into the membrane restored the correct orientation of LacY (78). Consequently, 
when describing the properties of membrane proteins, it is beneficial to include the 
19 
 
effects of the membrane on the studied protein, since both the structure and behaviour 
of the protein can be heavily dependent on the composition of the membrane. 
 
The complexity of the plasma membrane environment is difficult to reproduce and makes 
the biophysical measurements very difficult. Several biomimetic systems exist that allow 
studying of proteins in in vitro systems; these include lipid monolayers, bilayers and lipid 
vesicles (79). The fundamental property of these systems is the solubilising unit that 
enables the protein to assume its native structure. Later, the composition of the system 
is modified by addition of more solubilising components or other folding co-factors. Once 
the membrane protein is isolated and solubilised it often becomes unstable and tends to 
aggregate in the solution. A variety of solubilisation methods and chemicals were 
developed to address the issues of membrane protein solubilisation and the ability of the 
experimental in vitro system to mimic the environment of the cell. 
 
1.4.3 Detergents and lipid systems 
Detergents are amphiphilic chemicals that are commonly used in membrane protein 
purification. They are composed of both hydrophilic and hydrophobic groups that 
together close the gap between the two different environments. The polar head group 
interacts with the aqueous environment, while the hydrophobic tails orient themselves 
towards apolar conditions. In an aqueous environment the detergent molecules bury their 
hydrophobic tails by assembling into micelles. Micelle formation is concentration 
dependent and to successfully observe micelles the concentration of detergent needs to 
be kept above the critical micelle concentration (CMC), which is specific for each different 
detergent. Below the CMC, the detergent molecules are still soluble, but persist as 
monomers. To solubilise the membrane protein a concentration greater than the 
detergent’s CMC is used (80). The micelle then forms around the protein mediating the 





The choice of the right detergent can be important, as the conditions of the purification 
and the experiment may differ. The right balance needs to be found to choose a 
detergent in which the protein is stable, while at the same time remains active (81). 
Certain detergents force the protein to adopt a new conformation that is similar to the 
native fold, but through either formation of new contacts or occlusion of the active site, 
renders it unable to retain functionality (82). Both size and shape of the micelle depends 
on the detergent forming it. In the detergent-protein complex, the micelle will change its 
shape and size in order to protect hydrophobic stretches of the protein from aqueous 
solution.  
 
Detergents can be classified into four groups based on their structure. The ionic 
detergents, such as sodium dodecyl sulphate (SDS), are excellent at solubilising the 
protein, but at the same time often result in denaturing the protein to some extent. The 
SDS-denatured protein can sometimes be refolded by a transfer to a more favourable 
detergent system. Bile acid salts, such as sodium deoxycholate, are structurally related 
to cholesterol and are considered as mild detergents, seldom deactivating the protein 
(80). Nonionic detergents, DDM, are mild and non-denaturing, however short chain 
hydrophobic tails tend to result in a loss of protein functionality. Zwitterionic detergents, 
such as CHAPS, combine both positive and negative charges. They are favoured for 
structural studies, as they are less deactivating than nonionic detergents (80).  Examples 







Figure 1.5 Comparison of detergent structures 
The structures of four different types of detergents: ionic, nonionic, zwitterionic and bile acids are 
shown above. Figures created in Chemdraw software PerkinElmer Informatics 
(http://www.cambridesoft.com). 
 
Although detergents are successful at solubilising membrane proteins and aiding in their 
purification they do not mimic the complexity of the plasma membrane. However, certain 
structural studies require the system to remain simple.  
 
The importance of studying membrane proteins is reflected by the focus on developing 
solubilising systems that mimic some of the membranes properties. One such type of 
systems are nanodisc structures, which utilise a small lipid bilayer, surrounded by the 
scaffolding protein ‘’belt’’ that protects the lipid chains (83). A new system employing 
styrene–maleic acid copolymers (SMAs) instead of scaffolding proteins was used to 
purify membrane proteins directly from their lipid environment in soluble nanodiscs (84). 
Alternatively, the proteins can be solubilised using amphipathic polymers called 




The ever growing diversity and size of the artificial membrane protein solubilisation 
systems shows the intrinsic tolerance of membrane proteins to the chemical character 
of solubilising agents. Whether it is via detergent, peptide or native lipid, the membrane 
protein is able to maintain the majority of its secondary contacts, as the results from 
different model systems can be similar to each other (87, 88). Moreover, this tolerance 
is preserved across different domains of life as an evolutionary advantage that allows 
organisms to alter their lipid composition of membranes according to the environment 
they are challenged with (6). However, the importance of lipid-protein interactions cannot 
be ignored, as the native membrane environment is used to modulate protein 
functionality and location through dynamic cell-specific variations. 
 
1.5 Major facilitator superfamily 
Most studies are focused on small, single domain proteins that are relatively easy to 
purify and study (79). Focusing the studies on a single family gives the benefit of 
uncovering some shared principles behind membrane protein folding. Moreover, 
studying the large multi-domain proteins gives the opportunity of investigating 
interactions between different domains and their shared contribution to the stability of 
the protein. In the case of the family of transporters, the relationship between these 
domains also drives the transportation function of these proteins, giving an insight into 
the function-fold relationship. 
 
The major facilitator superfamily (MFS) is one of the largest known families of structurally 
related secondary transporters observed both in eukaryotes and prokaryotes. A quarter 
of all transporters within the cell are in the major facilitator superfamily (89). They are 
known to facilitate the transport of a wide range of substrates, including: ions, drugs, 
sugar phosphates, amino acids, peptides and nucleosides (90). In this thesis a member 
of the MFS family, GlpT, is investigated. Its stability and functionality, as well as the 
influence of the two domains on the protein structure are discussed and compared to the 
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other known and studied members of the same family. The two examples of the E.coli 
MFS transporters, whose stability was previously investigated, are the lactose permease 
(LacY, 91) and galactose transporter (GalP, 92). The answer as to whether or not these 
domains exist and fold independently of each other or rather cooperatively fold and 
assemble in vivo will also help in shaping the understanding of their mechanism of 
transportation. Most of the previous research into MFS transporters was related to their 
substrate selectivity and mode of transport. However, little is known about the MFS 
conformational stability in vitro.  
 
1.5.1 MFS structure 
Regardless of low sequence similarity, structures of all resolved MFS transporters share 
a similar structure of 12 transmembrane α-helices, which are split into 2 domains, with 
an aqueous cavity located between the two domains (93). It is also believed that most 
MFS transporters share the same rocker-type switch mechanism of transport (94). Some 
transporters from the MFS family have an additional 2 transmembrane helices, for 
example transporter PepT. The function of the extra helices is not known, but is thought 
to serve functions other than transport (95). 
 
The first structure of an MFS transporter to be resolved was lactose permease (LacY) 
(96) in 2003. This was soon followed by the structure of the glycerol-3-phosphate 
transporter GlpT (97), and by the multidrug transporter EmrD (98), the fructose 
transporter FucP (99) and the xylose transporter XylE (100). Since 2011, 15 more 
structures of MFS transporters were solved, those include human glucose transporter 
GLUT1 (101, 102). All of the resolved structures show 12 transmembrane α-helices 
arranged in characteristic two domains, enveloping the central cavity responsible for 






Figure 1.6 Examples of researched members of the MFS transporters 
XylE, above, is in an outward-facing and partially occluded conformation (4GBZ, 100, Uniprot: 
P0AGF4, 23% identity and 39% similarity, 4.11 RMSD, 1110.14 Z-score with GlpT), LacY is in an 
inward facing conformation (2CFQ, 104, Uniprot: P02920, 20% identity and 38% similarity, 3.80 
RMSD, 1300.66 Z-score with GlpT), EmrD is in an intermediate state (2GFP, 98, Uniprot: P31442, 
23% identity and 37% similarity, 3.57 RMSD,  335.42 Z-score with GlpT) and GlpT is in an inward 
facing conformation (1PW4, 97, Uniprot: P08194).  Structures were rendered in PyMOL software. 
Analysis of sequence alignment (similarity and identity) was done in RCSB PDB Protein 
Comparison Tool (105) with Needleman-Wunsch sequence alignment method (106). Analysis of 
structure alignment (RMSD and Z-score was also performed in RCSB PDB Protein Comparison 






The genetic sequence research (95) provided evidence of the MFS structure origin. It is 
thought that the MFS structure similarity did not arise from an early triplication event of 
two transmembrane helices, but rather the duplication of three helices, which gave rise 
to six helical bundles. Through an additional gene duplication event, two six helical 
bundles gave the MFS characteristic structure of six helices arranged in two structurally 
similar symmetrical domains.  According to the IUBMB-approved Transporter 
Classification Database (103), there are 74 distinct major facilitator transporter families 
within the superfamily. In addition, each transporter has its own set of substrates. Out of 
the 74 families, 17 are not functionally characterized yet. The diversity of substrates 
transported by MFS is thought to have arisen from a common precursor from which 
additional substrate selectiveness was incorporated through mutations. Subsequent 
genetic events, resulting in frequent domain swapping between different members of the 
MFS families, have led to the substrate diversity currently observed within these 
transporters. 
 
The diversity of a family as big as MFS relates to their importance in viability of the cell. 
It is therefore not surprising that the disorders targeting MFS transporters were found to 
contribute to several diseases. The examples include an organic anion transporter 
causing renal failure through harmful accumulation of indoxyl sulphate (108), mutations 
in peptide transporter (PepT) leading to inflammatory bowel disease (109) and glucose 
transporters (GLUT family) associated with type 2 diabetes and cancer (110). 
Unfortunately, the technical issues associated with studying membrane proteins have 
made characterisation of many disease-implicated transporters unattainable. 
Furthermore, the ubiquitous expression of mammalian MFS proteins is further 
complicated by an inherent instability of these proteins in in vitro conditions, as well as 
the need for post-translational modifications required for their function. The already 
mentioned conservation of structure seen in MFS transporters allows for predictions of 
the unresolved mammalian structures by choosing a close bacterial homologue template 
of known structure in order to identify possible protein folds through homology modelling. 
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Both LacY and GlpT were used many times as model transporters to predict the structure 
of physiologically important mammalian proteins, such as the glucose 6-phosphate 
transporter, G6PT (111), or GLUT1 (98, 112) 
 
The function, variety and size of MFS transporters highlights the importance of their 
contribution to mammalian physiology. Studies that improve the understanding of the 
MFS proteins help to uncover the identity of unclassified transporters, as well as their 
input into debilitating conditions. Moreover, expanding the folding and stability 
knowledge of similar proteins within the same family has the benefit of uncovering shared 
behaviour and trends that contribute to their stability and folding pathway (113). 
 
1.5.2 MFS mechanism of transport 
All members of the MFS family are thought to share a common mechanism of transport 
based on the high degree of shared structural homology. The most supported model for 
an MFS transport is through the mechanism of alternating access, also called the rocker-
switch (114). This mechanism is based on structural conformations induced by ligand 
binding. Diagram of the mechanism can be seen in figure 1.7. 
 
First, the aqueous binding pocket is exposed to one side of the membrane, allowing the 
substrate to interact with the residues located in the binding pocket. Ligand binding 
induces the shift of the two domains, leading to two events. The previously open side of 
the pore closes with hydrophobic residues blocking the substrate withdrawal. At the 
same time, the second side of the membrane opens, exposing the binding pocket to the 
aqueous media (115). The inversion of the protein structure during the rocker-switch 
cycle involves breaking and formation of several salt bridges as shown in LacY (116) 
and GlpT (117). However, as the crystal structures show, the arrangement of helices 
remains mainly undisturbed (118).  The ligand is released, the transporter returns to its 
original confirmation and the cycle is repeated. The main support of the alternating 
access model comes from crystal structures of the transporters themselves. Further 
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evidence comes from the deactivation (117, 119, and 120) and cross-linking mutation 









Figure 1.7 Schematic representation of GlpT rocker-switch mechanism of transport. 
The transport cycle shows inward-facing and outward-facing conformations of GlpT as it 
transports a G3P molecule from periplasmic environment to cytoplasm in exchange for a 
phosphate molecule. The mechanism involves a reversible conformational switch occurring upon 
G3P binding leading to inversion of the protein structure. The helices are numbered sequentially 
from the N-terminal end. 
 
1.5.3 GalP 
GalP is a proton-galactose transporter in the MFS and its expression is readily induced 
in E.coli. Both equilibrium unfolding and refolding curves were established in the DDM-
solubilised protein with the free energy of the folding reaction calculated (124). The 
protein refolding was assayed by both return of the secondary structure and the return 
of effective substrate binding. Approximately one third of the protein structure was lost 
when the protein was denatured with 8 M urea. The kinetic measurements of GalP 
unfolding have shown a single exponential trend of unfolding, supporting the two state 
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unfolding mechanism. Moreover, the GalP stability was investigated under varying lipid 
compositions, which showed that refolding was more efficient when reconstituted directly 
into lipid vesicles, rather than in DDM micelles. However, the return of the helicity was 
not related to the return of the original transport activity, compared with the folded 
reconstituted protein. This suggests the helical packing not returning to the native state 
is subsequently affecting the transport efficiency.  
 
1.5.4 LacY 
LacY is one of the most studied members of the MFS. It facilitates the transport of 
galactopyranosides by using a negative proton gradient. The structure of LacY was 
successfully unfolded and refolded in the DDM micelles, with binding of the NPG (p-
nitrophenyl α-d-galactopyranoside) ligand returning upon refolding, measured via ITC 
and the return of secondary structure, measured by far-UV CD (125). The structure of 
LacY was shown to be very dynamic with a fast rate of hydrogen\deuterium exchange 
achieving 90% of labelling in less than 5 minutes (96). The high rate and extent of 
deuterium labelling could also be an indication of unfolding process in the sample. LacY 
has a high tolerance to mutations with only 6 residues being irreplaceable for the 
successful transport function. An experiment in which, a series of single-Trp mutants of 
LacY were analysed in a urea denaturing assay, has found an increased stability of the 
first helix of the LacY’s first domain, compared to the rest of the protein. It was therefore 
proposed that a stable helix 1 could aid in the process of membrane insertion (126). 
 
1.5.5 GlpT 
The glycerol-3-phosphate transporter is a novel protein to include in the studies of the 
MFS transporters. Compared to the LacY and GalP, GlpT is a much larger transporter 
that facilitates transport via an exchange of two substrates. The structural similarities 
between these transporters help to draw attention to a common folding pathway and 
sources of potential stability. Glycerol-3-phosphate transporter (GlpT) shares 90% of 
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sequence similarity with LacY. Stability and composition of the GlpT and its helices has 
already been studied via molecular dynamics simulations and mechanical denaturation 
(127, 128) giving context to the chemical stability measurements discussed in this thesis.  
 
Homologue transporters related to GlpT are widely spread and are found in bacteria, 
eukaryotes, plants and humans (129). Several studies on the function of MFS 
transporters have highlighted GlpT as a structural and functional model of the MFS 
family, along with LacY (59, 94, 118 - 122). The common topology of MFS transporters 
is also found in GlpT. The two domains are only limited in their relative movement to a 
few hydrogen bonds that exist in the interface between the domains made by helices 1 
and 7 (97). The overall native structure of GlpT is therefore easily adaptable and flexible 
enough to facilitate transport via alternating access.  
 
1.5.6 GlpT binding and function 
GlpT is located in the inner membrane of E.coli, where it facilitates uptake of glycerol-3-
phosphate (G3P) in exchange for inorganic phosphate (Pi). G3P acts as a substrate for 
glycerophospholipids, the main component of the membrane. (119). In the absence of 
other substrates, G3P may serve as a source of carbon and energy for E.coli (130). It is 
thought that Pi binding on the cytoplasmic side induces the conformational change that 
opens the transporter to the periplasmic side. Replacement of Pi with G3P, on the 
periplasmic side, causes the transporter to revert to the original cytoplasm open state. In 
the absence of G3P, GlpT is still able to mediate exchange of Pi across the membrane 
(117). The two arginine residues, R45 and R269, which line the central pore, display a 
strong positive charge, which mediates binding to the GlpT substrates. Additional 
residues K80 and H165 have also been found to have a role in stabilising the phosphate 
moiety of G3P or Pi (119, 131). Residues Y38, Y42, Y76, Y266 and Y393 are also 
involved in transport, but do not interact with ligands directly. Instead, they are important 




1.5.7 GlpT in disease 
The G3P molecule was found to take part in metabolic control of low density lipoprotein. 
It is also an important precursor to lipid synthesis in eukaryotes (130). In the glycerol 
phosphate shuttle system, G3P is used to protonate NAD+ at the inner membrane of 
mitochondria (132). The SLC37A1 protein is believed to be a human equivalent of 
glycerol-3-phosphate transporter (133). The SLC37A1 gene is widely expressed in all 
tissues, with a higher rate of expression in kidney, bone marrow and liver. It has also 
been found to be upregulated in breast cancer and endometrial cancer cells. An 
increased phospholipid biosynthesis due to SLC37A1 gene upregulation in cancer was 
proposed to drive tumour proliferation (134). Furthermore, GlpT, along with the hexose 
phosphate transporter (UhpT), was found to facilitate transport of antibiotic 
phosphomycin (135). The inactivation of the GlpT gene results in a significant increase 
in phosphomycin resistance in Pseudomonas aeruginosa, which is responsible for 
nosocomial outbreaks in cystic fibrosis (22). 
 
1.6 Differences in helix stability 
Transporters within the MFS family share topology of 12 transmembrane helices found 
between two domains. Studies performed on LacY (125) suggest that, certain protein 
regions show increased stability and may also possess a functional role in the process 
of folding of the MFS proteins. It is believed that the structure of the first helix of the first 
domain shows increased stability when compared to the remainder of the protein (136, 
137). The process that leads unfolded protein towards the folded and functional structure 
is driven by forces that influence the interactions between amino acids towards the lower 
energy state. In order to probe the individual contributions of amino acids in the folding 
process, an alanine scan methodology is implemented and discussed in this work (138).  
 
The measured change in the free energy upon the substitution mutation is composed of 
several components and can be interpreted as missing covalent interactions, 
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rearrangement of hydrogen bonds, changes in solvation energy, non-covalent 
interactions and changes in any additional energy terms caused by rearrangement of 
protein structure (139). The experiments described in chapter 4 are designed around the 
alanine scan methodology and are based on the similarity of environments between two 
chosen mutation sites on two similar helices, in order to cancel any extra energetic terms 
and make the analysis of energy differences simpler. Each mutation on helix 1 will have 
its corresponding second mutation located on helix 7, the first helix of the second domain. 
Like in all MFS proteins, the two domains structurally resemble each other. This second 
mutation will be selected based on a similar amino acid substitution change as well as a 
similar electrostatic environment to its respective pair. As a result, both helices will be 
subjected to a similar series of mutations, where possible, based on the mutation position 
and immediate environment of mutated residue. 
 
1.6.1 Alanine substitutions 
Systematic substitutions of amino acids to alanine residues are used to estimate the 
individual contributions of the targeted residues to the protein stability and functionality 
(140). Although alanine scanning is employed widely in the analysis of soluble proteins, 
membrane proteins have lagged behind due to their low expression and complications 
arising from methods of solubilisation. Moreover, the final membrane protein structure 
and function are affected by the micelle environment, as well as alanine substitutions. 
Therefore, the use of alanine substitution method requires understanding how a 
substitution mutation has affected the structure of protein and protein-micelle complex. 
However, this method can be used to quickly generate a series of mutations, targeting 
protein regions of interest. Unless, combined with another method, the results are 
missing any structural information and only relate to general change of protein function 
or stability. The method is most useful when applied in a high-throughput screen. In this 
approach, through targeting and elimination of molecular contacts, functional binding 





Frequently, studies employing alanine mutations have focused on site-specific, non-
conservative substitutions of charged amino acids in order to assay the role of these 
residues in the protein function. An example of alanine scanning methodology can be 
seen in a systematic substitution of charged residues on the surface of the epithelial 
sodium channel (142). The mutations identified sites that are responsible for modulating 
channel conductance and are also essential for the transport of proteins to the cell 
surface. Other examples involve the use of alanine mutations to determine specificity of 
α3β4 nicotinic acetylcholine receptor (143), determination of functional epitope of 
phosphatase type 1 in Saccharomyces cerevisiae (144), contributions of the salt bridges 
to activity of Pseudomonas aeruginosa elastase (145), as well as in protein folding (126, 
137). The final analysis step is time consuming, as each alanine mutation needs to be 
assayed for potential change in the protein fold due to the mutation. Furthermore the 
folding pathway needs to be investigated by the unfolding and refolding assays. 
 
1.7 Aims of the project 
A recent study on the MFS transporter LacY (125) has implied an increased stability 
localized to the vicinity of the first helix of the protein. If this trend is extended to other 
membrane proteins it could suggest a folding characteristic of the integral membrane 
proteins, where the first helix may aid in cellular events, such as integration of the protein 
into the membrane. 
 
The aim of this study is to examine the difference in stability between different helices of 
GlpT. This will be done by identifying whether or not the first helix shares the same 
stability as the first helix of the second domain, helix 7.  The folding of GlpT is investigated 
by the combined measurements of fluorescence and circular dichroism spectroscopies 
during urea, GuHCl and thermal denaturation. The available crystal structure of GlpT 




The urea-induced unfolding was found to be reversible in both GalP and LacY. Chapter 
3 will assess the extent of GlpT unfolding and its ability to refold, as well as the 
development of the substrate binding assay that will later determine the return of 
transporter functionality upon refolding of the chemically denatured state. Chapter 3 also 
focuses on the single-Trp variants of GlpT, as well as the design and function of the 
double rhodamine labelled GlpT and whether they can be used as molecular reporters 
of unfolding. 
 
As the suitability of GlpT to the unfolding study is established, the main hypothesis of the 
GlpT’s helix 1 stability is approached in chapter 4. The main narrative of chapter 4 is 
focused around the consecutive alanine substitutions of amino acids located on helix 1 
and 7. The effect of each mutation on stability is then compared against WT and similar 
mutations on helix 7. As a result, both helices are subjected to a similar series of 
mutations, based on the mutation position and immediate environment of mutated 
residue. Any differences in stability between related helices would highlight complex 
environment in this membrane protein, as well as show likeness to another protein, LacY 
in the same MFS superfamily. 
 
This thesis will show that through multi-approach techniques of probing the protein 
behavior it is possible to gain further insight into the stability of a multi-domain membrane 
proteins. Use of single alanine substitution analysis in measuring the differences in 
unfolding of different parts of GlpT will be discussed.  The importance of binding pocket 

















Chapter 2  





The majority of the reagents used were supplied by either Sigma-Aldrich or Fisher 
Scientific UK Ltd, with the exception of the following: 
Detergent DDM (n-Dodecyl-β-D-maltopyranoside) obtained from Anatrace, Amicon spin 
concentrators obtained from Millipore, mGelRed, obtained from Biotium and The Quick 
Coomassie Stain obtained from Generon 
 
2.2 Buffers and media 
Luria-Bertani (LB) media was prepared by dissolving the following pre-mixed 
components in deionised water: 0.5 % (w/v) yeast extract, 1 % (w/v) bactotryptone and 
0.5 % (w/v) NaCl pH 7.4 (1 L of LB was used for protein purification, 5 ml for DNA 
purification and 100 ml for overnight cultures). All media were then autoclaved for 20 
minutes at 121 °C and 138 kPa. 
 
LB agar plates were prepared by adding 1.5 % (w/v) agar to LB medium before 
autoclaving. Colony selection was achieved by adding kanamycin to the cooled molten 
agar to a final concentration of 30 μg/ml, unless stated otherwise. 
 
In all the unfolding, refolding and ligand binding experiments the same assay buffer was 
used, except for temperature-induced protein denaturation. The standard assay buffer 
was prepared by dissolving 0.05 % (w/v) DDM and 2 mM β-mercaptoethanol in 50 mM 
Tris buffer at pH 7.4. Stock concentrations of GuHCl and ligands were also prepared in 
this buffer. GuHCl stocks were adjusted to pH 7.4. The temperature denaturation buffer 
solution used was identical to the assay buffer with the exception of the Tris buffer, which 




2.3 Plasmids and E.coli strains 
The GlpT gene used in this work was isolated and provided by Dr. Heather Findlay 
(King’s College London) by subcloning the mentioned gene from the E.coli genome into 
the later used vector. 
 
All the changes to the GlpT gene were done using plasmid pST-Blue-1 as a vector, later 
transformed into either commercially bought or grown in-house One Shot Top10 
Chemically Competent E.coli. The GlpT gene was cloned into the plasmid pET-28a, 
modified with a 10-His tag, and transformed into either commercially bought or grown in 
house One Shot BL-21-AI Chemically Competent E.coli for protein overexpression. All 
plasmids used conferred kanamycin resistance for product selection and were supplied 
from Novagen. Both strains of E.coli were purchased from Invitrogen Life Technologies. 
The competent cells grown in-house were made according to the Promega protocol 
described in section 2.4.3. 
 
2.4 Molecular biology 
Restriction endonucleases and their relevant buffers were purchased from New England 
Biolabs. All oligonucleotides used for mutagenesis were synthesised by Eurofins MWG 
Operon using high purity salt-free purification, and delivered in a lyophilised form. Pfu 
polymerase was used for all PCRs, and was obtained from either Thermo Fisher 
Scientific or Promega. Gene ruler 1 kb DNA ladder and DNA loading buffer were supplied 
by the Thermo Fisher Scientific. Diagnostic and preparative DNA electrophoresis was 
carried out in a 1 % agarose (w/v) gel made in either purchased or self-made TBE 
(Tris/Borate/EDTA) buffer (45 mM Tris-Borate, 1mM EDTA). The DNA staining was 
accomplished by either addition of ethidium bromide or GelRed (Biotium, Inc.). DNA 
images were visualised using Amersham Imager 600 using 520 nm excitation 
fluorescence mode. DNA sequencing was carried out by Eurofins MWG Operon using 
the Value Read service. Concentration and quality of DNA purification was determined 
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using NanoVue Plus™ Spectrophotometer (GE Healthcare). Presence of RNA and 
protein impurities was estimated by recording OD260 /OD280 and OD260 /OD230 ratios, 
respectively.  
 
The following commercially available kits were used for DNA purification, and used 
according to the manufacturer’s instructions: 
 
QIAprep Spin Miniprep Kit                               Qiagen 
QIAprep Spin Midiprep Kit                               Qiagen 
QIAquick Gel Extraction Kit                   Qiagen 
GeneJET Plasmid Miniprep Kit                   Thermo Ficher Scientific 
 
2.4.1 QuickChange mutagenesis 
All site-directed mutations with the exception of V43A, L268A and L44A were introduced 
using QuikChange PCR protocol in pST-Blue-1 plasmid using an Arktik™ Thermal 
Cycler (Thermo Fisher). PCR reactions were optimised by varying the amount of PCR 
template and the magnesium concentration. Primers and the individual PCR conditions 
can be found listed in the Appendix A. All PCRs contained the following reaction mixture: 
1 μl dNTPs (final concentration of 0.2 mM), 5 μl of 10x Pfu buffer 1 μl of Pfu polymerase, 
1.25 μl of both forward and reverse primer (final concentration 0.25 nmol/μl), 1 μl of 
DMSO (final concentration 2%), 1 μl of the GlpT gene template (final concentration 25-
50 ng/μl), varied concentration of MgSO4 (final concentration 1-4 mM), and molecular 
biology grade filtered water from Sigma Aldrich was added to volume of  50 μl. The PCR 
mixture was amplified in a thermocycler, starting with a 1 minute incubation at 95 °C to 
completely separate the double-stranded template. This was followed by 25-30 cycles of 
the following steps: 95 °C for 30 seconds, then by 30 s at the annealing temperature 
specific to the primers used, and then a final extension step at 12 minutes at 72 °C. For 
the I30A, I256A, L26A and L267A mutagenesis reactions a touch-down PCR was 
performed, where after every 5 cycles the annealing temperature was lowered by 2 °C, 
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starting from primer’s theoretical melting temperature. At the end of all the PCR reaction 
programs, samples were subjected to a final 12 minute extension step. The 
unmethylated PCR product was then selected by a 2 hour incubation at 37 °C with 1 μl 
DpnI restriction enzyme, to remove the template from the reaction.  
 
PCR product was analysed on the 1% agarose gel. The resulting gel presented a single 
band at 5.1 kb indicating amplification of the template with several less intense bands 
showing DpnI digestion fragments of the methylated template DNA. The PCR product of 
the right size was then excised and purified using QIAquick Gel Extraction Kit, and 
subsequently transformed into Top10 chemically competent E.coli using the usual 
transformation protocol. 
 
2.4.2 ‘Round the horn mutagenesis 
A variation of the standard mutagenesis protocol was used on less efficient mutation 
sites, where primer would bind non-specifically due to long repeats of a single nucleotide 
or a high predisposition to form dimers or secondary structure. Moore mutagenesis or 
‘Round the horn PCR, developed by S. Moore (https://openwetware.org/wiki/%27Round-
the-horn_site-directed_mutagenesis), makes use of different primer design, shown in 
Appendix A. Due to the later ligation step, primers used were first phosphorylated for 1 
hour at 37 °C in the following 50 μl reaction mixture: 5 μl 10X kinase reaction buffer, 1 μl 
50 mM MgSO4, 5 μl primer 10 μM final concentration), 1 μl of 100 mM ATP and 1 μl T4 
polynucleotide kinase. The reaction was then heat deactivated at 95 °C for 5 minutes.  
 
All ‘Round the horn PCR reactions contained the following: 1 μl dNTPs (final 
concentration of 0.2 mM), 5 μl of 10x Pfu buffer 1 μl of Pfu polymerase, 1.25 μl of both 
phosphorylated forward and reverse primers, (final concentration 0.25 nmol/μl), 1 μl of 
DMSO (final concentration 2%), 1 μl of the GlpT gene template (final concentration 25-
50 ng/μl); and varied concentration of MgSO4 (final concentration 1-4 mM). The 
remaining volume was completed by the molecular biology grade filtered water from 
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Sigma Aldrich to the volume of 50 μl. PCR mixture was amplified in a thermocycler, 
starting with a 1 minute incubation at 95 °C to completely separate the double-stranded 
template, followed by 25-30 cycles of melting temperature of 95 °C for 30 seconds. This 
was followed by a varied annealing temperature, depending on the reaction done for 30 
seconds and an extension time of 12 minutes at 72 °C. The PCR reaction was then 
subjected to the final 12 minutes extension step. The unmethylated PCR product was 
then selected by a 2 hour incubation at 37 °C with a 1 μl DpnI restriction enzyme.  
 
PCR product was analysed on the 1% agarose gel. The resulting gel presented a single 
band at 5.1 kb indicating amplification of the template with several less intense bands 
showing DpnI digestion fragments of the methylated template DNA. The PCR product of 
the right size was then excised and purified using QIAquick Gel Extraction Kit and 
subsequently used in an overnight ligation reaction completed at 16 °C containing the 
following: 3 μl of 10 x T4 DNA Ligase buffer, 1 μl of T4 DNA Ligase, 100 ng of the PCR 
product. Deionised water was then added to the solution to make the volume up to 30 
μl. Ligated product was the transformed into Top10 chemically competent E.coli using 
the usual transformation protocol, detailed in section 2.4.4. 
 
2.4.3 Promega protocol for competent E.coli 
A single colony from the agar plate or from glycerol stock was incubated in a 10 ml of 
the overnight culture. On the following day, 2.5 ml of the overnight culture was added to 
the 250 ml of the fresh LB and grown at 37 ºC until OD600 of approximately 0.5 was 
reached. Cells were then harvested for 5 minutes at 4500 g at 4 ºC. The pellet was then 
resuspended in a 100 ml of TFB1 buffer containing: 15% glycerol adjusted to pH 5 with 
acetic acid, 30 mM potassium acetate, 10 mM calcium chloride, 50 mM manganese 
chloride and 100 mM rubidium chloride. The resuspended pellet was then incubated on 
ice for 5 minutes. Cells were harvested again at 5 minutes at 4500 g at 4 ºC and then 
resuspended in a 10 ml of TFB2 buffer containing: 15% glycerol adjusted to pH 6.5 with 
potassium hydroxide, 10 M MOPS (3-(N-morpholino)propanesulfonic acid), 75 mM 
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calcium chloride, and 10 mM rubidium chloride. After 1 hour of incubation on ice, cells 
were aliquoted into 200 μl fractions and frozen in liquid nitrogen for storage at -80 ºC. 
 
2.4.4 Transformations 
Chemically competent E.coli were either purchased from Promega or grown according 
to the Promega protocol. Aliquots of competent E.coli, were defrosted on ice followed by 
the addition of 30-100 ng of plasmid DNA. The mix was incubated on ice for 20 to 30 
minutes and then subjected to a heat shock at 42 °C for 45 seconds followed by a further 
incubation on ice for 2 minutes. After the transformation, 200 μl of fresh pre-warmed LB 
media was added, and transferred to the 37 °C incubator, with shaking, for 1 hour. The 
transformed E.coli was then spread onto LB agar plates containing 30 μg/ml kanamycin 
and incubated overnight at 37 ºC. To make glycerol stocks, the E.coli was re-seeded into 
fresh LB and grown until OD600. The cells were then harvested at 4000 g for 10 minutes. 
The pellet was then resuspended in 10% glycerol and stored at – 80 ºC. After thawing, 
the glycerol stock transformed E.coli were grown on Kanamycin inoculated petri dish 
before being used for large scale protein expression, detailed in section 2.5.1. 
 
2.4.5 Subcloning 
All mutagenesis steps were performed in the pST-Blue-1 vector. Once a successful 
mutation had been confirmed by DNA sequencing the entire gene was subcloned into 
the expressing vector pET-28a using both XbaI and XhoI endonuclease restriction 
enzymes for 1 hour at 37°C. The 1.3 kb GlpT gene insert was isolated using DNA gel 
electrophoresis, and purified using the gel extraction kit according to the manufacturer’s 
instructions. The empty 5.3 kb expression vector pET-28a, without an insert, was treated 
in the same manner as mentioned above. The purified insert was then ligated into the 
empty pET-28a vector at a 3:1 molar ratio respectively, using T4 DNA ligase in an 
overnight reaction at 16 ºC. The ligation reaction was transformed into E.coli Top10 cells 
using the standard heat shock protocol. The resulting E.coli colonies’ plasmids were then 
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isolated and screened with an XbaI/XhoI digestion for the presence of the insert. The 
positive hits contained bands corresponding to a digested 5.3 kb vector and 1.3 kb size 
insert visualised on a 1% agarose DNA gel. The DNA was then sequenced to ensure the 
correct orientation of the insert. Successfully ligated plasmid was then transformed into 
BL-21-AI Chemically Competent E.coli, ready for protein expression. 
 
2.4.6 Mutagenesis of single Trp mutants 
Single Trp mutants of GlpT were made in two stages. Firstly, a tryptophan-free GlpT was 
designed by substituting all 15 trp residues with phenylalanine. The gene was 
synthesised by MWG Eurofins and delivered in a pEX-A2 vector with ampicillin 
resistance. The gene was then subcloned into pST-Blue-1 vector, where the rest of the 
mutagenesis steps were performed as described in the previous section. The individual 
single trp mutants were generated by substituting M107, F148 and V332 amino acids 
with Trp coding codon TGG in the tryptophan lacking gene variant of GlpT. The presence 
of the mutations was confirmed by sequencing before subcloning into the pET-23a vector 
for protein expression. 
 
2.4.7 Mutagenesis of cysteine mutants 
To further investigate the stability of the WT and alanine mutants, a cysteine mutant was 
designed to monitor the degree of unfolding using fluorescence recovery with rhodamine 
unquenching during the unfolding process. Out of 7 cysteines present in the GlpT gene, 
C215 is the only cysteine that is exposed to the protein exterior and could be reactive 
with the thiol-reactive dye. As a first step, the C215 was substituted with serine. C215S 
GlpT construct was then used to add cysteine residues, by substituting S61 and V283, 
present on cytoplasmic loops between the first helices of the first and second domain, 
respectively. The reaction was transformed into Top10 E.coli and then screened using 
PCR. The colony with a 1.3 kb PCR fragment was purified and sent for sequencing. The 
plasmid containing all 3 mutations was confirmed by sequencing and digested with XbaI 
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and XhoI restriction endonucleases, and the gene subcloned into pET-28a vector for 
protein expression. 
 
2.4.8 DNA sequencing and primer synthesis 
DNA sequencing was carried out by Eurofins MWG Operon using the Value Read 
service, based on cycle dideoxy chain termination sequencing technology. Sequences 
were analysed using Omega Clustal alignment algorithm and examination of a supplied 
chromatogram.  
 
All oligonucleotides used for the mutagenesis reactions were synthesised by Eurofins 
MWG Operon using high purity salt-free purification method and delivered in lyophilised 
form. Delivered samples were solubilised in molecular biology grade filtered water from 
Sigma Aldrich to standard stock concentration of 100 nmol/μl and kept at -20°C. 
 
2.5 Protein expression and purification 
Throughout the protein purification protocol, all protein samples were kept on ice, and 
purified at 4°C in the in-house cold room. All protein buffers contained: 50 mM Tris buffer 
pH 7.4, 2 mM β-mercaptoethanol and 10 % (w/v) glycerol. Variation and detail of these 
buffers is further listed in the appropriate sections. 
 
2.5.1 GlpT overexpression in E.coli 
For a standard, large scale protein expression, 6 L of kanamycin inoculated media were 
used to grow GlpT. The use of baffled flasks increases aeration of media, contributing to 
the increased total bug growth and consequently increased protein yield per protein 
purification. No improvement in the protein yield was observed when the E.coli were 
grown in TB media, regardless of increased OD600 values measured throughout the 




A transformed E.coli colony containing GlpT in pET-28a from an LB agar plate, or a 
glycerol stock, was used to seed a 100 ml LB media inoculated with 30 μg/ml kanamycin, 
and incubated overnight at 37°C and 220 rpm. The overnight culture was then added at 
a 1:100 ratio to six 1 L flasks of pre-warmed LB media. The cultures were grown at 37°C 
with shaking at 220 rpm, and the growth was monitored at approximately 30 minute 
intervals, corresponding to the E.coli mean doubling time. The growth culture was 
induced with 1 mM IPTG and 0.1% arabinose at approximately 2.5 hours into the bacteria 
growth, when the OD590 reached 0.8 AU. The growth was continued for another 2 hours 
until it became stationary. At this point, the bacterial cells were harvested by 
centrifugation at 5000 g for 45 minutes at 4 °C (using Beckman Coulter J6-MI 
Centrifuge). The supernatant was discarded and the pellets were re-suspended in 200 
ml PBS. The cells were then re-harvested at 5000 g for 10 minutes (Beckman Coulter 
Avanti J-26 XP). The supernatant was discarded and the bug pellet was weighted and 
re-suspended in 50 ml PBS with 10 mM β-mercaptoethanol and a protease inhibitor 
cocktail tablet (Roche Applied Science). The cells were frozen and stored at -20°C 
freezer until further use. 
 
2.5.2 Protein purification 
The frozen cells were defrosted and incubated with DNase I for 10 minutes at room 
temperature. The cells were then lysed using a cell disruptor (Constant Systems Ltd.) 
with an attached Thermoflex 1400 cooling unit (Thermo Ficher Neslab), followed by 
membrane sedimentation at 100,000 g for 30 minutes at 4°C (Beckman Coulter Optima 
XPN-90 Ultracentrifuge with type 70 Ti rotor). The membrane pellet was re-suspended 
in solubilisation buffer (50 mM Tris buffer pH 7.4, 10 mM β-mercaptoethanol, 200 mM 
NaCl, 20 mM imidazole, 10 % (w/v) glycerol, 2 % (w/v) DDM, 100 mM PMSF with the 
addition of EDTA free protease inhibitor cocktail tablet (Roche Applied Science)), and 
solubilised for 2 hours at 4 °C with stirring. 30 to 50 ml of solubilisation buffer (50 mM 
Tris buffer pH 7.4, 10 mM β-mercaptoethanol, 200 mM NaCl, 20 mM imidazole, 10 % 
(w/v) glycerol, 2 % (w/v) DDM, 100 mM PMSF with the addition of EDTA free protease 
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inhibitor cocktail tablet (Roche Applied Science)) was used, depending on the weight of 
the E.coli pellet at the end of the bacteria growth. solubilisation buffer (50 mM Tris buffer 
pH 7.4, 10 mM β-mercaptoethanol, 200 mM NaCl, 20 mM imidazole, 10 % (w/v) glycerol, 
2 % (w/v) DDM, 100 mM PMSF with the addition of EDTA free protease inhibitor cocktail 
tablet (Roche Applied Science)). The solubilised membrane fraction containing the 
overexpressed protein was then isolated by centrifugation at 100,000 g for 30 minutes 
at 4 °C. The resulting supernatant was then injected into a 50 ml superloop attached to 
an ÄKTA pure chromatography system. The supernatant was passed through the 1 ml 
HisTrap HP Ni2+ metal ion affinity column (GE Healthcare) at a rate of 1 ml/min. The 
HisTrap column was pre-equilibrated with 10 ml of binding buffer (50 mM Tris buffer pH 
7.4, 2 mM β-mercaptoethanol, 10 % (w/v) glycerol and 0.05 % (w/v) DDM). The column 
was then washed with 40 column volumes of wash buffer (50 mM Tris buffer pH 7.4, 75 
mM imidazole, 2 mM β-mercaptoethanol, 10 % (w/v) glycerol and 0.05 % (w/v) DDM), to 
remove all nonspecific bound and unbound contaminating protein. Depending on the 
next purification step, the protein was then eluted into either a 2 ml loop on the ÄKTA 
pure, or eluted directly into an Amicon Ultra 50 kDa MWCO (Millipore) spin concentrator.  
 
2.5.3 Desalting 
The elution from the 1 ml HisTrap HP Ni2+ column was concentrated to a volume of 2 ml 
using an Amicon Ultra 50 kDa MWCO (Milipore) spin concentrator at 3500 rpm for 
approximately 20 minutes in a Megafuge 1.0R centrifuge (Heraeus Instruments). The 
concentrating was stopped at 5 minute intervals to stir the sample in order to avoid local 
crowding of the protein at the filter piece that could start protein aggregation. The 
concentrated protein sample was then loaded onto 5 ml HiTrap Desalting column (GE 
Healthcare) equilibrated with 10 ml of binding buffer (50 mM Tris buffer pH 7.4, 2 mM β-
mercaptoethanol, 10 % (w/v) glycerol and 0.05 % (w/v) DDM) at of rate of 1 ml/min. The 
protein fractions were collected was and their concentration was measured using the UV 
absorbance at 280 nm using Cary 300 UV-visible spectrophotometer (Agilent 
Technologies), using the extinction coefficient calculated by ExPASy ProtParam tool 
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(146). The sum of the total protein yield was used to estimate the total yield for the protein 
per 1 L of E.coli culture grown. The fractions collected were then aliquoted, or if required 
concentrated again for storage or for further purification using gel filtration column. All 
protein samples were snap frozen using the liquid nitrogen before being stored at -80 
°C. 
 
2.5.4 Gel purification 
Using gel filtration after purification with a HisTrap column yields a more purified product, 
compared to the HiTrap Desalting column, at the expense of slight dilution and protein 
loss. The majority of GlpT purifies as a monomer. However, following elution from a 
HisTrap column, GlpT oligomers can be observed by SDS-PAGE analysis. To remove 
these oligomers and ensure artefact-free measurements during the sensitive kinetic 
experiments, an additional purification step was utilized. The HiLoad Superdex 200 PG 
gel filtration column (GE Healthcare) was equilibrated with 120 ml of degassed desalting 
buffer (50 mM Tris buffer pH 7.4, 2mM β-mercaptoethanol, 10 % (w/v) glycerol and 0.05 
% (w/v) DDM). The protein sample was loaded into AKTA Pure (GE Healthcare) via a 2 
ml loop. If the protein was previously spin concentrated, the protein was filtered through 
a 0.45 μm Minisart syringe filter (Sartorius) prior to loading the sample onto the column. 
The column was then run at 1 ml/min for 2 hours with 1 ml fractions collected. The purified 
GlpT in a DDM micelle could be found exiting the column after approximately 70 ml into 
the run, corresponding to molecular weight of roughly 72 kDa, determined via calibration 
using gel filtration standards found in figure 2.1. The eluted fractions containing the 
protein were identified and their concentration established using a 280 nm UV 
absorbance (Cary 300 UV-visible spectrophotometer (Agilent Technologies)). A 
chromatogram of the representative purification recorded throughout entire purification 
procedure can be seen in Figure 2.2. The sum of total protein concentration was used to 
estimate the total yield for the protein per 1 L of E.coli culture grown. The fractions 
collected were then aliquoted or if required, concentrated again for storage or further 
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purification using gel filtration column. All protein samples were snap frozen using the 



















Figure 2.1 Gel filtration standards elution profile 
The molecular size of GlpT in a DDM micelle was calculated using gel filtration column. Column 
calibration using molecular weight standards can be seen resolved in the elution chromatogram 
in panel A, the standards were supplied by GE Healthcare and contained thyroglobulin (669 000 
Mr), ovalbumin (440 000 Mr), aldolase (158 000 Mr), conalbumin (75 000 Mr) and ferritin (44 000 
Mr). The resulting data was collected and fit to a straight line equation, shown in panel B, with the 
point of y intercept equal to 7.5 ± 0.1 and gradient of -0.04 ± 0.01 Errors were taken from the 
standard error of the fit. 
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Figure 2.2 Chromatogram of GlpT WT purification 
GlpT WT was purified from overexpressed E.coli culture with the solubilised cell lysate being 
purified via Ni2+ affinity column and gel filtration column. The first step of the purification involving 
Ni column is described in panel A, where in the first ml of purification procedure cell lysate is 
passed through the column, saturating the detector. After 30 ml of cell lysate the column was 
washed with moderate concentrations of imidazole. The sharp elution peak is collected in a 2 ml 
superloop, when the column is washed with 500 mM concentration of imidazole. The elute is 
loaded straight onto the gel filtration column and second purification step is initiated, shown in 
panel B. The sample is eluted as a monomer at 70 ml mark, with a small aggregated fraction at 
the void volume found at 40 ml. The fraction of the gel filtration peak representing the top 
concentration of the protein is then collected, concentrated and kept at -80 °C for further use. 
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2.6 SDS-Page analysis 
Protein gel electrophoresis was used to determine the quality, efficiency and any 
potential differences in the purification protocol of the GlpT wild type and any of its 
mutants. The samples were run on a precast 10 % Tris-Glycine polyacrylamide gels 
(NuSep) containing: 100 mM Tris pH 8.25, 100 mM Tricine and 0.1 % SDS. Precision 
Plus Protein™ All Blue Standard protein marker (Bio-rad) was run with the samples to 
estimate the molecular size of the protein samples. The protein samples were mixed with 
2x SDS loading buffer (50 mM Tris pH 6.8, 5 % β-mercaptoethanol, 12% glycerol, 3 % 
SDS and 0.01% bromophenol blue) in a 1:1 ratio prior to loading. Samples were then run 
at 190 V until the buffer ran to the bottom of the gel, for approximately 60 to 90 minutes. 
The purified GlpT band was observed just above the 37 kDa marker, as seen in the gel 
stained with the Coomassie dye in figure 2.3. The GlpT band does not appear at the 
predicted region of 52 kDa, which is due to the resistance of GlpT to SDS unfolding. The 




































Figure 2.3 SDS-PAGE gel of GlpT WT purification visualised by coomassie blue staining 
SDS-PAGE analysis was used to determine efficiency and purity of GlpT at various stages of 
purification. Samples of 10 µL were taken at each stage and run on gel as follows: All-blue protein 
standard (corresponding molecular weight of each band labelled on the left in kDa, solubilised 
membrane fraction derived from the cell lysate, flow-through of unbound fraction, 50 mM 
imidazole wash step, 500 mM imidazole elution of the Ni affinity column, top gel filtration fractions 
pooled together, spin concentrated fraction of protein before being stored at – 80 °C. Both Ni 
affinity (1 ml HisTrap HP Ni2+ metal ion affinity column) and gel filtration (HiLoad Superdex 200 















2.6.1 Coomassie staining 
SDS-PAGE gels were visualised with Coomassie stain. The Quick Coomassie (Generon) 
was used to stain gels for 60 minutes. Background staining was eliminated by leaving 
the stained gel overnight in a deionised water. For gels with high background stain, gels 
were microwaved at full power for 10 seconds with frequent water changes. Stained gels 
were then imaged in Amersham Imager 600 using the trans-illumination picture. 
 
2.6.2 Western blotting 
SDS-PAGE gels were also visualised by western blot. The protein was transferred onto 
a Hybond-EXL nitrocellulose Protran membrane with 0.45 μm pore size (Amersham) at 
45 A for 60 minutes, using a TE 70 PWR Semi-Dry Transfer Unit (GE Healthcare). The 
membrane and stacks of filter paper were soaked with transfer buffer (25 mM Tris base 
pH 8.3, 150 mM glycine and 10% (w/v) methanol) prior to transfer. To eliminate non-
specific binding of the antibody, the membrane was blocked in 5 % milk and 0.05 % (w/v) 
PBS-Tween for 60 minutes at room temperature with rocking.  Horseradish peroxidase 
conjugated monoclonal anti-polyHis antibody from mouse was then added at a 1:2000 
dilution to 5 % milk in 0.05 % (w/v) PBS-Tween solution for further 60 minutes at room 
temperature with rocking. The unbound antibody was then washed off with 3 1 minute 
washes of 0.05 % (w/v) PBS-Tween followed by 3 10 minute washes of 0.05 % (w/v) 
PBS-Tween. The nitrocellulose membrane was then incubated for 1 minute at room 
temperature with LumiGLO (Cell Signalling Technology), in a total volume 10 ml. The 
nitrocellulose membrane was then dried and visualised in Amersham Imager 600 using 
cheminolumiescence settings with automatic exposure setting unless stated otherwise.  
 
2.7 Fluorescence spectra 
All fluorescence spectra were measured in a spectrofluorometer Fluoromax-4 (Jobin 
Yvon, ISA Instruments, S.A Inc). Each sample was excited at both 280 nm and 295 nm, 
and their emission recorded at 0.25 nm increments between 300 and 450 nm with an 
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integration time of 0.1 s. Both excitation and emission slits were set to a 5 nm bandwidth. 
A 4 mm pathlength Starna Quartz cuvette was used, with the temperature set to 25 °C 
with a temperature tolerance of 0.1 °C, unless stated otherwise. The baseline of the 
buffer and denaturant were subtracted from each spectrum before the analysis of the 
scan, as both urea and guanidinium chloride have an emission band at 330 nm. All of 
the fluorescence data analysis was done in GraFit software (Version 5, Erithacus 
Software Limited). For an accurate estimation of fluorescence intensity at the wavelength 
maxima and position of the wavelength maxima, a normal distribution curve was fitted to 
the data of the obtained spectra. If the fitting of the curve was acceptable, the position of 
the peak was used to estimate the wavelength maxima, as well as maximum 
fluorescence. The normal distribution fit equation can be seen below, with µ being mean 








2.8 Circular dichroism spectra 
All circular dichroism measurements were taken on an Aviv Circular Dichroism 
Spectrophotometer, Model 410 (Biomedical Inc, Lakewood, NJ USA), with a custom 
telescopic detector installed in order to reduce possible scattering artefacts. CD spectra 
were recorded at 1 nm increments with 3 repeated scans between 270 and 185 nm and 
integration time of 1 s, unless stated otherwise. Measurements containing urea were 
taken between 270 and 200 nm due the absorbance of urea in the lower wavelength 
region. The type of the cell, as well as its pathlength depended greatly on the demands 
of the experiments and the protein concentration used. The cell pathlength varied 




2.9 Circular dichorism spectra analysis 
All CD spectra were processed using the CDtool program (version 1.4) (142). The buffer 
baseline of the matching cell pathlength was subtracted from each spectrum. The 
spectra were also zeroed to a common set baseline between 253 and 260 nm. The raw 
spectra were also automatically smoothed by an inbuilt Savitsky-Golay filter. The buffer 
baseline of the matching cell type and cell pathlength was subtracted accordingly from 
each spectra to aid in more accurate deconvolution of the data.  
To analyse multiple experiments and to allow comparison, the data was converted to a 
standardised unit of mean residue ellipticity expressed by deg.cm2.dmol-1 units. 
Expression used to convert raw milidegrees signal (mdeg) into the mean residual 
ellipticity in deg.cm2.dmol-1 (MRE), is shown below, with mean residue weight (MRW) in 
kDa, pathlength, L, in cm and concentration, c in mg.ml-1, the MRW, mean residual 
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Alpha-helical proteins have two negative peaks at 222 nm and 208 nm. The change of 
peak at 222 nm rather than 208 nm was used as indication of the structure change. The 
208 nm peak of GlpT is much shallower than 222 nm peak, especially at the higher urea 
concentrations. Furthermore, the increasing urea concentrations interfere with 
measurements recorded below 200 nm, due to the urea’s own spectroscopic properties. 
 
2.10 Circular dichroism deconvolution 
Insight into the folded structure of proteins can be estimated via comparison of acquired 
CD spectra to a large database of known crystal structures and their respective CD 
spectra. The dichroweb web server (http://dichroweb.cryst.bbk.ac.uk/, 147) was used to 
estimate the secondary structure of GlpT (148). The process of spectra deconvolution 
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requires a wide wavelength range, inaccessible for denatured protein and limited by low 
protein concentration and scattering effects. The membrane protein specific SMP180 
dataset 4 was used for samples with spectra recorded to 180 nm (149). Samples with 
spectra recorded to only 190 nm were analysed with a less accurate estimations from 
dataset SP175 (150). The fitting was considered good when the NRMSD value did not 
exceed 0.1. 
 
2.11 Circular dichroism equilibrium unfolding 
A range of concentrations of urea were made from a 10 M stock solution. The stock was 
made by dissolving urea in a premade buffer (50 mM Tris pH 7.4 and 0.05% DDM). 
Aliquots of GlpT were defrosted on ice, and added to the denaturant to make up the final 
denaturant concentration in a total volume of 50 μl. Each unfolding reaction was 
incubated for 5 minutes at 25 °C. The total protein concentration was kept at a range 
between 0.3 and 0.5 mg.ml-1, giving a good quality CD spectra. Both rectangular and 
circular Suprasil demountable cells were used in acquiring unfolding spectra. Depending 
on the quality and protein concentration pathlengths of 0.1 mm or 0.2 mm were used. 
The sample was equilibrated for 1 minute in the sample holder. 
 
2.12 Fluorescence equilibrium unfolding  
The protein sample was incubated with increasingly higher concentrations of denaturant, 
either urea or GuHCl, in a total sample volume of 300 μl, for 5 minutes at 25 °C. The final 
protein concentration was kept constant throughout the experiments, at 0.025 mg.ml-1. 
The sample was equilibrated for 1 minute in the sample holder prior to measurement. 
 
2.13 Circular dichroism equilibrium refolding 
The method described in section 2.12 was also used to unfold GlpT prior to refolding. 
The protein was denatured in 8M urea for 5 minutes at 25 °C, followed by a rapid ten-
fold dilution with refolding buffer (50 mM Tris, 0.05% DDM). The urea concentration 
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varied between the samples in order to give a range of final urea concentrations after 
the rapid dilution, ranging from 0.8 to 8 M. The final protein concentration varied between 
0.01 mg.ml-1 to 0.04 mg.ml-1. The sample was then incubated for 10 minutes at 25°C. To 
acquire a good CD signal the spectra of the refolded samples were measured in a 0.5 
mm quartz rectangular or round Suprasil demountable cells (Hellma Analytics). 
 
2.14 Fluorescence equilibrium refolding 
To achieve a final protein concentration of 0.025 mg.ml-1 in a sample volume of 400 μl, 
the starting 1 mg.ml-1 of protein was unfolded in 8 M urea for 5 minutes at 25 °C. 
Afterward the unfolded mixture was diluted into refolding buffer with decreasing 
concentrations of urea, to give a final range of urea between 8 M to 0.8 M. Each emission 
spectra was subtracted against the background emission of each of urea concentrations 
using the same volumes without the protein present. 
 
2.15 Circular dichorism thermal denaturation 
Thermal denaturation was measured by heating the protein from a temperature of 5 °C 
to 95 °C degrees in 2 °C steps. The detector was set at 222 nm to monitor the loss of 
alpha helical structure. The sample was allowed to equilibrate for 30 seconds at each 
temperature step before the scan was taken.  Instead of 50 mM Tris pH 7.4, 50 mM 
HEPES buffer was used, due to the temperature pH sensitivity of Tris buffer. The protein 
sample was measured at a concentration of 0.1 mg.ml-1 in a rectangular 1 mm pathlength 
cell. The high protein concentration and longer pathlength used ensure a good CD signal 
during the large amount of structure loss at temperatures above. 
 
2.16 Crystal structure images 
All figures featuring crystal structures were rendered using The PyMOL Molecular 
Graphics System, Version 1.8 Schrödinger, LLC. The crystal structures were acquired 
from the protein data bank using PDB codes stated below: 1pw4 (GlpT, Uniprot: P08194, 
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97). UCSF Chimera (http://www.rbvi.ucsf.edu/chimera) was used to model the missing 
interdomain loop. The model with the lowest energy was used in making GlpT molecular 
images in PyMOL. 
 
2.17 Two-state analysis 
The parameters from the spectroscopic measurements such as wavelength of the 
fluorescence maximum, the fluorescence emission and the mean residual ellipticity 
recorded at 222 nm were used to monitor the extent of the folded structure at different 
denaturant concentrations. These results were then fitted into two-state model to find 
the free energy of unfolding in the absence of denaturant (ΔGUH2O) using the equation 
 
𝑦 =  𝑠𝑡𝑎𝑟𝑡 +  𝑟𝑎𝑛𝑔𝑒 
𝑒𝑥𝑝 (−𝑚(𝐶𝑚 − 𝑥)/−𝑅𝑇)  
1 + 𝑒𝑥𝑝 (−𝑚/(𝐶𝑚 − 𝑥)/−𝑅𝑇)
 
 








The zero denaturant containing point, where protein is thought to be folded, was 
chosen as a start parameter, while the range is described as an amount of total 
denaturation between the points of zero denaturant and maximum denaturant 
concentration x, The R is the gas constant (1.987 x 10-3 kcal/K.mol), T is the absolute 
temperature, x describes the denaturant concentration with m being the gradient of the 
transition slope  
 
2.18 Markwell-Lowry 
A modified version of the Lowry quantification assay (151) designed for the membrane 
and lipoprotein preparations was used in estimating protein concentration for the single 
tryptophan assays, using bovine serum albumin as a standard. Protein samples of 
unknown concentration and the standard were pipetted into a 0, 5, 10, 15, 20, 25, 50 µL 
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series of volumes. The samples were then fully solubilised by addition of 50 µL of 10 
mg.ml-1 sodium deoxycholate. After 1 minute incubation at room temperature, 1 ml of 10 
% (w/v) trichloroacetic acid was added to the samples. The precipitate was spun down 
at 10 000 g for 5 minutes, and the supernatant discarded. Protein precipitate was 
solubilised with 1 ml alkaline copper reagent. The reagent was made of solution A (200 
mM anhydrous Na2CO3,100 mM NaOH, 7 mM potassium sodium tartrate, 1%  (w/v) 
SDS), and solution B (4% (w/v) CuSO4.5H2O) premixed in a 100:1 ratio, respectively.  
Afterwards, 10 µL of the 1 M Folin and Ciocalteu’s phenol reagent, was added to the 
solubilised mixture and stirred immediately. The sample was left to incubate at room 
temperature for 1 hour before the UV absorbance readings were taken at 750 nm in 1 
ml quartz cell. Protein amount was then determined according to the known bovine 
serum albumin concentrations by interpolation. 
 
2.19 Rhodamine conjugation 
Tetramethylrhodamine-5-maleimide (TMR), purchased from Thermo Fisher Scientific, 
was used in labelling of the double cysteine mutant of GlpT. The 0.5 M stocks of TMR 
were kept frozen at -20 °C in DMSO. Prior to conjugation, the protein was diluted to a 
concentration of 20 µM in buffer containing 50 mM Tris at pH 7.4, 200 µM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) and 0.05 % (w/v) DDM in a total reaction 
volume of 250 µL. The protein was incubated in TCEP on ice for 10 minutes to reduce 
any disulphide bonds prior to dye conjugation. The protein sample was then transferred 
to a darkened light-safe 0.5 ml eppendorf along with the excess of the TMR solution. It 
was found that an overnight incubation at 4°C with the 40-fold molar excess of the TMR 
label provided the best labelling efficiency of 1.7 moles of labelled dye to moles of protein.  
 
2.19.1 Free dye removal 
The fluorescent dye removal resin and columns (Pierce dye removal columns) were 
acquired from Thermo Fisher Scientific. All procedures were performed at room 
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temperature. First, 400 µL of the uniform suspended resin was added to the spin column 
and centrifuged at 1000 g for 45 seconds to remove the resin storage solution. Next, 400 
µL of 50 mM Tris at pH 7.4, 200 µM TCEP and 0.05 % (w/v) DDM were added to 
equilibrate the column before another 1000 g spin for 45 seconds. Finally, 250 µL of the 
labelling reaction were pipetted into the resin and left to incubate for 1 minute. The 
column was then spun down for further 45 seconds at 1000 g. The eluted sample was 
collected and the process was repeated again with fresh column and resin to remove 
any free TMR label that might have been left. The purified labelled protein was protected 
from light and either immediately used or stored at -80 °C avoiding multiple freeze-thaw 
cycles.  
 
2.19.2 Determination of degree of cysteine labelling 
A Cary 300 UV-visible spectrophotometer (Agilent Technologies) was used to record the 
UV absorbance of the labelled samples. The sample was diluted in 400 µL of 50 mM Tris 
pH 7.4 and 0.05 % (w/v) DDM, and the UV absorbance at 280 and 541 nm was measured 
in a 1.4 ml UV-vis ES quartz cell (Aireka Cells). 
 
 In order to assess successful dye removal and efficiency of dye conjugation, the 












 Ax is the UV absorbance of the dye at the maximum wavelength, and ε is the extinction 
coefficient of the fluorescent dye used. Both the equation and the TMR 541 nm UV 
absorption maxima and 97 000 M-1cm-1 extinction coefficient were taken from the 





2.20 Cysteine mutant fluorescence unfolding assays 
The cysteine labelled sample was incubated at 25 °C for 5 minutes with increasingly 
higher concentrations of urea denaturant, ranging between 0 to 8 M, in a total sample 
volume of 300 μl. All reactions were performed in light-safe 1.5 ml eppendorf tubes. The 
final protein concentration used was kept constant throughout the experiments at 0.015 
mg.ml-1. The sample was equilibrated for 1 minute in the sample holder prior to 
measurement in a 4 mm pathlength Starna Quartz cuvette. The fluorescence emission 
spectra was recorded at 0.25 nm increments between 555 and 650 nm with an 
integration time of 0.1 second with the excitation wavelength set at 550 nm. Both 
excitation and emission slits were set to a 3 nm bandwidth. The difference in 
fluorescence intensity, as well as shift of the fluorescence maxima were estimated from 
the recorded fluorescence spectra as described in section 2.7. 
 
2.21 Cysteine mutant circular dichroism assays 
All CD spectra of cysteine mutant were taken as described before, with the exception of 
extra addition of 10 mM TCEP, to stop unwanted cross-linking of two cysteines. CD 
spectra of assay buffer containing TCEP was used to subtract each spectra. The decay 
of the 222 nm peak with the increasing concentrations of urea was collected and 

























Chapter 3  




3.1 Introduction  
3.1.1 Unfolding of detergent bound α-helical proteins 
Protein stability can be assessed by monitoring the reduction in protein’s structure during 
denaturation, followed by estimation of free energy of unfolding. The free energy of the 
unfolding can be summarised as the difference between the free energies of two states, 
the folded protein and the denatured structure. A relatively simple method of stability 
assessment is via denaturation curve performed at steady state conditions (152). 
Measurements of unfolding at steady state give a relatively straightforward insight into 
the equilibrium thermodynamics of the unfolding pathway leading to an increased 
understanding of underlying origin of protein stability. 
 
Protein denaturation can be brought about by either a change in temperature or addition 
of chemical denaturants. Thermal denaturation occurs when increasing temperature 
disrupts amino acid contacts and as a consequence disturbs the protein structure. 
Alternatively, chemical denaturation methods can be used with chaotropic agents as 
denaturants (153). Examples of useful protein denaturants are SDS, urea and GuHCl. 
Interactions between water and urea or GuHCl, have been found to be less favourable 
than with protein’s amino acids (154). Interestingly, both denaturants interact with polar 
and non-polar surfaces of the protein. However, GuHCl was found to interact more 
favourably with polar residues than non-polar residues. Urea was found to act in an 
opposite manner, and interact more favourably with non-polar residues over polar 
residues (155). Still, the exact mechanism through which these denaturant molecules 







The unfolded state of the proteins cannot be described using single structure. Instead, 
the unfolded membrane protein may exist as a collection of different states with a range 
of varying micelle-protein structure complexes and different stabilities (156). Therefore, 
specific information on the structure of the protein is difficult to obtain and analyse. In 
this chapter, the degree of GlpT unfolding by both chemical and temperature methods is 
monitored by fluorescence and CD spectroscopy. The GlpT’s reversibility ability is also 
assayed by measuring the return to the same structure content as before the 
denaturation. 
 
The detergent systems do not fully reproduce the conditions of membrane proteins in 
their native cell environment. When denatured, many membrane proteins tend to form 
irreversible aggregates of multiple different conformations. Although, membrane proteins 
are considered to be unstable and ‘’frail’’ in contrast to soluble proteins the membrane 
proteins resist the denaturation resulting in their unfolded state displaying elements of 
secondary structure (14). When considering the use of different denaturants, it is good 
to consider that the denaturant does not destabilise the lipid or detergent environment 
present in an experimental setup. The suitability of different denaturants is measured 
and discussed later in this chapter. 
 
3.1.2 Two-state folding and free energy 
In order, to apply thermodynamics equations that yield the free energy linked to protein 
folding, the protein needs to be shown to exist in a reversible equilibrium. Experimentally, 
the easiest circumstance is when protein folding occurs in a single step without any 
intermediates. In such two state reaction, only the unfolded and folded states exist 
without any intermediate states in-between. The reaction can then be represented as: 
 




During denaturation experiments, higher concentrations of the denaturant drive this 
equilibrium towards the unfolded state. The relative populations of the folded and 









The likelihood that a reaction is populated by one state over another is described by free 
energy, ΔG, and is calculated by: 
 
ΔG=-RT ln Keq  
 
Where R is the gas constant (1.987 x 10-3 kcal/K.mol) and T is the absolute temperature. 
Both fluorescence and CD measurements can be used to track the progress of the 
unfolding in the denaturation experiments. To find the free energy of unfolding in the 
absence of denaturant (ΔGUH2O) the following equation is used:  
 
ΔG= ΔGUH2O-m[denaturant]  
 
This model assumes linear dependence between the concentration of the denaturant 
and the free energy change, ΔG, where m defines an extent of the dependence of ΔG 
on the concentration of the denaturant (157). The denaturant concentration at the 
midpoint of the unfolding curve characterizes a state of equilibrium where ΔG=0. In that 
state it is possible to describe ΔGUH2O by following equation: 
 
ΔGUH2O=Cm x m 
 
At the midpoint of the reaction the population of the protein is split equally between the 
folded and the unfolded state, described by the Cm value. In the case of the simple two 
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state reaction described by a sigmoidal plot,  the regions before and after the slope on 
the sigmoidal curve represent folded and unfolded states, where as the gradient of the 
transition slope of the denaturation curve describes the value m, and midpoint of the 
curve defines the value Cm (155). Alternatively, ΔGUH2O can be estimated by an 
extrapolation of a linear plot of free energy change ΔG at every denaturant concentration 
in the transition state against the denaturant concentration used.  
 
The reversible equilibrium two-state system also implies that the free energy of unfolding 
is the same regardless of measuring it through the unfolding or refolding experiments, 
since both the forward and reverse reactions follow the same pathway. It is however 
more accurate to use the free energy calculated from unfolding rather than folding due 
to unfolding experiments being made out of fewer steps and the measurements are taken 
at higher and more accurate protein concentrations. 
 
3.1.3 Reversibility of the unfolded state 
The process of protein refolding from the denatured state would usually involve reduction 
or elimination of the denaturant that has led to protein unfolding. For example, by 
decreasing the temperature or dilution of the chemical denaturant, the protein is allowed 
to return to its native conformation, which was present before the process of unfolding. 
Generally, the temperature denaturation of large soluble proteins and membrane 
proteins results in a formation of irreversible unfolded aggregates. However, the 
reversibility of a chemically denatured state is frequently observed and has become a 
common method used in studying stability of membrane proteins. The most 
straightforward way of eliminating the chemical denaturant is via dilution or dialysis. 
When the concentration of denaturant decreases below that of a denaturing 
concentration, the protein recovers its structure.  
 
Upon reduction of the denaturant concentration, the structure of the protein can be 
recovered. Although, even in the cases of full structure of recovery, it is possible that the 
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protein refolding has occurred via different pathway than the unfolding reaction (158). A 
possible cause for different pathway could be due to a change of renaturing environment, 
the state of a solubilising agent could have been affected by the denaturant or the 
refolding process itself. When the reaction of unfolding and refolding proceed through 
different reaction steps, it is no longer possible to interpret any thermodynamic 
equilibrium results, as the unfolding cannot be described as reversible, since the two 
pathways are not in equilibrium, and therefore the resulting free energy cannot be 
calculated. The diagram of different folding-reaction pathways presenting different 
outcomes is shown in figure 3.1. In this chapter, the extent of GlpT structure recovery 
upon the dilution of the denaturant is assayed and then compared to that of the other 












Figure 3.1 The differences between reversible and irreversible folding 
The protein starts in the folded state, upon addition of denaturant and conditions it can assume 
different unfolded states. If the native structure of the protein returns when the denaturant is 
removed, then the process of unfolding is reversible. Frequently, the process of refolding is 
accompanied by addition of different renaturing lipids, in which case, the reaction is not reversible 
as it follows a different pathway even though the original structure is recovered. Diagram adapted 
from (159). Structures were rendered in PyMOL software. 
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3.1.4 Return of the protein function in the refolded state 
The reversibility assay and the return of native protein structure is further examined by 
the additional test of measuring the return of protein function. Comparing the efficiency 
of substrate binding or substrate transport before and after denaturation adds an extra 
argument that the protein has regained some aspects of the structure that were present 
before the denaturation, since the substrate binding affinity is dependent on the 
conformation of its binding site. The ideal solution would be to test the ability of the 
transporter to shuttle substrates across the membrane into the liposomes. However, due 
to reconstitution inefficiency and addition of many extra factors, such as changing the 
solubilisation system during the reconstitution, the results collected from functionality 
assay may be inaccurate.  
 
An alternative assay that measures affinity to substrate binding is also complicated. The 
transporters tend to have a low affinity to their substrates and the process of protein 
solubilising during purification may result in the binding pocket being obstructed by the 
detergent. The development of a GlpT functionality assay, based on measuring the 
affinity to substrate binding, is discussed later in this chapter. 
  
3.1.5 The case for fluorescent labels 
The process of unfolding of alanine mutants, described in chapter 4, is followed by 
changes of GlpT’s structure, measured by CD. However, an additional method of 
following the steps of denaturation would expand the structural information about the 
denatured state. Measurements of protein fluorescence are one of the most commonly 
used experimental approaches in examining the transition phases present in the protein 
folding. This is due to the nature of fluorescence being sensitive to the changes in the 
fluorophore’s environment. Moreover, fluorescence requires little material to produce a 
high signal-to-noise ratio. Compared to the circular dichroism recordings, which 
measures the global extent of the secondary structure, the fluorescence signal originates 
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from individual fluorophores and is directly linked to the local conditions surrounding the 
fluorophores. 
 
Measurements of the intrinsic fluorescence of GlpT negate the benefit of linking 
fluorescence to the local environment due to well-spread presence of 15 tryptophan 
residues. This abundance is not uncommon in membrane proteins, as tryptophans were 
shown to stabilise the protein via interactions with lipid head groups (160). The following 
sections, are trying to lay down design principles of fluorescence reporters in GlpT. 
 
3.1.6 Single tryptophan introduction 
One method to determine the extent of unfolding in specific regions of the protein is 
through the substitution of single tryptophan residues into the tryptophan-free protein of 
interest (161). For example, the unfolding of a single tryptophan containing protein 
SNase can be followed by multiple observations of emission energy, anisotropy and 
fluorescence intensity (162, 163). In a more recent work (125), single tryptophan 
mutations were introduced to a tryptophan free template of LacY. The study identified 
regions of the protein that show a greater degree of unfolding, when compared to other 
single tryptophan sites in LacY. Although, the single tryptophan produces a fluorescence 
signal informing on the state of the local environment, for large proteins with multiple 
domains the fluorescent residue may be too far to report on the state of those regions. 
In that case, multiple single tryptophan substitutions need to be made in order to provide 
a complete picture of the protein unfolding reaction (164). Most membrane proteins 
contain more than one tryptophan residue. In the case of multi-tryptophan proteins a 
template needs to be made where the number of fluorescent reporters is reduced (165). 
  
In order to use tryptophans as reporters of GlpT’s unfolding, all 15 native tryptophan 
residues were replaced with phenylalanines. The fluorescence of phenylalanines 
(extinction coefficient around 200 M-1cm-1 at 280 nm) is much smaller than that of 
tryptophan (extinction coefficient around 5500 M-1cm-1 at 280 nm). At the same time 
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phenylalanine is the most conservative of mutations for replacing aromatic tryptophan. 
See figure 3.2 for the locations of tryptophan residues in WT GlpT as well as placement 
of single tryptophans in the mutant GlpT. None of the replaced tryptophans were reported 
in the previous GlpT studies as essential for protein function. Secondly, single tryptophan 
substitutions were made onto a tryptophan-free template, referred to in the text as Trp-
free, with the intention that the fluorescence recorded from the protein would reflect the 
environment from the single fluorescence reporter. Allowing the comparison between 
different regions changes upon unfolding. 
 
 
Figure 3.2 Representation of tryptophans in GlpT WT and single tryptophan variants 
The structure on the left shows placement of all 15 tryptophans, in red, in GlpT WT. They are 
arranged in two planes, where they likely interact with lipid head groups in the native environment. 
On the right, positions of single-tryptophans are shown, in orange M107W, in blue F148W and 
finally in magenta V332W. The single tryptophans were placed to probe different environments, 
M107W is placed at the interhelical space in the first domain, F148 at the cytoplasmic interface 









3.1.7 Rhodamine label 
An alternative technique to single tryptophan constructs uses the interactions between 
two closely placed rhodamine labels to report on the change in the protein structure. 
When the two rhodamines are placed in a close proximity to each other, they form stacks 
causing fluorescence quenching between them via the mechanism of excitation coupling 
(166). During the conformational change, which occurs during protein unfolding, the 
distance between the two labels would change, therefore altering their fluorescence 
intensity. The majority of the studies that used double rhodamine labelled proteins were 
used to report major conformational changes in large soluble protein complexes (164, 
168-169).  An example includes a phosphate biosensor constructed using two rhodamine 
labels, which experiences a 20 fold increase in fluorescence upon phosphate binding 
(169).  A similar method was used to measure the association of subunits during the 
dimer formation of E.coli ribosomal protein (170). 
 
The distance between two labels is a major consideration in the design of this system, 
the labels are put in the most dynamic positions, so that during protein folding or 
unfolding the distance change between them would produce biggest effect on the 
fluorescence change. See figure 3.3 for representation of proposed sites of rhodamine 
labels. The accessibility of residues that would be labelled also needs to be considered. 
The thiol groups of cysteines need to be exposed for the thiol-reactive label to interact 
with them. The presence of solubilising agents may hinder labelling, if the molecule has 
a strong affinity towards a site that is close to the chosen cysteines. 
 
In this work, two cysteine residues on the periplasmic side, S61C and V383C, were 
placed on the cytoplasmic loops connecting helices 1-2 and 7-8 in close proximity of 15.8 
Å.  An alternative placement of two labelling sites is present on the cytoplasmic side of 
residues S150 and A376, this construct was not tested due to time constraints. The 
stability of the S61C-V383C construct was tested and the fluorescence changes of 






















Figure 3.3 Representation of cysteine mutations in GlpT WT with the rhodamine labels 
The structure on the top shows placement of rhodamine labels present on the endoplasmic face, 
on the bottom the alternative position of labels present on the cytoplasmic interface. The closest 
distance between α carbons of cysteine residues on the endoplasmic face (top figure) 
approximately equal to 15 Å, respective to the cytoplasmic face (bottom figure) 25 Å. Structures 




3.1.8 Aims of the chapter 
The aim of this chapter is to characterise both the unfolding and refolding extent of the 
GlpT WT using different denaturants. Different methods, such as, circular dichroism and 
fluorescence techniques are used to follow the changes in structure during the 
experiments. The GlpT WT structure is unfolded using urea, GuHCl or temperature. The 
reversibility of the unfolding reaction is assayed by recovery of the secondary structure 
upon reduction of the denaturant by dilution. The return of the tertiary structure and the 
functionality of the refolded GlpT is assessed with a substrate binding assay.  
 
Finally, the effect of the ligand binding on the protein stability is established. In the end, 
the suitability of single tryptophan constructs as well as potential placements of 
rhodamine labels is discussed. The initial stability studies of single-Trp variants and the 
rhodamine label GlpT were made using circular dichroism and fluorescence. Firstly, the 
stability of single-tryptophans is evaluated. Followed by an analysis of the rhodamine 
labelled GlpT unfolding and its purification. Throughout the text the unlabelled GlpT 
construct is referred to as the cysteine mutant. When a GlpT rhodamine label is added it 
is referred to as a rhodamine labelled GlpT. 
 
The outlined experiments and results are used in establishing the difference in stability 












3.2.1 Denaturant-induced unfolding at steady-state 
The GlpT WT samples solubilised in 0.05% DDM were denatured with either 8 M urea 
or 6 M GuHCl. No further reduction of the secondary strucutre was observed after 5 
minutes of incubation with either of these denaturants. The extent of the unfolding was 
measured by far-UV CD spectroscopy. The fluorescence measurements of GlpT’s native 
tryptophans were also recorded. 
 
The resulting changes in GlpT’s CD or fluorescence spectra were plotted against the 
denaturant concentration to yield an unfolding curve, which in turn is used to calculate 
the free energy of unfolding in the absence of denaturant, provided that the reaction has 
reached equilibrium and is reversible.  
 
3.2.2 Fluorescence measurements of unfolding in urea 
A sample of GlpT WT was incubated in a range of 0 – 8 M urea concentrations for 5 
minutes before fluorescence spectra measurements were taken. As the structure of GlpT 
becomes more denatured, with increasing urea concentrations, the environment around 
aromatic residues changes, resulting in a different fluorescence emission spectra for 
GlpT. Representative fluorescence emission spectra are shown in figure 3.4. The shift 
of the fluorescence emission spectra is coupled with a decrease in fluorescence 
intensity, which could be caused by the surrounding solvent quenching the fluorescence 
of the affected amino acid resides (160, 165, and 171). Between 0 M and 8 M urea 
concentration, a total of 48 % decrease in fluorescence intensity was observed with 280 
nm excitation wavelength in regards to a 37 % reduction measured at 295 nm excitation 
wavelength. The shift of the wavelength of maximum fluorescence intensity was 
measured and plotted against urea concentration shown in figure 3.5.  The observed red 
shift of the emission band is an indication of the environment around aromatic residues 
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becoming more polar. It does not directly relate to protein unfolding, but instead 
describes the increasing exposure of protein to the surrounding solvent. 
 
The shift of the wavelength maximum against the urea concentration, for both excitation 
wavelengths, was fitted to the two state function with calculated midpoint of 4.9 ± 0.1 M 
and slope of 0.9 ± 0.1 for the 280 nm measurements and midpoint of 5.1 ± 0.1 M and 
slope of 0.9 ± 0.1 for the 295 nm excitation data, displayed in table 3.1. The 280 nm 
experiment spectra are due to fluorescence of tyrosine and tryptophan residues. 
Alternatively 295 nm or higher wavelengths are largely due to fluorescence of 
tryptophans. The discrepancy between different fluorescence experiments suggests that 
a different technique, which represents a more global change in the protein state would 
be more suitable to follow the GlpT unfolding. The choice of rhodamine labels and CD 
methodology is later discussed in this chapter and chapter 4 respectively. 
 
 
The free energy change of unfolding in the absence of a denaturant (ΔGUH2O) was 
calculated from the emission band shift as a result of protein unfolding. The calculated 
unfolding slope and the midpoint obtained from the sigmoidal plot is equal to 4.5 ± 0.5 
kcal.mol-1 and 4.8 ± 0.3 kcal.mol-1 for 280 and 295 nm excitation data, respectively. The 
ΔGUH2O was also calculated by a linear extrapolation method, where the ΔG values at 
each denaturant concentration were fitted to a linear equation. The y-intercept of the 
fitted straight line is descriptive of the ΔGUH2O.  The linear fit for wavelength shift plotted 
against urea concentration can be seen in figure 3.6. The ΔGUH2O values derived from 
the linear fit are 3.4 ± 0.1 kcal.mol-1 for 280 nm excitation data set and 3.5 ± 0.1 kcal.mol-
1 for 295 nm data set, with calculated slopes of -0.8 ± 0.3 and -0.7 ± 0.1 for 280 and 295 
nm, respectively. The summary of results from fluorescence measured experiments of 
unfolding assays can be found in table 3.1. The proof of reaction reversibility and 









































































































































































































































































































































































































































































































































































































































































Figure 3.4 Representative fluorescence spectra of GlpT WT incubated with urea 
Representative spectra of 0.025 mg.ml-1 GlpT WT, in a 4 mm pathlength quartz cuvette, measured 
at 280 nm and 295 nm excitation wavelength (in panels A and B, respectively), at increasing 
concentrations of urea displayed in different colours on the right. Decrease in fluorescence can 
be seen as the concentration of urea increases. The largest decrease is seen around the 5 M 
mid-point. A decrease of the fluorescence intensity due to urea unfolding is seen at both excitation 
wavelengths and is equal to 48 % decrease of the original fluorescence intensity for 280 nm 
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Figure 3.5 Wavelength shift recorded upon urea unfolding with GlpT WT 
Measurements at 280 nm excitation wavelength, shown as squares produce a smaller 
wavelength shift of 2.1 nm compared to measurements at 295 nm, represented by circles which 
produce a 3.1 nm shift. All spectra were measured with 0.025 mg.ml-1 of GlpT WT in a 4 mm 
pathlength quartz cuvette, incubated in urea for 5 minutes with data collected at 0.25 nm 
increments from between 300 and 450 nm with a slit width of 5 nm. 
 
 
Figure 3.6 Linear fits of GlpT WT unfolding measured by fluorescence 
GlpT WT was unfolded in urea and the shift of wavelength at maximal fluorescence was recorded 
to monitor the state of the protein. The linear transformation of 280 and 295 nm excitation data 
sets can be seen in panels A and B, respectively. The fit y intercept, equivalent to ΔGUH2O was 
calculated at 3.4 ± 0.1 kcal.mol-1 for 280 nm excitation data set and 3.5 ± 0.1 kcal.mol-1 for 295 
nm data set. 
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3.2.3 CD measurements of unfolding in urea 
GlpT WT unfolding was monitored by a reduction in structure measured by CD 
spectroscopy. Samples were incubated in a 0 – 8 M range of urea concentrations, at 1 
M intervals, for 5 minutes at room temperature. The full recorded spectra, between 180 
to 260 nm, of folded GlpT WT in a DDM micelle with no urea present is shown in figure 
3.7 at 0 M urea concentration.  The folded spectra were fitted to the DICHROWEB (147) 
database, which predicted the GlpT sample to be composed of 75% alpha helices.  This 
is in close agreement with previous studies (93, 122) and the published GlpT crystal 
structure of 71 % (98). Approximately 33% of the GlpT’s structure is lost in 8 M urea. An 
additional information on the state of the protein can be measured from recording a 
positive 190 nm band, which has an intensity strongly dependent on protein helicity and 
is therefore required for secondary structure content estimation. The high absorption of 
urea below 210 nm wavelength makes the measurement inaccessible, hence all 
subsequent scans at increasing urea concentration were taken between 205 and 260 
nm. The unfolded GlpT WT CD spectra is shown in figure 3.7. The CD scans were 
converted into a normalised value of mean residual ellipticity (MRE) against which urea 
concentrations were plotted to yield the unfolding curve of GlpT WT in a DDM micelle, 
seen in figure 3.8. The negative band at 222 nm wavelength was used as an indicator of 
structure lost, as well as to estimate the percentage of protein unfolded. 
 
The concentrations of 1 and 2 M urea do not denature GlpT, as determined by this assay.  
The majority of denaturation occurs above 3 M urea, with the midpoint of the denaturation 
curve occurring around 4.5 M urea.  If the CD unfolding data is fitted to a sigmoidal plot 
the resulting parameters are 4.7 ± 0.1 M for midpoint value of 0.9 ± 0.1 for slope, shown 
in figure 3.8. The resulting free energy change calculated from the sigmoidal plot is equal 
to 4.3 kcal.mol-1, compared to free energy change from linear plot, shown in panel B, 
indicated by the y intercept at 3.8 kcal.mol-1.  These fits and resulting free energy values 
are made under an assumption that the unfolding reaction is reversible and follows a two 






















Figure 3.7 CD spectra of folded GlpT WT and incubated in urea 
In top figure, GlpT WT was unfolded in increasing concentrations of urea for 5 minutes at 25°C 
after which CD spectra was taken to follow a decrease in the negative band centred at 222 nm 
wavelength. The decay of MRE at 222 nm is plotted in figure 3.6 and fitted to sigmoidal or linear 
equation to yield the ΔGUH2O value.  Spectra were recorded in a 0.2 mm pathlength cell at 1 nm 
intervals and 1 second acquisition time from 260 nm to 180 nm in buffer and from 260 nm to 205 
nm in denaturant containing samples. HT values for each urea concentration sample are shown 
in the bottom figure. In each case HT value did not exceed 500, therefore allowing use of scans 
for qualitative analysis. The raw spectra from three repeated measurements was first averaged 
with the buffer scan subtracted, the baseline between 260 and 255 nm was zeroed in CDTool 
then plotted and converted to MRE in GraFit software.  
Wavelength (nm)

























































Final data point of samples 
that contain urea 
Wavelength (nm)































Figure 3.8 Unfolding of GlpT WT in urea measured by CD fitted to sigmoidal plot 
GlpT WT was unfolded in urea for 5 minutes and the degree of unfolding monitored by a decay 
of the 222 nm band intensity was plotted against urea concentration. The resulting data was fit to 
a sigmoidal plot with a midpoint at 4.6 ± 0.1 M and slope equal to 0.9 ± 0.01, with errors from the 
standard fit of the plot, shown in panel A. Alternative method of data fitting is shown in panel B 











































































3.2.4 Reversibility of the urea unfolded GlpT WT 
The ΔGUH2O calculation for a two state unfolding reaction, shown in sections 3.2.2 and 
3.2.3, is based on the assumption that the unfolding reaction exists in a reversible 
equilibrium and consists of only two different states, unfolded and folded. 
  
The return of the secondary structure from the urea induced unfolded state to the original 
folded state was assessed by far-UV CD. The refolding reaction was initiated by rapid 
dilution of the urea. The spectra for the folded, unfolded and refolded states can be seen 
in figure 3.9. The spectrum of the refolded protein overlays with spectrum of the native 
GlpT before denaturation. It is observed that both bands at 222 and 208 nm overlay, 
signifying the return of the original intensity of CD signal when the concentration of 
denaturant is reduced ten-fold. For comparison, the unfolded spectra of GlpT is shown 
in red. Measuring the CD spectra of a refolded protein is difficult as the large dilution of 
the protein during the refolding results in a decreased CD signal. The use of higher 
pathlength cells and SRCD high intensity beam helps to reduce the noise found in the 
measurements. Moreover, the accuracy of dilution affects the total volume calculation 
and thus final protein concentration, which in turn produces additional errors during the 
CD signal to MRE conversion.  
 
The refolding reaction was repeated with GlpT being refolded using a range of refolding 
buffers containing different concentrations of urea. The resulting refolding curve, where 
the return of a CD signal, present at 0 M urea concentration, can be followed at each 
urea concentration is shown figure 3.10. The refolding curve shows an identical shape 
to the unfolded curve presented in the same figure for comparison. Although CD 
measures return of the structure, it does not provide detail into assembly of tertiary 
contacts. An additional ligand binding assay that supplements the CD data is described 

















Figure 3.9 CD spectrum of refolded GlpT compared with the folded and unfolded sample 
GlpT WT was refolded by a ten-fold dilution of GlpT sample incubated with 8 M urea. Top figure 
shows the overlay of refolded and folded samples, shown here in green and blue respectively. 
Similarity between folded and refolded CD scans represents the return to similar conditions like 
in the original structure before the denaturation by urea. The protein was unfolded for 5 minutes 
in 8 M urea at room temperature giving the spectra seen in red. The sample was then refolded by 
a ten-fold dilution into buffer and incubated for 10 minutes at room temperature before taking the 
full spectrum. HT values for each urea concentration sample are shown in the bottom figure. In 
each case HT value did not exceed 500, therefore allowing use of scans for qualitative analysis. 
The SRCD scans of folded and refolded samples were recorded at ANKA with 12 µm and 0.5 mm 
pathlength cells, respectively, with 0.5 wavelength mm intervals between 175 – 270 nm for folded 
protein and 200-270 nm for refolded sample. The unfolded spectra was measured using in-house 
Aviv Circular Dichroism Spectrophotometer, Model 410 in 0.2 mm pathlength with 1 mm interval, 
the spectra shown are an average of 3 repeated experiments.  
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Figure 3.10 Comparison of GlpT WT unfolding and refolding curves measured by CD 
The extent of GlpT structure change was monitored by CD signal at 222 nm band for both 
unfolded sample, shown as open squares, and refolded sample, shown as black circles, the errors 
are from standard error of the fit. The CD signal measured at 222 nm was converted to MRE and 
overlaid to demonstrate similarities between unfolding and refolding processes. The data was 
recorded with 0.2 mm and 0.5 pathlength cell for unfolded and refolded samples, respectively, at 
1 nm intervals and 1 second acquisition time from 260 nm to 200 nm. The raw spectra were first 
processed in CDTool then converted to MRE and plotted in GraFit software. 
 
3.2.5 Fluorescence measured unfolding induced by GuHCl 
Alpha helical membrane proteins are naturally resistant to denaturation and do not unfold 
completely, due to high energy cost of exposing their hydrophobic core (18). To further 
test GlpT stability an additional unfolding assay with GuHCl was performed. The data 
presented is the result of a single experiment and therefore needs to be repeated for 
more accurate analysis. The use of a chaotrope, GuHCl, increases the degree of protein 
unfolding, resulting in a greater loss of secondary strucutre and an increased loss of 
fluorescence upon incubation with the denaturant, due to greater degree of aromatic 
residues exposed to surrounding solvent and therefore fluorescence quenching. The 
change of protein fluorescence was monitored by excitation at 295 nm wavelength. In 
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figure 3.11, the fluorescence emission spectra of GlpT WT denatured with various 
concentrations of GuHCl are presented. The GuHCl incubation shows a more drastic 
effect on wavelength shift at fluorescence maximum as well as maximal fluorescence 
intensity compared to the denaturation experiment with urea. 
 
Approximately 37 % of fluorescence is lost in the 295 nm excitation experiment. In the 
same way as in urea denaturation assay, a shift of the wavelength maximum was 
monitored and estimated from the normal distribution fit. The resulting wavelength shift 
data can be seen in figure 3.11, with an overall 5.5 nm shift for the 295 nm excitation 
measurement. When compared to urea denaturation, GuHCl shows an increased red 
shift of the fluorescence spectra when measured in 295 nm excitation wavelength. 
Fluorescence measurements of GuHCl induced unfolding show different unfolding 
behaviour with different end points due to different denaturants having different 
































Figure 3.11 GlpT WT unfolding in GuHCl measured by fluorescence 
GlpT WT was unfolded in increasing concentrations of GuHCl for 5 minutes before spectra were 
recorded at 295 nm excitation wavelength. Different concentrations of GuHCl are represented by 
their respective colour on the right, top figure. The decrease and shift of the fluorescence peak 
can be noted, with an overall decrease of fluorescence intensity of 37 % and overall wavelength 
shift of 5.5 nm for 295 nm measurement. The peak wavelength data was analysed and plotted in 
the bottom figure, showing the wavelength shift at increasing GuHCl concentrations. All spectra 
were measured with 0.025 mg.ml-1 of GlpT WT in a 4 mm pathlength quartz cuvette, incubated in 
urea for 5 minutes, with data collected at 0.25 nm increments from between 300 and 450 nm with 
a slit width of 5 nm. 
Wavelength (nm)











































3.2.6 CD measured unfolding induced by GuHCl 
The change in GlpT’s structure induced by a 5 minute denaturation with GuHCl 
denaturant was measured via CD spectroscopy. The resulting spectra of different steps 
of denaturation can be seen in figure 3.12. The overall loss of CD signal due to GuHCl 



















Figure 3.12 CD spectra of GlpT WT incubated in GuHCl 
Top figure, GlpT incubated with increasing concentrations of GuHCl for 5 minutes, before the CD 
spectra were taken. Different concentrations of GuHCl are represented by their respective colour 
on the right. The intensity of the band at 222 nm decreases by 57 %, showing more dramatic loss 
of CD signal when compared to urea denaturation. HT values for each GuHCl concentration 
sample are shown in the bottom figure. In each case HT values recorded below 210 nm did not 
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exceed 500, therefore allowing use of scans for qualitative analysis.  Spectra were recorded with 
0.025 mg.ml-1 of GlpT WT in a 0.2 mm pathlength cell at 1 nm intervals and 1 second acquisition 
time from 260 nm to 180 nm in buffer and from 260 nm to 205 nm in denaturant containing 
samples. The raw spectra were first processed in CDTool then plotted and converted to MRE in 
GraFit software. 
 
The loss of CD signal was monitored by decay of the 222 nm band and plotted against 
increasing concentrations of GuHCl shown in figure 3.13. The data presented is the 
result of single scans and therefore needs to be repeated for a more accurate analysis. 
 
 
Figure 3.13 Unfolding of GlpT WT in GuHCl measured by CD 
The intensity of the 222 nm band was plotted against concentrations of GuHCl to follow the degree 
of unfolding of the protein. There is an immediate loss of structure due to GuHCl with steep pre-
transition baseline and noticeable saturation at 4 M concentration. The data was first processed 
in CDTool then 222 nm band was converted to MRE and plotted against GuHCl concentrations 
in GraFit software. 
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3.2.7 Time-resolved measurements of unfolding 
Urea induced unfolding of GlpT was further assessed by recording time-resolved 
measurements of fluorescence intensity during the process of protein unfolding. The goal 
was to establish a time-resolved experiment to show GlpT’s two state behaviour during 
urea unfolding, as well as to gain further insight into protein stability. The experiments 
were performed on protein purified using a gel filtration column as a last step of 
purification in order to avoid any residual dimer unfolding that may cause incorrect 
interpretation of rate constants, thus affecting results. The loss of fluorescence intensity, 
associated with the unfolding may be misinterpreted when recording the kinetics of the 
dimer unfolding due to an extra step in the unfolding reaction. An extra step is possibly 
linked to the dissociation of the two monomers at low concentrations of the urea, followed 
by unfolding of more denaturation resistant individual monomers. The steady state 
spectra were not influenced by the final method of protein preparation since the 
measurements were taken after samples had reached equilibrium. GlpT was unfolded in 
urea and each unfolding experiment was recorded for the first 200 seconds with the first 
10 seconds recorded at increased frequency in order to obtain more data points in the 
initial stages of the experiment. Up to eight traces were recorded for protein unfolding at 
the stated urea concentration. The traces were then averaged to reduce the noise, 
followed by fitting to a double exponential equation. Occasionally, a single exponential 
fit could have been made to unfolding performed at higher urea concentrations. However, 
it was not possible to fit any measurements to a single exponential fit with 6.5 M urea or 
below. To make all analysis comparable, all fits were made to a double exponential 
function. Representative unfolding measurements recorded during GlpT unfolding are 
shown in figure 3.14 with the residual for the double exponential fit to the 8 M trace 
presented below.  
 
The two rate constants calculated from each fit, corresponding to denaturation with 
different urea concentrations, were converted to a natural logarithm and plotted against 
their corresponding urea concentration, shown in figure 3.15. The rate of unfolding in the 
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absence of the denaturant can then be calculated from the inverse of the natural 
logarithm defined by an intercept at the y-axis. The error of each point on the linear plot 
is the result of the difficulty to accurately fit an exponential rate of decay to the first few 
seconds of the reaction. The reason for the GlpT’s unfolding behaviour at the beginning 
of the fluorescence recording could be due to a rich aromatic environment that is wide-
spread throughout the protein and could have led to a complex fluorescence behaviour 
















Figure 3.14 Time resolved unfolding of GlpT WT in urea measured by fluorescence 
Traces of unfolding of GlpT are shown at individual urea concentrations, shown in panel A. 
Different concentrations of urea are represented by their respective colour on the right. The top 
trace at 0 M urea concentration was recorded with protein in buffer. It shows fluorescence decay 
due to photo bleaching.  Each trace is an average of up to 8 repeats, before the resulting trace 
was fit to a double exponential fit. A single exponential equation could not be fit accurately, mainly 
due to the unclear initial rate measurements. An example of the residual from the fit is seen below 
in panel B.  
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The resulting first and second rate constants from the linear plot were calculated to be 
6.7 x 10-3 ± 4.0 x 10-3 s-1 and 3.9 x 10-3 ± 5.7 x 10-4 s-1 respectively, with error taken from 
the standard error of each linear fit. The gradient of the linear fit to kinetic data is 
characteristic of the dependency of the unfolding on the denaturant concentration, with 
the first and second rate gradient equal to 0.42 ± 0.05 kcal.mol-1.M and 0.22 ± 0.01 
kcal.mol-1.M, respectively. The second reaction rate could be associated with the protein 
undergoing photobleaching during the experiment (172). The GlpT photobleaching 
during this assay can be seen from the grey coloured trace, measured in the absence of 
urea, in figure 3.14. The lower dependency on the denaturant, described by a smaller 
gradient of second rate compared to first rate confirms this possibility. The unreliability 
of kinetic measurements makes the assessment of a two state behaviour difficult. Future 
experiments with time resolved measurements and single fluorescence probes 
discussed later should clarify and conclusively show the existence or lack of any 
intermediates in the GlpT’s unfolding reaction mechanism. 
 
Figure 3.15 Unfolding kinetics of GlpT WT 
The rate of unfolding for each urea concentration was calculated from the double exponential fit 
with the resulting first and second rate shown in panels A and B, respectively. The natural 
logarithm of the rate of unfolding in the absence of denaturant, represented by the intercept at y-
axis was calculated to be -5.0 ± 0.3 and -5.5 ± 0.1 for first and second rate respectively, the errors 
shown are from standard error of the fit and a result of 4 repeats. 
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3.2.8 Thermal denaturation of GlpT WT 
The GlpT unfolding was investigated with increasing temperature. At each temperature 
step a recording of either fluorescence or CD signal was taken in order to monitor the 
state of the protein, shown in Figure 3.16. The CD signal at 222 nm band, the maximum 
fluorescence intensity and the peak fluorescence wavelength were chosen as 
parameters to construct denaturation curves that were then fitted to sigmoidal equations, 
with the midpoint of the transition curve taken as the denaturation midpoint Tm. The 
temperature denaturation curves for fluorescence and CD measurements are found in 
figures 3.17 and 3.18, respectively. The concentration of the protein used in each 
temperature denaturation experiment was kept constant at 0.1 mg.ml-1 in order to keep 
calculated Tm values comparable. The summary of individual Tm values from each 
parameter recorded can be seen in Table 3.2 
 
Parameter recorded Tm (°C) 
Fluorescence intensity (280 nm 
excitation) 
51.0 ± 0.3 
Fluorescence intensity (295 nm 
excitation) 
54.6 ± 0.5 
Wavelength at fluorescence emission 
maximum (280 nm excitation) 
52.9 ± 1.3 
Wavelength at fluorescence emission 
maximum (295 nm excitation) 
53.2 ± 1.1 
CD signal decay at 222 nm 49.0 ± 0.2 
 
Table 3.2 Thermal denaturation of GlpT WT 
The Tm values of GlpT WT were calculated by fitting sigmoidal equation to each denaturation 
curve, the errors are given from the standard error of the fit. Regardless of the method of analysing 
the temperature denaturation in fluorescence based experiments, the resulting Tm is in the same 




Figure 3.16 Thermal denaturation scans of GlpT WT 
Each scan was taken at an increasing different temperature on the same protein sample. The 
corresponding temperature of each scan is displayed on the right for both A, CD measured 
denaturation, and B, fluorescence measured denaturation. Fluorescence spectra were recorded 
with 0.1 mg.ml-1 GlpT WT, in a 1 mm pathlength quartz cuvette measured at 280 nm. The CD 
spectra were recorded with 0.1 mg.ml-1 of GlpT WT in a 0.2 mm pathlength cell at 1 nm intervals 


















































































Overall, there is no difference between Tm values determined from fluorescence 
intensity change or wavelength maximum, as most Tm values lie close within 53 °C 
range.  The protein unfolding measured by CD has a smaller pre-transition slope and 
bigger transition phase than the fluorescence recorded experiment. The resulting Tm 
from CD temperature denaturation was determined to be 49.0 ± 0.2 °C. Different 
transition phases and resulting Tm values between fluorescence and CD temperature 
experiments could be due to a CD signal change being a global representation of shifting 











Figure 3.17 Thermal denaturation of WT measured by fluorescence 
The fluorescence scans, shown in figure 3.16, were taken at 5 °C intervals, each scan was fitted 
with a normal distribution fit to estimate maximal fluorescence intensity (panel A) and fluorescence 
emission maximum (panel B), presented in the figure above. A sigmoidal equation with fixed pre- 
and post-transition slopes was fit to both experiments at 280 nm excitation, shown as squares, 
and 295 nm excitation, shown as circles, to find the midpoint of transition upon thermal 


































































Figure 3.18 Thermal denaturation of WT measured by CD 
The CD scans were taken at 5 °C intervals to monitor the extent of CD signal loss with increasing 
temperature. The decay of CD signal at 222 nm was then fit to sigmoidal curve to find the midpoint 
of transition upon thermal denaturation, Tm of 49.0 ± 0.2 °C, with the error taken from the standard 
error of the fit. 
 
3.2.9 Ligand binding  
A ligand binding assay was employed as an additional assessment of the efficiency of 
GlpT to undergo refolding from the urea denatured state. The CD refolding assay 
discussed in section 3.2.4 shows the return of pre-denaturation CD spectra, however it 
does not provide any extra information on the return of tertiary structure content. By 
comparing the binding pocket’s affinity for the ligand before and after refolding it is 
possible to assess whether the refolding is fully reversible.  
 
During the protein refolding, both the protein and denaturant are diluted tenfold from the 
saturating urea concentration of 8 M to a concentration of 0.8 M. The unfolding assay, 
discussed in section 3.2.3 shows the majority of denaturation occurs above 3 M urea.  
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Therefore, the structured content present at 0.8 M urea should closely resemble that of 
the non-denatured GlpT. Furthermore, a tenfold dilution of the sample is desirable in this 
experimental design, in order to avoid saturating binding sites at low ligand 
concentrations, thus enabling accurate measurement of the ligand binding constant. If 
the protein concentration exceeds the binding constant it can lead to a false recording of 
ligand saturation and therefore incorrect calculation of the dissociation constant. 
 
The binding affinity in transporters is usually found in the µM to mM range. Several 
methods and compounds were used to find an appropriate ligand with strong binding 
affinity in the µM range, which would enable easier estimation of the return of substrate 
affinity upon protein refolding. Furthermore, the ligand binding needs to be accurately 
and robustly measured in the detergent micelle-protein system. Through literature 
research, 4 ligands were identified for their strong affinity to GlpT: G3P, Pi, P5P and 
phosphomycin. Fluorescence quenching via ligand binding, presented in the previous 
research (98) was found to be difficult to repeat due to the small degree of fluorescence 
quenching and photobleaching during the titration experiments with the same sample.   
 
The ligand binding assay was also measured by recording changes in the CD signal 
upon ligand binding. Out of 4 ligands, P5P and phosphomycin showed the largest 
change in the CD spectra with a 7 % and 3 % signal increase at the 222 nm band, 
respectively. The SRCD spectra recorded with GlpT WT incubated with phosphomycin 
and P5P are shown in Figure 3.19. Deconvolution of CD spectra of the GlpT WT with 
phosphomycin and P5P using the SMP180 dataset gives helical structures of 70 % and 
78 % alpha helix for phosphomycin and P5P bound GlpT WT, respectively. Both G3P 
























Figure 3.19 CD scan of WT incubated with ligands 
GlpT WT was incubated for 10 minutes with phosphomycin, shown in blue or P5P represented 
by green line and GlpT WT with no ligand in red. Spectra were recorded with 0.1 mm pathlength 
cells at ANKA SRCD source at 0.5 nm intervals and 1500 ms averaging time from 180-270 nm. 
Panel A shows whole spectra recorded, negative alpha helical bands of the same measurements 
can be seen magnified in panel B. The raw spectra were processed with CDTool and plotted 
using GraFit software. 
Wavelength (nm)








































































































The P5P was chosen as the best ligand for the refolded ligand binding assay due to its 
large effect on the CD signal change. A 2 mm pathlength cell was used in recording CD 
spectra due to the low protein concentration necessary for ligand binding. Precautions 
were made to make sure that bigger pathlength does not lead to any light scattering 
during the experiments and therefore contribute to a smaller change of CD signal. CD 
signal change at 222 nm was used to monitor the change, and was plotted against P5P 
to give saturation binding curve shown in figure 3.20. Compared to the binding assay 
recorded with fluorescence, the CD orientated method provided a more accurate and 
repeatable method of calculating Kd. 
 
 
Figure 3.20 Saturation binding experiment with GlpT WT incubated with P5P 
Changes in CD signal change upon P5P binding between folded and refolded GlpT WT are shown 
in black and open squares, respectively. Denatured protein showing lack of binding is represented 
by triangles. Single site binding model was found to fit best to the data giving binding constant for 
folded protein equal to 0.71 ± 0.11 µM and refolded protein equal to 0.84 ± 0.11 µM, error taken 
from the standard error of the fit. Data shown is a repeat of 3 experiments. The raw spectra were 
processed with CDTool with data converted into percentages, plotted and fitted applying single 




























CD data for folded GlpT WT in the native state fitted to the single binding site model 
gives a Kd of 0.71 ± 0.11 µM. Protein was then denatured and refolded by a tenfold 
dilution. After 10 minute incubation in the refolding buffer, P5P ligand was added, giving 
a total protein concentration of 0.02 mg.ml-1. Sample was allowed to reach steady state 
before a CD scan was taken. Calculated binding constant from a single binding site 
model for refolded GlpT WT was given as 0.84 ± 0.11 µM. The denatured protein showed 
no change in CD signal upon ligand binding.  
 
3.2.10 Stability of ligand bound GlpT WT 
The stability of transporter GlpT WT in the native unbound state was investigated in 
contrast to its stability in the bound state. The protein sample was incubated for 10 
minutes with various ligands prior to addition of various concentrations of urea. Unfolding 
curves of GlpT WT in the presence of phosphomycin only, G3P only and inorganic 
phosphate only are found in figure 3.21. None of the ligands above showed any change 
in the unfolding with urea or temperature-induced denaturation when compared to the 
WT. Only incubation with the P5P was found to affect the stability of the protein.  
 
Sensitivity to the temperature denaturation of the P5P bound state of the GlpT WT was 
also investigated and was found to be equal to 59.5 ± 0.2 °C, observing a 10.5 °C change 
in Tm to GlpT WT in the absence of any ligands. Both temperature and urea denaturation 
curves of GlpT WT incubated with and in absence of P5P ligand can be seen in figures 
3.22 and 3.23, respectively. The profile of urea denaturation changed noticeably when 
GlpT WT was incubated with the ligand P5P. The protein remained mostly unchanged 
until a concentration of 6 M urea was reached. The total percentage of CD signal loss at 













Figure 3.21 Unfolding curves of GlpT WT in the presence of phosphomycin, G3P and 
inorganic phosphate 
GlpT WT was incubated for 10 minutes with 1 mM phosphomycin, shown as black circles, 1 mM 
P5P represented by open circles, 1 mM inorganic phosphate, shown as squares and control, 
shown as triangles, prior to 5 minute incubation with various concentrations of urea. Percentage 
of structure unfolded was calculated based on shift of the wavelength maximum fluorescence 
recorded on Fluoromax-4 fluorescence emission recordings at 295 nm excitation wavelength, in 
which 0 % represents protein in buffer (absence of urea) and 100 % protein unfolded at 9 M of 













































Figure 3.22 Temperature denaturation curves of GlpT WT with P5P 
GlpT WT was incubated for 10 minutes at RT with 100 µM P5P, shown as open circles, before 
the sample was cooled down to 5° C and the temperature was increased at 2 °C intervals. The 
decay of CD signal at the 222 nm was used to monitor the extent of protein unfolding loss and 
was fit to sigmoidal curve to find the midpoint of transition upon thermal denaturation, Tm of 59.5 
± 0.2°C. Error taken from the standard error of the fit. GlpT WT denatured in the absence of ligand 









Figure 3.23 Urea denaturation curve of GlpT WT incubated with P5P 
Sample of GlpT WT was incubated for 10 minutes at RT with 100 µM P5P, before the sample 
was denatured for 5 minutes with various concentrations of urea. The CD signal at 222 nm was 
used to monitor the extent of protein unfolding. No change is noted until 5 M urea in contrast to 
the 4.8 M midpoint of a two state denaturation mechanism of GlpT WT in absence of any ligands. 
Data are shown as average of 3 repeats with error taken as standard error of the mean. 
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3.2.11 Single tryptophan variants of GlpT 
Three sites were chosen to test protein structure tolerance for tryptophan substitution. 
Each tryptophan mutant was analysed by CD spectrometry. The scans of single-
tryptophan mutants and the folded WT are shown in figure 3.24. As described previously 
in chapter 2, the single tryptophan mutations were individually mutated into a tryptophan 
lacking gene of GlpT. The F148W mutant, located on a loop between helices 3 and 5, 
shows an identical spectrum to the Trp-less variant. However the M107W and V332W, 
located in the inter-helical bundle of domain 1 and 2, respectively, show an altered CD 
spectrum, implying there was an incomplete folded structure. Moreover, all the single-
tryptophan mutants as well as the Trp-less variant show a smaller negative band at 208 
nm, suggesting an altered structure content to WT. The mutants were also subjected to 
a lower yield during the purification as well as increased tendency to aggregate 
problems. Due to the small extinction coefficient of tryptophan, compared to the extrinsic 
commercial labels, a high quantity of purified protein would be necessary for time-
resolved experiments. Overall, the single tryptophan mutants, were found to be non-
suitable probes for unfolding, due to the difficulty in sample preparation, protein yield and 
altered structure. Consequently, attention was given to the rhodamine labelled variant of 




Figure 3.24 CD spectra of GlpT WT and single tryptophan variants in DDM micelles 
Above, the single-tryptophan variants F148W, M107W and V332W are shown along with the Trp-
less mutant and the WT for comparison. Below, the same spectra are shown expanded between 
270-200 nm wavelengths to clearly show differences in the negative bands of the CD spectrum. 
Spectra were recorded in buffer with 0.2 mm pathlength cell at 1 nm intervals and 1 second 
acquisition time from 270 nm to 180 nm. The raw spectra were first processed in CDTool then 
plotted and converted to MRE in GraFit software. 
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3.2.12 Purification of cysteine mutant GlpT and rhodamine labelling 
Cysteine mutations were introduced to GlpT in order to provide sites for GlpT labelling 
with fluorescent probes. A ‘complete’ cysteine mutant GlpT is characterised by three 
mutations. Two cysteine substitutions were placed at desired label sites located at the 
cytoplasmic loops connecting helices 1-2 and 7-8. The remaining mutation was a serine 
substitution of a solvent exposed cysteine (C215S), which could interfere in the future 
process of rhodamine labelling. There was a marked drop in yield associated with the 
purification of the ‘complete’ cysteine mutant, with a significant fraction of it lost in the 
void volume of the gel filtration column as an aggregate. The remaining protein was 
collected as a monomer at an expected molecular size observed in a WT protein. The 
final protein elute was then spin concentrated to a stock of approximately 1 mg.ml-1, 
before it was subjected to the conjugation reaction. The resulting SDS-PAGE gel of the 
purification procedure can be seen in figure 3.25. The far-UV spectra of the cysteine 
label GlpT before the process of labelling can be seen in figure 3.26. The CD spectrum 
of the cysteine mutant closely resembles the WT. Repeated measurements with a higher 

































Figure 3.25 SDS-PAGE gel of rhodamine label GlpT purification visualised by coomassie 
blue staining 
SDS-PAGE analysis was used to determine the efficiency and purity of rhodamine labelled GlpT 
at various stages of purification. Samples of 10 µL were taken at each stage and run on gel as 
follows: All-blue protein standard (corresponding molecular weight of each band labelled on the 
left in kDa); solubilised membrane fraction derived from the cell lysate; flow-through of an 
unbound fraction; 50 mM imidazole wash step; 500 mM imidazole elution collected from the Ni 
affinity column and spin concentrated; top gel filtration fractions pooled together and spin 
concentrated and finally, rhodamine labelled GlpT with the excess label removed via spin column. 
Both Ni2+affinity (1 ml HisTrap HP Ni2+ metal ion affinity column) and gel filtration (HiLoad 
Superdex 200 PG gel filtration column) were carried out at a flow-rate of 1 ml\min and mounted 
on the ÄKTA pure chromatography system. The dye removal step was performed using a dye 













Figure 3.26 CD spectra of cysteine label GlpT and GlpT WT in DDM 
The far-UV CD spectrum of cysteine mutant GlpT, marked with a solid line, and GlpT WT, 
represented with a dotted line was taken in native conditions to assess the similarity of the 
structure between the cysteine mutant and the WT. The GlpT WT and cysteine label GlpT spectra 
were recorded with 0.2 mm pathlength cell and 0.5 mm pathlength cell respectively, at 1 nm 
intervals and a 1 second acquisition time from 270 nm to 190 nm in buffer. The raw spectra were 
first processed in CDTool then plotted and converted to MRE in GraFit software 
 
After the cysteine mutant GlpT was purified, it was incubated with an excess of 
rhodamine label. The commercial protocol comparing UV absorbance at 280 nm and 
541 nm found that the recommended incubation of 2 hours labelled only 60 % of all 
possible label sites, yielding only a small fraction of double-labelled protein. An overnight 
incubation at 4°C temperature improved the efficiency by producing a yield of 
approximately 85 % of all possible label sites being conjugated, resulting in a better 
Wavelength (nm)




















































potential for a measureable signal change in future experiments. It is possible that the 
DDM micelle was interfering in the labelling process, therefore a higher molar excess of 
the rhodamine label and extended incubation time was necessary. Care needs to be 
taken when estimating the labelling efficiency of the purified protein. The monomer and 
dimer of rhodamine give off different spectra. Therefore the resulting measurement is a 
collection of two different species. The efficiency of the labelling was calculated from the 
UV-vis spectra of protein incubated in 8 M GuHCl, as described in the methods in chapter 
2. The cysteine mutant remained stable throughout the process of rhodamine labelling 
and subsequent dye removal process. The dye excess was removed using two dye 
removal columns, provided by Thermo Fisher, per labelling reaction. Approximately 10% 
of the protein was lost at each dye removal step. Further experiments focusing on the 
optimisation of labelling and purification would provide a greater final yield of the labelled 
protein. Moreover, additional quantification methods, for example using mass 
spectroscopy techniques, would identify the number of labelled residues as well as the 
efficiency of labelling. 
  
3.2.13 CD measurements of rhodamine labelled GlpT in urea induced 
unfolding 
An initial test of the newly purified cysteine mutant, GlpT C215S, was used to establish 
its capacity to unfold and to compare its stability to the WT. Only few CD scans of the 
urea unfolded sample could be collected, as the low protein yield restricted the study. 
The protein sample was first incubated with reducing conditions of TCEP to fully 
eliminate any disulphide bridges that could have formed during the experiment. The scan 
of the newly purified cysteine mutant GlpT shows a close resemblance to the WT, as 
seen previously in figure 3.26. During the urea-induced unfolding the structure of the 
cysteine mutant GlpT lost approximately 34 % of its structure, similar to the WT which 
also loses a third of its structure in 8 M urea. The full CD scan of the folded and unfolded 
state in DDM is shown in figure 3.27. The high noise of the scan is associated with the 
105 
 
low protein concentration of 0.02 mg.ml-1. The profile of urea unfolding for the cysteine 
mutant is shown in figure 3.28. The one-time measurement of unfolding is insufficient to 
establish the ΔGuH2O value and the two state system. Repeats of the CD urea unfolding 
assay would be necessary to compare the midpoint and gradient of transition, however 
the results so far suggest a similar extent and profile of unfolding. The CD results are 
encouraging as it is beneficial that the GlpT mechanism of unfolding remained unaffected 
by the cysteine mutations thus enabling probing of the specific regions of the protein 















Figure 5.27 CD spectra of cysteine label GlpT and GlpT WT in DDM 
Cysteine mutant GlpT was unfolded in urea for 5 minutes and the degree of unfolding monitored 
by 222 nm band intensity plotted against urea concentration. Spectra was recorded using 0.08 
mg.ml-1 cysteine GlpT mutant in DDM and TCEP with a 0.5 mm pathlength cell at 1 nm intervals, 
a 2 second acquisition time from 270 nm to 190 nm in the buffer and from 270 nm to 205 nm in 
denaturant contained sample. The raw spectra were first processed in CDTool then plotted and 
converted to MRE in GraFit software. 
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Figure 3.28 Unfolding of cysteine mutant GlpT in urea measured by CD 
Cysteine mutant GlpT, shown as black dots, was unfolded in urea for 5 minutes and the degree 
of unfolding monitored by 222 nm band intensity plotted against urea concentration. Unfolding of 
the GlpT WT is shown as white squares for comparison. There was little unfolding of the cysteine 
mutant GlpT, shown in the first few urea concentration points, with the structure beginning to 
unfold after a 3 M concentration was reached, similarly to GlpT WT.  The total CD signal lost 
between the 0 and 8 M concentration points is estimated to be around 34 %. 
 
The stability of the cysteine GlpT mutant was further assayed via a thermal denaturation 
experiment. Similar to the CD urea unfolding assay, the sample of the protein was 
incubated with excess TCEP, in order to reduce any disulphide bridges that could have 
formed and influence the structure stability. The unfolding was monitored by the decay 
of a 222 nm CD signal. The CD signal was converted to MRE and plotted against the 
temperature, the resulting chart can be seen in figure 3.29. The calculated unfolding 
parameters from the sigmoidal fit show Tm of 45.6 °C ± 0.5 °C and a gradient of transition 
phase of 1.5 ± 0.4. Both of these are comparable with the CD measurements for WT 
(TmWT 48.9 ± 0.1 °C, gradientWT 2.2 ± 0.1) suggesting that cysteine changes did not 
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greatly affect the temperature stability of the protein, any differences are due to the 














Figure 3.29 Thermal denaturation of cysteine mutant GlpT measured by CD 
The cysteine mutant GlpT, shown as white squares, was incubated with TCEP prior to 
temperature denaturation, GlpT WT results are shown as black dots for comparison. The decay 
of the CD signal at 222 nm was converted to MRE and used to monitor the extent of the structure 
loss. The sigmoidal curve was fit to the cysteine mutant GlpT denaturation data, resulting in a Tm 
of 45.6 ± 0.5 °C and gradient of transition phase of 1.5 ± 0.4. The CD scans were taken at 2 °C 
intervals with 0.1 mg.ml-1 of protein sample in 1 mm pathlength cell. Data was plotted, converted 








































   


























3.2.14 Fluorescence measurements of rhodamine labelled GlpT 
unfolding 
Rhodamine labelled cysteine mutant of GlpT was unfolded in urea with the progress of 
unfolding measured by the fluorescence response of two rhodamine labels. Both labels 
were placed on an endoplasmic loop located on a separate domain. The interaction 
between the two labels was used in monitoring the progress of unfolding seen by a 
fluorescence spectra recorded by 550 nm excitation in figure 3.30. 
 
Surprisingly, denaturation by either urea or GuHCl resulted in a fluorescence loss. 
Approximately 21.9 % of fluorescence intensity was lost due to 9 M urea, compared to 
22.5 % fluorescence lost due to GuHCl. The maximal fluorescence intensity was plotted 
against the denaturant concentration and can be seen in figure 3.31. The urea 
denaturation plot looks comparable to the two state urea unfolding plots discussed in 
earlier in this chapter, with a midpoint approximately near 5 M urea concentration. The 
current fit provides ΔGUH2O equal to 5.0 ± 1.7 kcal/mol, however the experiment would 
need repeating for a clearer picture of unfolding and subsequent ΔGUH2O calculation. The 
similarity of ΔGUH2O magnitude is encouraging, but more experiments into labelled GlpT 
are needed. The further fluorescence quenching recorded in the unfolding assay were 
possibly brought about by a further increase in proximity of the two labels in the unfolded 

























Figure 3.30 Representative fluorescence spectra of rhodamine labelled GlpT incubated 
wit urea and GuHCl 
Representative spectra of rhodamine labelled GlpT incubated with urea and GuHCl in panels A 
and B, respectively. The increasing concentrations of each denaturant are shown in different 
colours on the right of the respective panel. A large drop of fluorescence coupled with big shifts 
of wavelength at maximum fluorescence can be seen in all measured spectra. The overall 
decrease of fluorescence due to urea and GuHCl unfolding was recorded at 22 % and 23%. All 
spectra were measured with 0.0025 mg.ml-1 of GlpT WT in a 4 mm pathlength quartz cuvette, 
incubated in urea or GuHCl for 5 minutes with data collected at 0.25 nm increments from between 
355 and 620 nm with a slit width of 3 nm. 
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Figure 3.31 Fluorescence intensity recorded upon urea and GuHCl unfolding with 
rhodamine labelled GlpT 
The unfolding of the rhodamine labelled GlpT with urea, in panel A, and GuHCl, shown in panel 
B, is accompanied with the fluorescence lost due to quenching of rhodamine labels by an  
increase in their proximity or due to interactions with another amino acid residue.  The urea 
induced unfolding was fitted to sigmoidal equation with the midpoint and gradient equal to 5.4 M 
and 0.9, respectively. All spectra were measured with 0.0025 mg.ml-1 of rhodamine labelled GlpT 
in a 4 mm pathlength quartz cuvette, incubated in urea or GuHCl for 5 minutes with data collected 
at 0.25 nm increments from between 550 and 620 nm with a slit width of 3 nm. Data was analysed 
in plotted in GraFit software. 
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Moreover, the label’s fluorescence spectra is shifted towards a longer wavelength 
spectrum as the protein unfolds, as shown in figure 3.31. The wavelength shift at 
maximum fluorescence was analysed by fitting a normal distribution curve, as shown in 
chapter 3, as well as comparing the ratios of fluorescence intensity recorded at 365 and 
385 nm. The resulting data was plotted against the urea concentration and is displayed 
in figure 3.32. The urea-induced denaturation produced a total wavelength shift of 5.7 
nm compared to the 8.1 nm shift recorded for the GuHCl induced denaturation. Both 
denaturation graphs, show a uniform wavelength shift with difficult to distinguish pre- and 
post-transition baselines, making any two state fit impossible.  
 
In the folded protein, the close proximity between the two rhodamine labels causes them 
to form dimer rhodamine stacks with different fluorescent properties. As the protein 
unfolds the ratio of rhodamine dimer to monomer population changes, affecting the 
fluorescence spectra recorded. Recording OD365/OD385, alongside the peak wavelength 
shift, provides an additional insight into the distribution of rhodamine monomers and 
dimers during the process of unfolding. The OD365/OD385 ratio shows a slightly different 
profile of unfolding with urea shifting by a total value of 0.35, compared with a value of 
0.41 measured for the GuHCl induced denaturation. Interestingly, there is a big change 
in OD365/OD385 values recorded at the 6 M point for the urea induced denaturation and 
the 5 M point for the GuHCl denaturation. It is possible that at this point, the region around 
the rhodamine label experiences the biggest conformational change that could be 
represented by a transition point of the two state unfolding of GlpT. If that reasoning is 
correct, then it is possible that the periplasmic side of GlpT, where the two rhodamine 

























Figure 3.32 Wavelength shift recorded upon urea and GuHCl unfolding with rhodamine 
labelled GlpT 
The protein unfolding with urea, panel A, and GuHCl, shown in panel B, is coupled with the 
wavelength shift used to monitor the degree of unfolding. The wavelength shift of 5.7 nm was 
recorded for the urea induced denaturation, compared with 8.1 nm with the GuHCl. The ratio of 
fluorescence intensities at 365 and 385 nm. This was used as an additional measure of the 
fluorescence peak shift, due to a rhodamine dimer formation, the ratio analysis can be seen on 
the right with their respective peak wavelength shift graph. The OD365/OD385 ratio shows a slightly 
different profile of unfolding with the urea shifting by a total value of 0.35, compared to 0.41 value 
measured for the GuHCl induced denaturation. All spectra were measured with 0.0025 mg.ml-1 
of GlpT WT in a 4 mm pathlength quartz cuvette. Data was analysed and plotted in GraFit 
software. 
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3.2.15 Fluorescence measurements of a refolding reaction of 
rhodamine labelled GlpT 
The refolding capacity from the urea denatured state of the rhodamine labelled GlpT was 
assayed by fluorescence measured at 550 nm excitation wavelength. The fluorescence 
spectra of the folded and refolded sample with the unfolded spectra for comparison can 
be seen in figure 3.33. Approximately 95 % of total fluorescence is recovered. The 
refolding is also coupled with the return of the native wavelength at maximum 
fluorescence intensity, implying rhodamine labels return to their original environment in 
the folded state. Similarly to GlpT WT, no refolding was observed from the GuHCl 
denatured state. The progress of refolding at various urea concentrations was followed 
by the wavelength shift and can be seen in figure 3.34. The refolding and unfolding 
profiles show close similarities, implying a similar folding and refolding pathway. The 
fluorescence refolding experiments would need repeating for a more complete picture of 
refolding, however data so far is encouraging as it suggests minimal impact of the 
labelling and cysteine mutation on protein behaviour seen in earlier in this chapter. 
Further experiments focusing on optimisation of labelling and protein purification would 
solve the issue. Similarly, the ligand binding assay would have to be performed to assess 
the effect of mutations on the ligand binding affinity as well as the return of the tertiary 

















Figure 3.33 Representative fluorescence spectra of the folded, refolded and unfolded 
rhodamine labelled GlpT 
The rhodamine labelled GlpT was refolded by a ten-fold dilution of the unfolded GlpT sample 
incubated with 8 M urea. The overlay of refolded and folded samples, shown here in solid and 
dashed lines respectively, represents the almost complete return of original fluorescence. The 
protein was unfolded for 5 minutes in 8 M urea at room temperature giving the spectra seen by a 
dotted line. The refolded sample was unfolded in the same manner, followed by a ten-fold dilution 
into the buffer and incubated for 10 minutes at room temperature before taking the measurement. 
The scans of all samples were taken with 0.0025 mg.ml-1 of GlpT WT in a 4 mm pathlength quartz 
cuvette, with data collected at 0.25 nm increments from between 355 and 620 nm with a slit width 














































Figure 3.34 Comparison of rhodamine labelled GlpT unfolding and refolding profiles of 
wavelengths shifts in the urea denaturation experiments 
The progress of refolding was monitored at each urea concentration by estimating the peak 
wavelength using a normal distribution fit. The refolding data, shown by black circles, is compared 
to the unfolding data displayed earlier in figure 5.11 and represented here by white circles. Both 
profiles overlay closely with each other with a small difference present at 0.8 M point, resulting in 
an almost complete return of the native peak wavelength. The data was analysed and plotted 




































3.3.1 Stability of GlpT WT to denaturants 
The stability of GlpT WT was investigated using chemical denaturants such as urea and 
GuHCl. Approximately 33 % of protein CD signal was lost upon denaturation with urea. 
Alternatively, the stronger denaturant GuHCl was found to unfold up to 45 % of the 
protein. GlpT WT unfolding was also investigated by fluorescence emission experiments 
excited at both 280 and 295 nm. These experiments provided different ΔGUH2O values of 
4.5 and 4.8 kcal.mol-1, respectively. The difference between ΔGUH2O derived values is 
difficult to interpret, as the abundance and wide-spread positons of aromatic residues 
across the GlpT structure, complicate the interpretation. Changes affecting one 
tryptophan can be offset by interactions with other aromatic residues. Any change to 
fluorescence spectra can therefore be misinterpreted as little unfolding happening.  
Therefore, fluorescence experiment results are mainly used as a complementary picture 
of GlpT unfolding. The discrepancies between different fluorescence experiments, from 
using different excitation wavelengths, suggest that a CD technique is better in 
measuring ΔG differences in the chapter 4, as it represents a global change in the protein 
state. Although GuHCl unfolds the protein to a much larger extent it is more difficult to 
assess the pre-transition baseline of unfolding. Alternatively, the unfolding reaction using 
urea shows clear pre- and post- transition baselines, as well as reversibility, which in turn 
makes the urea unfolding assay appropriate to calculate ΔGUH2O values. The following 
chapter 4’s analysis of alanine scan is therefore based on urea denaturations. 
 
Superimposed unfolding curves and similar fitting parameters from fluorescence and CD 
experiments show that the loss of structure is closely followed by an increase in solvent 
exposure indicated by red shift of the wavelength maximum, as well as fluorescence 
intensity quenching. Furthermore, during the process of unfolding, GlpT losses a third of 
helicity, combined with only a small wavelength shift. These outcomes suggest that the 
GlpT unfolding process results primarily in disrupted helix interactions, while most 
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aromatic residues stay protected at the expense of loss of structure. It is likely that the 
extent of helix structure unfolding is mostly limited to the ends of helices and possibly to 
disrupting coiled coil helix interactions of two domains of GlpT. The comparison between 
CD and fluorescent measurements hints at a non-uniform GlpT unfolding, where different 
areas of protein unfold to a different extent. Additional studies using fluorescence probes, 
sensitive to changes of environment would help to obtain more localised information, 
which would then help to determine the extent of unfolding in individual regions of the 
protein. 
 
3.3.2 Temperature denaturation 
Thermal denaturation was performed to assay the stability of the GlpT WT, as well as to 
compare it to the temperature stability of other MFS proteins. The assay is also used to 
measure the differences in stability of GlpT’s alanine mutants in chapter 4. The process 
of protein unfolding due to increasing temperature was monitored by both fluorescence 
and CD. Both experiments were fitted to the sigmoidal equation to calculate the melting 
point, Tm. A slight difference was observed in the calculated values for Tm, with the 
fluorescence recorded Tm value being a few degrees larger. The difference could be 
attributed to the error in protein concentration, which was found to vary with the 
measured Tm. Therefore, to provide comparison, all protein temperature denaturation 
experiments were performed at the 0.1 mg.ml-1 protein concentration. Bigger protein 
concentrations increase the risk of protein aggregation and therefore the resistance to 
temperature denaturation. However, lower concentrations decrease the CD signal, 
leading to an increased error of the measurement.   
 
The measurements of fluorescence at a range of temperatures showed a great 
dependence of fluorescence on temperature, with a steep pre- and post-transition 
baseline recorded for the fluorescence intensity. These results suggest great flexibility of 
GlpT structure to respond to changes in environment, exposing the aromatic amino acids 
to the surrounding solvent. While fluorescence shows a sharp baseline, structure 
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changes are less obvious at the pre-transition stage. The results suggest that as 
temperature increases and the protein unfolds, first the tertiary contacts are lost with 
most of structure loss occurring at the most solvent exposed areas of the helices. 
Followed by the loops and then in the final stage, the alpha helices unfold. However, this 
needs be further investigated using methods that provide more specific measurements 
on stability of individual regions of the protein. The effect of individual alanine 
substitutions on the temperature stability of GlpT is later discussed in chapter 4. 
 
3.3.3 Reversibility of the GlpT WT unfolding 
Unfolding of GlpT WT from urea induced denaturation was found to be reversible by the 
complete return of the CD signal measured at the 222 nm. Furthermore, the full CD 
spectra of the refolded sample was found to overlay with the scan of the protein before 
denaturation. These results are indicative of the native secondary structure return upon 
removal of the denaturant. Once the concentration of urea was reduced to a lower range, 
the secondary structure contacts were re-established to the same extent, as shown by 
the refolding curve comparison of the secondary structure content between the unfolding 
and refolding curves at each different urea concentrations. The overlay and close 
resemblance of both unfolding and refolding curves is a good indication that forward and 
reverse changes belong to the same reaction. Further evidence is provided by 
comparison of ΔG values from folding and unfolding curves. If both curves belong to the 
same reaction, then the ΔG values should be similar. This is indeed the case as the 
folding and unfolding curves of GlpT WT overlay against each other, with ΔGuH2O and 
ΔGFH2O both found in close proximity to the 4.6 kcal/mol value.  
 
To further assay GlpT reversibility, information on the return of tertiary contacts is also 
required. The results from P5P binding assay show closely related binding affinities 
measured in the sample before denaturation and after the refolding reaction. This 
suggests that the GlpT is able to regain its secondary structure as well as tertiary 
conformation, as the amino acid residues responsible for binding have likely returned to 
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their native positions before denaturation, thus resulting in a similar affinity to substrate 
binding.  
 
3.3.4 P5P binding assay 
A ligand binding assay was primarily developed to assay the reversibility of GlpT 
unfolding. The effect of ligand binding on protein stability as well as the effect of alanine 
mutations on the GlpT functionality were also investigated.  
 
The mechanism of GlpT ligand binding was first described by Law (117, 119). However, 
the previously published protocol was not successfully reproduced. The assay suffered 
problems with binding not causing significant changes of fluorescence when substrate 
was introduced. Furthermore, photobleaching was found to cause too much interference 
during the titration experiments, making substrate induced fluorescence quenching 
difficult to analyse (173). The assay was modified to follow the extent of ligand binding 
by measuring changes of CD signal upon addition of substrate. Both the G3P and Pi, 
previously tested in fluorescence assay, did not show significant changes in the CD 
spectra. Out of the remaining substrates tested, the P5P based assay was found to be 
the most reliable and robust method of calculating ligand binding affinity and hence is 
further used in chapter 4’s estimation of alanine mutants’ reversibility.  
 
The results from P5P binding assay showed the binding constant, Kd, to be 0.84 µM. 
The previously discussed refolding experiment showed the return of the native binding, 
suggesting the return of tertiary structure and function upon reduction of denaturant 
concentration. The single binding fit was most accurate for both experiments, agreeing 
with the theory that P5P acts as inhibitor of G3P transport by binding near the G3P 
binding pocket. The change in CD signal upon P5P binding also suggests that the P5P 
mediated inhibition of G3P transport could be associated with conformational changes, 




The stability of P5P bound state was also investigated. The P5P bound protein showed 
both increased temperature and urea stability. The dramatic change of urea resistance 
could suggest that the P5P-bound state has less solvent exposed pockets, resulting in 
urea denaturation sites being less accessible to the denaturant. Surprisingly, P5P was 
the only ligand to invoke such change in stability, suggesting a different binding 
mechanism compared to other GlpT substrates: G3P, Pi and phosphomycin. Combined 
with the increased temperature resistance, it is possible that P5P bound state is less 
flexible, prohibiting interaction of other ligands. The binding of P5P uncovered interesting 
dynamics about GlpT and provides some information on how this interaction affects 
inhibition of G3P/Pi transport. These conclusions need to be further investigated before 
any clear mechanism is uncovered. It is equally possible that the DDM micelle has also 
affected these interactions by blocking the G3P-Pi binding site, but not P5P nor 
phosphomycin site. A series of silent mutations along the binding pocket could determine 
the similarities between P5P and G3P binding sites. Two of these mutations Y38A and 
Y266A are discussed in chapter 4. 
 
3.3.5 Stability of cysteine mutant measured by CD 
The cysteine mutant was found to unfold to a similar degree in urea compared to the WT 
variant, losing approximately a third of the structure in 8 M urea. Due to the necessity of 
sufficient protein concentration to gain accurate measurements, further protein 
preparations are required to ascertain ΔGuH2O value. It would be useful to be able to 
compare this value to the ΔGuH2O of the WT, in order to fully understand the effect of 
mutations on the stability of the protein. A suitable cysteine mutant would have similar 
stability to the WT with the additional advantage of having an accessible labelling site.  
 
The loss of secondary structure due to temperature was also measured via CD 
spectrometry. No significant differences were found in the Tm measured for the WT and 
cysteine mutant. The reduction of –SH groups on cysteines eliminated possible formation 
of salt bridges and associated rise in temperature stability. 
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3.3.6 Fluorescence unfolding and refolding of cysteine mutant 
The changes in the fluorescence spectra in one area of the protein compared to the data 
from other regions would ultimately be used to gain information on stability of specific 
regions of the protein. Currently, the data is available from only the periplasmic site of 
the protein in the vicinity of helices 1 and 7.  
 
The data collected so far detects a big shift of the wavelength of the band maximum after 
the 6 M urea concentration point (3.4 nm shift) and 4 M GuHCl point (3.7 nm shift), a 
result that could mean slowed unfolding of the periplasmic region. The shift could be 
caused by an interaction with the polar residue, such as lysine. Alternatively, the shift 
could be caused by an exposure to the surrounding solvent, a result that is indicative of 
the protein unfolding. Substitution mutation of the neighbouring lysine would eliminate its 
involvement in the wavelength shift, confirming the nature of the fluorescence spectra 
shift. 
 
A possible explanation of the delayed unfolding of the periplasmic region is provided by 
the crystal structure of GlpT in the open state. Without a ligand, the periplasmic side of 
the membrane remains closed to the transport of substrates by concealing the binding 
cavity. A previous single tryptophan study of LacY found that when a mutation blocking 
the binding cavity was introduced the protein gained stability. This is due to the limited 
accessibility of denaturant to the protein core. Only when the denaturant concentration 
exceeds a certain threshold, the denaturant is able to overcome this barrier leading to 
complete protein unfolding.  
 
A previous stability experiment with P5P-bound GlpT has shown that ligand binding 
accompanied with the bound-state conformational change can drastically alter the 
protein resistance to denaturation. Interestingly the measurements of fluorescence 
intensity do not seem to confirm the late unfolding step of the periplasmic region. It is 
possible that other factors affecting the fluorescence intensity masked the unfolding step, 
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such as affinity of two rhodamine labels to each other. Furthermore, the measurements 
of fluorescence intensity are more susceptible to error from the wrong protein 
concentration. Repeats of the experiment would be necessary to fully discuss the 
involvement of the periplasmic region in the unfolding pathway of GlpT. Also, other 
connections than cysteine links can be made. During incubation with a high 
concentration of TMR, it is possible to bind TMR to, for example lysine (169). Therefore, 
care needs to be taken when estimating the labelling efficiency of the purified protein. 
 
Further rhodamine quenching could be explained by an increased proximity of 
rhodamine labels and\or interactions with surrounding amino acids (173). The summary 
of possible interactions is displayed in figure 3.35. Previous studies of extrinsic labels 
have found that amino acids, such as: tryptophan, tyrosine, histidine, methionine and 
aspartate were responsible for some rhodamine quenching effects. Out of all natural 
amino acids tryptophan was identified as a main quencher of rhodamine (174). 
 
An additional test between rhodamine and denaturant interaction should also be 
performed. The previous study on associations between titin molecules (175) observed 
a decrease in fluorescence upon increase of denaturant concentration. They have 
concluded that a further decrease in fluorescence intensity was due to the direct 
interaction of chemical denaturants (GuHCl, urea and SDS) with the rhodamine markers, 
through an unspecified mechanism of quenching; either collisional or through dark-
complex formations. Although this explanation is likely and needs further 
experimentation with GlpT constructs, the decrease in florescence measured did not 
follow the linear relationship with the concentration of the denaturant. Further analysis 




The refolding from the urea-induced state was shown for the cysteine mutant of GlpT by 
the return of a native fluorescence spectra of the rhodamine label. Both the peak 
wavelength and the fluorescence intensity return to their original values. A small 
discrepancy is noted, that could’ve been caused by a drop in efficacy of refolding. Since 
the results come from a single experiment, repeats are necessary to define whether or 
not the refolding profile matches the unfolding. It is unlikely that the cysteine mutations 
caused a change in the usually robust refolding protein such as GlpT, however it is 
necessary to confirm the results with the return of the secondary structure as measured 
by the CD as well as ligand binding assay to probe the return of the tertiary structure. 
 
Figure 3.35 Crystal structure of GlpT’s periplasmic region in the context of cysteine 
mutations 
The mutated loops are located between helices 1-2 and 7-8. The cysteine mutations are shown 
in red, the nearby charged residues are coloured blue for aspartate, polar residues are coloured 




Overall. All results from the rhodamine labelled and cysteine mutant experiments of GlpT 
are incomplete and need further work to be done before definitive conclusions can be 
made. However, results presented in this work show a potential for such studies as well 
as possible methodology that could be adopted. 
 
3.3.7 Comparison with the other MFS transporters 
Only a handful of investigations are dedicated to studies of multi-subunit membrane 
protein folding. When comparing results from these experiments, it is important to 
compare proteins that were studied under similar conditions. The difficulty of membrane 
protein in vitro work has led to a development of a number of different solubilisation 
systems. Furthermore, a range of different denaturants is often used with membrane 
proteins as their common feature resistance to denaturation (176). The ability to compare 
GlpT’s behaviour during unfolding is therefore limited to a handful of other membrane 
proteins that were also studied under similar detergent\denaturant conditions.  
 
The MFS transporters, LacY, GalP and GlpT were solubilised in DDM and all show a 
loss of approximately third of the total CD signal when denatured with 8 M of urea. In all 
three proteins, the pre-transition unfolding phase looks similar. There is little change to 
either fluorescence or CD signal, when proteins were incubated with low concentrations 
of urea. Only when proteins were exposed to concentrations of 3 M of urea, did they start 
to unfold with a midpoint of unfolding curve of around 4 M. This emphasises alpha helical 
membrane protein’s shared feature to resist denaturation. 
 
GlpT, as well as other members of the MFS, LacY, GalP and XylE when unfolded with 
urea display urea denaturation reaction that exists in a reversible equilibrium. The return 
of native structure before denaturation was shown for all these protein via far-UV CD in 
conjunction with the return of substrate binding. Thus, MFS members so far have been 
shown to be good candidates for folding studies due to their robust refolding ability. 
However, there have only been a few successful attempts in obtaining full kinetic data 
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for microscopically reversible membrane proteins in dynamic equilibrium (59, 177). 
Performing kinetic analysis on a large two domain protein, such as GlpT, is complicated 
and although it requires more experiments, it might be possible to obtain more complete 
kinetic data with help of single fluorescent tags. 
 
Unfolding experiments for GalP and LacY have shown the ΔGUH2O of 2.5 kcal.mol-1 and 
2.2 kcal.mol-1, respectively. The size of the protein was found to be related to the degree 
of protein stability and resulting ΔGUH2O value (178). GlpT is an example of a larger 
protein, with molecular weight of 52 kDa compared to 42 kDa LacY, with a measured 
ΔGUH2O equal to 4.3 kcal.mol-1. Interestingly, GalP’s molecular mass is estimated to be 
equal to 50 kDa, similar to GlpT’s 52 kDa, however ΔGUH2O of GalP is only 2.5 kcal.mol-
1, compared to GlpT’s 4.3 kcal.mol-1. Regardless of size or structure similarity between 
these 3 MFS transporters, GlpT is an outlier in regards to its calculated free energy of 
unfolding. It is likely that ΔGUH2O is linked with the exposed surface of the protein, rather 
than the protein’s size. However, taking into account the effects of detergent micelle, it 
is difficult to estimate the actual denaturant exposed surface of the protein.   
 
Moreover, GlpT has higher energy of unfolding per residue of 0.10 kcal.mol-1.residue-1, 
similar to DGK (0.13 kcal.mol-1, 153) and bR (0.08 kcal.mol-1, 73), unlike the GalP and 
the LacY with a value of 0.05 kcal.mol-1.residue-1. According to the rocker switch 
mechanism of MFS transport, transporters undergo significant conformational changes 
in order to expose large hydrophilic binding sites to their substrates. The inherent MFS 
flexibility and dynamic structure, needed to facilitate substrate transport, is thought to be 
linked to a greater exposure to denaturants and therefore result in lower unfolding per 
residue energy and ΔGUH2O values for GalP and LacY. However, compared to GalP and 
LacY, GlpT has a higher unfolding per residue and ΔGUH2O value. Unlike GalP and LacY’s 
symporter transport cycle, GlpT is an antiporter. Different mechanism of transport and 
therefore accessibility to denaturant, could provide an explanation for a higher reported 
stability, and deviation from low energy of unfolding per residue reported for LacY and 
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GalP. This suggests that, regardless of common fold between MFS transporters, there 
are differences in protein’s chemical sensitivity. Furthermore, protein’s mechanism of 
transport may also be linked to the protein stability.  
 
3.4 Summary of chapter 
 GlpT WT two state analysis of the folding reaction measured by CD reports 
ΔGUH2O of 4.3 kcal.mol-1. 
 Fluorescence measurements of ΔGUH2O report values of 4.5 and 4.8 kcal.mol-1 for 
measurements taken at 280 and 295 nm excitation wavelength, respectively. 
 The binding of P5P can be measured by a ligand induced change, measured by 
CD spectroscopy, reports Kd of 0.71 µM. 
 Urea induced unfolding is reversible and is shown by return of secondary 
structure and P5P binding. 
 Unfolding of cysteine mutant, measured by CD spectroscopy, shows 
characteristics of a two-state behaviour, as seen in WT. 
 Urea-induced unfolding of cysteine mutant is reversible. 
 Unfolding of rhodamine labelled GlpT causes a decrease of fluorescence due to 



















Chapter 4  





4.1.1 Alanine substitutions of GlpT 
In the chapter 3, GlpT’s unfolding and refolding experiments were recorded by both 
fluorescence and CD spectroscopies. Furthermore, the free energy of GlpT WT unfolding 
was established, along with the ligand binding assay to demonstrate GlpT function. Both 
the CD monitored refolding assay and ligand binding assay have shown GlpT to follow 
the reversible equilibrium reaction when urea is used as a denaturant. The methodology 
established in chapter 3 is used in the following alanine scan experiments. 
 
As mentioned previously, studies performed on LacY, suggest that certain protein 
regions show increased stability and may also pose a role in the process of integration 
with the membrane (125). The aim of this study is to examine whether the stability of the 
GlpT structure could also be localized to the first helix of the first domain, by identifying 
whether or not the first helix shares the same stability as structurally similar the first helix 
of the second domain, helix 7. If GlpT shows similar stability tendency, like LacY, then it 
could indicate a folding trend in other MFS transporters. Each alanine substitution on 
helix 1 will have its corresponding mutation located on the opposite site on helix 7, the 
first helix of the second domain. This second mutation will be selected based on a similar 
amino acid substitution change as well as a similar electrostatic environment to its 
respective helix 1 mutation. 
 
4.1.2 Comparing helices 1 and 7 
The helices 1 and 7 of GlpT are the first helices of the first and second domain, 
respectively; figure 4.1 shows the structure of GlpT with highlighted helices 1 and 7. 
Based on the whole residue octanol scale hydrophobicity plots, showing preference of 
certain amino acids to hydrophobic parts of the membrane, and resolved X-ray crystal 
structure, Huang (97) estimated the length of the GlpT’s helix 1 to be 34 amino acids 
long compared to helix 7 which is made up of 37 amino acids. Both helices 1 and 7 are 
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located in similar central positions within the protein structure, lining the binding cavity. 
They both exceed the width of the bilayer and are hence tilted at a similar angle of 20° 
from the membrane interface, in order to hide the hydrophobic residues present at the 
ends of the helices. The solved crystal structure of GlpT, in an inward facing 
conformation, shows the cytoplasmic ends of the helices facing away from each other. 
The diagram of structure comparison between GlpT’s helices 1 and 7 can be seen in 
figure 4.1. A noticeable kink is seen towards the end of both helices. It is thought that 










Figure 4.1 The structure and sequences of helices 1 and 7 aligned to each other 
Top figure, the two domains of GlpT with helices 1 and 7 are highlighted and indicated by  colour 
as follows: the N domain of the GlpT is coloured green, while the C domain is shown in orange, 
helix 1, shown in red, while helix 7 is displayed in blue. In the middle, the helices 1 and 7, 
represented as a ribbon structure, were superimposed against each other, using PyMOL 
software, to show similarities in their fold and length. In the bottom diagram, the peptide sequence 
alignment of helices 1 and 7 show differences in amino acid composition of the two helices. An 
asterisk indicates positions which have a single, fully conserved residue between two helices, a 
colon indicates conservation between amino acid groups with strongly similar properties, and 
finally a period sign indicates conservation between groups with weakly similar properties. The 
small hydrophobic residues are highlighted in yellow, while aromatic residues are highlighted in 
green. The secondary structure alignment was achieved by superimposing positions of α carbons, 
using data from protein database (1PW4, 97, Uniprot: P08194). Structures were rendered in 
PyMOL software. The peptide sequence alignment was done using the Clustal OMEGA sequence 
web service (https://www.ebi.ac.uk/Tools/msa/clustalo/). 
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4.1.3 Effect of mutations 
Alanine is a small hydrophobic residue with a single methyl group attached. Substitution 
to alanine removes carbon chains past the β-carbon. Any functional group that may have 
contributed to the stability or function is thus eliminated. Alanine substitution 
methodology helps to identify contributions of amino acids containing large side chains 
(179).  Substitution into glycine would also serve a similar purpose. However, glycine 
possesses only a single hydrogen as its side chain. Substitutions to alanine retain some 
of the original size as well as mimic the secondary structure with the benefit of not having 
any potential functional group. In membrane proteins, it is important to also consider the 
energetic contributions of the bilayer or the solubilising agent, when discussing the 
stabilising influence of the amino acid residue. Alternatively, another small amino acid 
can be introduced instead of alanine in order to conserve the size of the mutated residue. 
In general, apolar to apolar substitutions are more conservative than polar to apolar or 
aromatic to apolar change (138). 
 
Multiple studies have shown that the folding pathway tends to remain largely unaffected, 
regardless of the positions of alanine substitutions (180). However, the changes in the 
free energy of unfolding, caused by an alanine mutation, cannot by directly associated 
with the equivalent energy that it takes to disrupt the protein structure. Both the position 
of the mutation and the surrounding environment contribute to the net energy change 
that results from the mutation. In order to make the mutations more informative, the 
number of potential factors that may influence the final energy change needs to be kept 
to a minimum. Thus, substitutions of large hydrophobic residues for similar smaller 
hydrophobic residues are much easier to analyse, as the main difference after the 







4.1.4 Alanine mutations in GlpT 
The alanine substitution sites were chosen based on the similarities of their position on 
both helices 1 and 7, and the surrounding environment they were found in. Only the 
mutations of hydrophobic residues were made, replacing larger hydrophobic amino acids 
with smaller hydrophobic side chains. The Y38A-Y266A mutation pair was based on its 
central location in the interface between two domains and its functional importance in 
mediating interactions with the substrates of GlpT. Reduction of the side chain size 
during the alanine substitution leads to creation of cavities between the helices, thus 
disrupting potential interactions that could potentially play a role during the protein folding 
event. These mutations are meant to test the targeted amino acids contributions to 
stability, as well as, protein’s resistance to these disruptions. 
 
The representation of locations of various alanine substitutions can be seen in figure 4.2. 
The structures of individual mutations and their respective environments are located in 
the supplementary appendix D. The residues Y38 and Y266 are located in the middle of 
both helices and are facing the central cavity, where they may interact with the GlpT 
substrates. Residues L26, I34, L254 and I258 are located on the cytoplasmic interface 
of the plasma membrane. These residues are facing towards peripheral helices 3 and 6, 
for L26 and I34, and helices 9 and 12, for L254 and I258. Both L44-L268 and V43-L267 
are located in the middle of the helices 1 and 7. They are facing towards the interhelical 
cavity made by the central helices 4 and 10 as well as peripheral helices 3, 6, 9 and 12. 
The final set of mutated residues, L50-L273 and L54-L279, are positioned near the 
periplasmic interface. Residues L50 and L273 are facing the same direction towards 
helices 5 and 8 respectively. Finally, L54 and L279 are set opposite to each other towards 
helices 4 and 10, respectively. The positions of residues and the final protein structure 








Figure 4.2 Diagram of alanine substitutions in the helices 1 and 7 
The individual alanine mutation sites are shown above and are colour coded along with their 
respective mutation on the opposite helix. The mutations are listed from top to bottom in the 
following order: L54A-L279A, L50A-L273A, L44A-L267A, V43A-L268A, Y38A-Y266A, I34A-
I258A, L26A-L254A.The more detailed diagrams of mutations and their locations within the 
protein can be found in appendix D. Structure was rendered in PyMOL software. 
 
4.1.5 Choice of CD measurements over fluorescence 
The method of measuring changes in structure upon denaturant unfolding was restricted 
to the use of far-UV CD spectroscopy. The previous measurements made by 
fluorescence, detailed in chapter 3, showed a complex aromatic environment, thus 
complicating interpretations of the results. Focus on the single global method in the 
unfolding assay, like the CD spectroscopy, is advantageous in detailed reporting of 





4.1.6 Aims of the chapter 
GlpT was found to undergo reversible denaturation. In this chapter the goal is to 
determine the free energy change of unfolding in the absence of denaturant in order to 
determine the differences in stability between helices 1 and 7 of GlpT and compare them 
to the stability of the WT. The free energy of unfolding was determined using established 
protocols of urea denaturation and refolding assay, previously introduced in chapter 3. 
The progress of unfolding with urea and temperature denaturation was monitored with 
the use of CD spectroscopy. Furthermore, every mutant was evaluated by control 
experiments, testing whether the alanine substitutions have hindered the ability of the 
protein to fully undergo the process of reversible denaturation. This was achieved by 
measurements of structure recovery upon dilution of denaturant and return of the original 
binding affinity towards substrate in the functional assay. In the end, the significant 



















4.2.1 Stability of the alanine mutants in urea 
The protein stability and resistance to mutation are examined in GlpT’s alanine mutants, 
which have been constructed with successive alanine substitutions of hydrophobic 
residues in helices 1 and 7. The progress of each alanine mutant unfolding in urea was 
followed by far-UV CD spectroscopy   The intensity of the CD signal at 222 nm band was 
normalised to MRE and plotted against the urea concentration.  A more accurate 
estimation of the unfolding would be gained by measuring both the amplitude of a much 
stronger absorption band at 190 nm and the negative bands at 210 and 222 nm. Together 
these measurements provide a detailed description of denatured protein’s structure 
content. However, because of the high concentrations of urea needed to unfold alpha 
helical protein, the measurement at 190 nm is inaccessible due to the denaturant 
absorption within that area of the spectrum. 
 
The CD spectra of folded and unfolded states, as well as unfolding curves from the urea 
denaturation assays, are shown for each alanine pair: L26A-L254A, I34A-I258A, Y38A-
Y266A, V43A-L267A, L44A-L268A, L50A-L273A, L54A-L279A in the following figures 
4.3, 4.4, 4.5, 4.6, 4.7, 4.8 and 4.9, respectively; all CD spectra presented were recorded 
at 1 nm intervals with 1 second acquisition time from 270 to 190 nm in the buffer solution 
and between 270 and 205 nm in urea. All scans were performed in 0.2 mm pathlength 
cell with 0.2-0.4 mg.ml-1 protein concentration. The raw spectra were first processed in 
CDTool then plotted and converted to MRE in GraFit software. The data was fit to the 





Figure 4.3 The L26A and L254A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of a L26A-L254A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for L26A and L254A mutant. Below, the position and orientation 


































































































Figure 4.4 The I34A and I258A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of an I34A-I258A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for I34A and I258A mutant. Below, the position and orientation 
































































































Figure 4.5 The Y38A and Y266A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of an Y38A-Y266A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for Y38A and Y266A mutant. Below, the position and orientation 



































































































Figure 4.6 The V43A and L268A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of a V43A-L268A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for V43A and L268A mutant. Below, the position and orientation 
































































































Figure 4.7 The L44a and L267A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of a L44A-L267A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for L44A and L267A mutant. Below, the position and orientation 



































































































Figure 4.8 The L50A and L273A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of a L50A-L273A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for L50A and L273A mutant. Below, the position and orientation 




































































































Figure 4.9 The L54A and L279A urea unfolding curves with their respective CD spectra 
On the left, the decay of the 222 nm negative band is plotted against 0-8 M urea concentrations 
to show the unfolding steps of a L54A-L279A unfolding pair, when incubated with urea for 5 
minutes. On the right, individual scans of the native state, (solid line), and denatured state in the 
8 M urea, (dotted line), are shown for L54A and L279A mutant. Below, the position and orientation 


































































































Comparison of the CD spectra of alanine mutants shows no differences in the shape or 
magnitude of alpha helical bands in the far-UV spectrum (Figure 4.10). All minor 
differences are thought to be due to quality of protein preparation, rather than differences 
in the structural content. 
 
Figure 4.10 Overlay of all CD scans of folded alanine mutants and GlpT 
CD scans of GlpT WT and alanine mutants were overlaid to show similar shape and magnitude 
of CD measurements. Spectra show only small differences in shape, which are due to differences 
of sample concentrations and noise of the measurement. Spectra were recorded in a 0.2 mm 
pathlength cell at 1 nm intervals and 1 second acquisition time from 270 nm to 190 nm in buffer. 
The raw spectra from three repeated measurements was first averaged with the buffer scan 
subtracted, the baseline between 270 and 190 nm was zeroed in CDTool then plotted and 
converted to MRE in GraFit software. 
 
All CD scans of folded protein were done with at least 5 repeats, and show similar shape 
and intensity within the range of -16150 deg.cm2.dmol for 222 nm band, -18000 
deg.cm2.dmol-1 for 210 nm band and 40000 deg.cm2.dmol-1 for 190 nm band, close to 
the CD measurements of the folded GlpT WT, showing no effect of the alanine 
substitutions on the GlpT’s folded structure in DDM micelles. The comparison between 
Wavelength (nm)


































































alanine mutant unfolding curves and the WT profile of unfolding is further discussed 
below in terms of the m-value and midpoint Cm (figure 4.11). 
 
The effect of the alanine mutations on the unfolded state is shown as a MRE difference 
recorded at 222 nm, between the folded state in 0 M urea and unfolded state at 8 M. 
This is a total value of MRE reduction in helix as a consequence of denaturation and is 
displayed in table 4.1 Out of helix 1 mutations, I34A (figure 4.4), I258A (figure 4.4), Y38A 
(figure 4.5) and L50A (figure 4.8) mutants show an increase in the total MRE reduction 
compared to the WT and their equivalent alanine mutation on helix 7, with an average 
loss of 280 deg.cm2.dmol-1 (6 % increase). Whereas, out of helix 7 mutations L254A 
(figure 4.3), V43A (figure 4.6), L268A (figure 4.6), L267A (figure 4.7), L273A (figure 4.8) 
and L279A (figure 4.9) all show an increased stability, with an average MRE change of 
4820 deg.cm2.dmol-1 (11% decrease in MRE lost) when compared to the WT. 
 
 In summary, out of all alanine mutations on helix 1, only V43A shows an increased 
stability of 5090 deg.cm2.dmol-1 (7 % decrease in MRE lost), when compared to WT. Out 
of alanine mutations on helix 7, with the exception of I258A, all show a decrease in total 
MRE reduction due to unfolding. Overall, the majority of the mutations on helix 7 show a 
decrease in total MRE reduction due to the unfolding compared to the mutations located 
on helix 1, which led to a bigger loss of MRE when unfolded. Moreover, 6 helix 7 mutants 
have shown to have a significant effect on total MRE change upon unfolding, compared 













MRE change at 222 
nm (deg.cm2.dmol-1) 
AlaMRE - WTMRE 
at 222 nm 
(deg.cm2.dmol-1) 
Increase or decrease 
of total MRE lost due to 
denaturation compared 
with the WT 
WT 5460 ± 200   
L26A 5630 ± 150 170 No change 
L254A 4910 ± 150 
-550 
Decrease 
I34A 6000 ± 200 
540 
Increase 
I258A 5830 ± 80 
370 
Increase 
Y38A 5860 ± 130 
400 
Increase 
Y266A 5010 ± 300 
-450 
No change 
V43A 5090 ± 150 
-370 
Decrease 
L268A 4710 ± 240 
-750 
Decrease 
L44A 5490 ± 140 
30 
No change 
L267A 4720 ± 150 
-740 
Decrease 
L50A 5940 ± 170 
480 
Increase 
L273A 4850 ± 260 
-610 
Decrease 
L54A 5600 ± 230 
140 
No change 




Table 4.1 Comparison of structure changes alanine substituted GlpT in 8 M urea 
The loss of structure was monitored by a decay of 222 nm negative band. The MRE change at 
222 nm was calculated  by subtracting an MRE value recorded at 0 M concentration of urea with 
a value recorded at 8 M urea, giving the total amount of MRE reduction in helix content as a result 
of unfolding. The difference between Ala mutants and WT was calculated by subtracting the total 
MRE value of WT against each of the mutants, so that negative values mean loss of stability and 
positive values indicate a gain of stability. The mean MRE values used to calculate the differences 





The measurements of the mutants located close to the periplasmic side of the membrane 
show a consistent profile of the protein unfolding, similarly to WT. For the majority of the 
structures, denaturation is observed after 3 M point, with the midpoint of the denaturation 
curve reached at 4.5 M urea concentration. Therefore, the resistance to the urea 
unfolding, indicated by the midpoint value, remains within the same magnitude, 
compared to WT. The calculated midpoint concentrations are shown in figure 4.11, along 
with the gradients of the transition phase. There seems to be a certain trend between an 
increasing mid-point value and the proximity of the alanine mutation site towards the side 
of the protein facing the periplasmic interface of the membrane in E.coli. The second 
parameter of the ΔGuH2O calculation, the gradient of the transition phase mu varies 
between different alanine mutants and shows larger errors, contributing to the overall 
error of the ΔGuH2O. 
 
Based on the mean ΔΔGuH2O comparison against the ΔGuH2O WT (ΔΔGuH2OWT  = 
ΔGuH2O WT - ΔGuH2O Ala) the most destabilising mutations, with change smaller than -
0.2 kcal/mol were located on helix 1 (V43A, L44A, L50A). There was only one mutation 
on helix 7, that was found to be strongly destabilising (I258A). The mutations with 
ΔΔGuH2O above 0.2 kcal/mol were found to be L268A and L273A, both located on helix 
7 and L54A, located on helix 1. The remaining mutations minimally altered the stability 
and are listed as: L26A, L254A, I34A, Y38A, Y266A, L267A and L279A. However, with 
the larger errors associated with the results it is difficult to fit the data accurately and 
make subsequent analysis. Although helix 1 shows a higher frequency of destabilising 
mutations, than helix 7, whereas helix 7 has more stabilising mutations, it is difficult to 
mark these results as significant due to a high error associated with the ΔGuH2O 
calculations.  
 
If the folding of the protein can be described by a two state reaction and the relationship 
between the unfolding and refolding is linearly dependent on the concentration of the 
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denaturant used, therefore it is possible to determine ΔGuH2O by extrapolation of the data 
to the y-axis. The linear fits of transformed data are shown in figure 4.12, presenting the 
linear dependence of ΔGu on the denaturant concentration. The following results and 
parameters from the linear fit are summarised in table 4.3. When the reversible 
thermodynamic equilibrium is established, either sigmoidal two state plots or linear plots 




















Figure 4.11 Differences in Cm and m-value between mutations on helix 1 and 7 
The gradient, mu and midpoint value, Cm calculated from the sigmoidal plots fitted to alanine 
mutants unfolding data are shown in panels A and B, respectively, with the WT values for 
comparison. Mutations on helices 1 and 7 are represented by white and black dots, respectively, 









































































































were fitted to the two state curve in GraFit. The following fit parameters and resulting ΔGuH2O are 
summarised in Table 4.2. Errors shown are from the standard error of the mean. 
The error bars for the mUH2O and Cm were taken from the standard error of the fit and 
were used to calculate upper and lower bounds for the error of ΔGuH2O. Similarly, the 
error of the mUH2O and ΔGuH2O calculated from the linear transformation was taken from 
the fit. Although care was taken to reduce all errors in the measurements, unavoidable 
inaccuracy in protein concentration measurements as well as small dissimilarities in 
protein sample preparations have contributed to the error in CD measurements, which 
then lead to an error with the calculated ΔG values. To confirm whether the differences 
between ΔG values are real, further experiments are needed, as well as, extended 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.12 Linear fits of alanine mutant unfolding curves measured by CD spectroscopy  
The progress of alanine mutations unfolding, measured by CD, is plotted against urea 
concentrations. The ΔGuH2O value is calculated from ΔG extrapolation of the y-axis intercept. The 
fit parameters used in this analysis are summarised in Table 4.3. CD data was recorded in a 0.2 
mm pathlength cell at 1 nm intervals with 1 second acquisition time. The raw spectra were 







































































































































Table 4.3 Summary of ΔGuH2O values for WT and Ala mutants from linear plots 
The free energy values for alanine mutants and WT were calculated from linear fits to CD 
unfolding data, shown in figure 4.11. Errors are taken from the standard error of the fit. The 
ΔΔGuH2O was calculated as ΔGuH2O Ala - ΔGuH2O WT, while ΔΔGuH2O Ala is described as helix 1 
ΔGuH2O – helix 7 ΔGuH2O. 
 
4.2.2 Reversibility of urea induced unfolding 
The conditions of the two state model, under which alanine ΔG values were calculated, 
state that the folded and unfolded protein exist in a reversible equilibrium. Therefore, to 
prove this, the unfolded state needs to be shown as recoverable. Similar to principles 
laid out in chapter 3, successful refolding of alanine mutants is assessed by regaining 









WT -0.85 ± 0.07 3.8 ± 0.6   
L26A -0.72 ± 0.06 3.9 ± 0.3 0.1 
-0.4 
L254A -0.73 ± 0.05 4.3 ± 0.4 0.5 
I34A -0.69 ± 0.07 4.5 ± 0.5 0.7 
0.5 
I258A -0.80 ± 0.03 4.0 ± 0.2 0.2 
Y38A -0.78 ± 0.09 4.1 ± 0.9 0.3 
-0.2 
Y266A -0.75 ± 0.08 4.3 ± 0.5 0.5 
V43A -0.70 ± 0.06 3.9 ± 0.3 0.1 
-0.6 
L268A -0.68 ± 0.06 4.4 ± 0.4 0.6 
L44A -0.70 ± 0.06 4.0 ± 0.3 0.2 
--0.4 
L267A -0.66 ± 0.03 4.4 ± 0.3 0.6 
L50A -0.70 ± 0.02 4.2 ± 0.2 0.4 
-0.4 
L273A -0.74 ± 0.08 4.6 ± 0.6 0.8 
L54A -0.78 ± 0.04 4.6 ± 0.3 0.8 
0.6 
L279A -0.65 ± 0.04 4.0 ± 0.3 0.2 
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First, the protein is unfolded by 5 minute incubation in urea, then the sample is refolded 
by rapid dilution, thus eliminating high concentration of the urea. Figure 4.13 shows the 
return of the CD signal at different urea concentrations, measured by MRE recorded at 
222 nm and plotted at corresponding concentrations of urea. The refolding curves of all 
alanine mutants show complete recovery of protein structure upon refolding from the 
unfolded state. Both refolding and unfolding curves are superimposable, with slight 
deviation at few points, located at the 4 M and 5 M urea concentrations at the transition 
phase on the refolding curve. These deviations could possibly be caused by an error in 
accurate estimation of protein concentration and reduced CD signal due to a necessary 
but sizeable dilution of the protein sample. 
 
A ligand binding assay was introduced to further test the reversibility of WT and alanine 
mutants unfolding. The refolding assay measured by CD informs of the global return of 
the secondary structure, but does not provide detail on the tertiary contacts. The ligand 
binding assay measures the return of the ligand affinity to the refolded sample. Out of 
GlpT ligands tested in chapter 3, the P5P was found to be the best ligand to test the 
return of the binding affinity in the refolding assay, due to its large and measureable 
effect on the CD signal.  
 
The binding was shown to follow closely with the single binding site model and can be 
measured as an increase in CD signal upon P5P binding. The saturation binding curves 
are shown in figure 4.14, with the summary of binding constants presented in table 4.5. 
The binding constants for both folded and refolded samples were all found to be close to 
each other, confirming the results shown by the refolding assay. The binding assay not 
only tells of recovery of binding affinities, but also the effect of the mutations on the 
binding of P5P. Out of all alanine mutations, only the V43A mutation led to a small 
change of binding affinity. Surprisingly, the mutations Y38A and Y266, located near the 












































































































































































































































































































































































































































Figure 4.13 Refolding curves of alanine mutants 
The extent of structure recovery was monitored at each urea concentration by CD spectroscopy. 
The unfolding data with its sigmoidal fits are represented by white squares and the refolding 
curves, shown by black dots. Both curves are superimposed to compare the similarities between 
unfolding and refolding data. The error bars are due to at least 3 repeats of each data point. The 
data was fit to two state curve in GraFit and the following fit parameters are displayed in Table 
4.4. 
[Urea] (M)



















































































































































































































































































































   
   
























   
   











































Table 4.4 Summary of the ΔGfH2O, mf and Cm values for the refolded alanine mutants and 
WT 
Parameters for alanine constructs were calculated by fitting a sigmoidal equation to each refolding 
data set from the urea-induced unfolded state, shown in figure 4.13. Errors taken from the 











Construct mfH20 Cm 
ΔGfH2O 
(kcal/mol) 
WT 0.85 ± 0.08 4.96 ± 0.05 4.2 ± 0.5 
L26A 0.82 ± 0.15 5.03 ± 0.22 4.1 ±  0.9 
L254A 0.72 ±0.08 5.10 ± 0.12 3.7 ± 0.5 
I34A 0.94 ± 0.10 4.49 ± 0.07 4.2 ± 0.5 
I258A 0.88 ± 0.09 4.68 ± 0.03 4.1 ± 0.4 
Y38A 1.02 ± 0.16 5.02 ± 0.12 5.1  ± 0.9 
Y266A 1.07 ± 0.16 4.82 ± 0.10 5.2 ± 0.9 
V43A 0.96 ± 0.18 4.93 ± 0.12 4.7 ± 0.9 
L268A 0.92 ± 0.14 5.35 ± 0.11 4.9 ± 0.8 
L44A 1.03 ± 0.08 4.85 ± 0.08 5.0 ± 0.5 
L267A 0.81 ± 0.34 5.23 ± 0.04 4.2 ± 0.5 
L50A 0.96 ± 0.30 5.57 ± 0.03 5.3 ± 0.5 
L273A 0.92 ± 0.30 5.49 ±  0.03 5.1 ± 0.5 
L54A 0.85 ± 0.07 5.31 ± 0.11 4.5 ± 0.5 

































































































































































































































































































































































Figure 4.14 Saturation binding curves for folded and refolded GlpT alanine mutants 
P5P-induced changes, measured by an increase in CD signal are plotted as a percentage of 
structure changed against corresponding P5P concentration. The binding curve of a folded 
sample, with its single binding fit, is represented by black dots, whereas refolded protein binding 
is marked as white squares. The fitting of refolded data was omitted for clarity. The binding plots 
show a similar extent of binding between folded and refolded samples. All scans were performed 
in a 2 mm pathlength cell in an in-house Aviv Circular Dichroism Spectrophotometer, Model 410. 
The raw spectra were first processed in CDTool then plotted and converted to a percentage 
change in GraFit software. The data was fit to the single binding site model in GraFit with the 
binding constant values displayed in Table 4.5. 
[P5P] (µM)







































































































































































































Construct Kd for folded sample (µM) Kd for refolded sample (µM) 
WT 
0.71 ± 0.11 0.84 ± 0.11 
L26A 
0.83 ± 0.27 0.88 ± 0.28 
L254A 
0.77 ± 0.31 0.88 ± 0.12 
I34A 
0.81 ± 0.23 0.74 ± 0.25 
I258A 
0.95 ± 0.37 0.71 ± 0.27 
Y38A 
0.86 ± 0.22 0.72 ± 0.29 
Y266A 
0.72 ± 0.22 0.80 ± 0.11 
V43A 
1.34 ± 0.21 1.19 ± 0.20 
L267A 
0.88 ± 0.24 0.86 ± 0.36 
L44A 
0.65 ± 0.26 0.73 ± 0.22 
L268A 
0.64 ± 0.30 0.70 ± 0.32 
L50A 
0.83 ± 0.21 0.70 ± 0.25 
L273A 
0.67 ± 0.16 0.80 ± 0.22 
L54A 
0.66 ± 0.21 0.83 ± 0.30 
L279A 
0.88 ± 0.28 0.85 ± 0.30 
 
Table 4.5 Binding constants for folded and refolded samples of WT and alanine mutants 
The binding constants from the saturation binding curves shown in figure 4.14 are listed here in 
order of mutations placed at the cytoplasmic side of the membrane to the mutations located at 
the side of the periplasm. The error are taken from the standard error of the fit. 
 
4.2.3 Temperature stability 
Thermal denaturation was used to provide an additional parameter to compare the effect 
of the alanine mutations on protein stability. Temperature melts are an easy and 
inexpensive method of comparison, as they require little protein to obtain a full set of 
data. In these experiments, the chosen protein is incubated at increasing temperatures, 
while the measurements of the current protein state are being taken. However, 
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temperature denaturation data shown does not provide means of calculating ΔG values, 
as the temperature denaturation of GlpT, like in most membrane proteins, is irreversible. 
The change in GlpT structure incubated at each increasing temperature step is recorded 
by following the decay in the CD signal at 222 nm. The midpoint of the transition was 
calculated from the two state curve and recorded in denaturation data set, shown in 
Table 4.6. Figure 4.15 shows individual denaturation curves for each alanine mutant. For 
comparison, the graphs are positioned with mutations on helix 1 located on the left and 
mutation on helix 7 on the right side of the figure. 
 
Overall, there is little difference in changes of thermal stability of alanine mutants. There 
is a higher frequency of helix 1 mutations decreasing the Tm of GlpT. The most disruptive 
mutations were Y38A and L44A. The mutations that showed the most stabilising effects 
were L279A, L273A, and L267A. The mutant pair Y38A-Y266A showed smaller Tm, 
compared to the WT and other alanine mutants. The change could be a result of 
increased cavity caused by an alanine substitution in the area of GlpT’s binding pocket, 
or the elimination of tyrosine OH group as a hydrogen bond acceptor. Alanine mutations 
located on helix 7 of GlpT, seem to increase temperature stability of the protein. 
Interestingly, alanine mutant urea denaturation experiments have shown two helix 7 
mutations (L268A and L273A) as strongly stabilising, compared to only one mutation on 
helix 1 (L54A). However, any proposition based on the temperature denaturation data 
should be taken carefully, as the method of denaturation itself is irreversible and the data 
is susceptible to noise. Care was taken to standardise each thermal denaturation 
experiment by equal protein concentrations and buffer conditions as the likelihood of 
protein aggregation and presence of multimeric species have the potential of skewing 









































































































































































































































































































































































































































































Figure 4.15 Thermal denaturation of alanine mutants 
The changes in structure were monitored by measuring CD signal at 222 nm band between 
temperatures of 15 °C to 90 °C at 2 °C intervals. Each protein melt was achieved using 0.1 mg.ml-
1 concentration of the protein in a 0.2 mm pathlength cell at 1 nm intervals and 1 second 
acquisition time from 260 nm to 180 nm in buffer. The melt curves were fitted with sigmoidal plot 
to calculate the midpoint on the slope of transition. The comparison graph of different Tm values 
obtained is found in figure 4.15 and summary in table 4.6. The raw data was plotted, fitted and 
converted to MRE in GraFit software. 
Temperature (°C)




























































































































































































































































































































































Mutation Tm (°C) ΔTm 
WT 49.0 ± 0.2  
L26A 49.9 ± 0.6 -0.9 
L254 51.5 ± 0.3 -2.6 
I34A 48.4 ± 0.1 -0.5 
I258A 48.9 ± 1.4 -0.1 
Y38A 45.5 ± 0.1 3.4 
Y266A 42.5 ± 0.2 5.5 
V43A 50.6 ± 0.3 -1.7 
L268A 51.7 ± 0.5 -2.8 
L44A 46.8 ± 0.4 2.2 
L267A 54.5 ± 0.9 -5.6 
L50A 48.9 ± 0.3 0.1 
L273A 55.0 ± 0.5 -6.1 
L54A 48.1 ± 0.4 0.9 
L279A 52.4 ± 0.4 -3.5 
 
Table 4.6 Summary of the temperature denaturation values from alanine mutants 
The Tm values were taken from the denaturation scans, shown in figure 4.14. Each melting 
midpoint was calculated by fitting sigmoidal equation to denaturation curve for each alanine 
mutant, the errors are given from the standard error of the fit. The difference between individual 











4.3.1 Two state folding model for alanine mutants 
The two-state model is the simplest way of analysing the unfolding and refolding data, 
as only folded and unfolded states are taken into consideration. The unfolding and 
refolding curves show only two phases with one transition phase around 5 M urea 
midpoint. However, the unfolding plots are made out of data points collected at 1 M urea 
intervals. The smaller data intervals may uncover smaller state within the transition 
phase of the unfolding that could have been missed otherwise. 
 
Further experiments should include time-resolved measurements of folding and 
refolding. Similar to the measurements performed at steady-state, the rates of folding 
and refolding should be in agreement with each other, showing the same linear 
dependence on the denaturant concentration. Such results would further confirm the two-
state model for GlpT, as well as show the existence of any kinetic intermediate in both 
folding and refolding assay. Moreover, the kinetic measurements would present an 
alternative method of measuring stability, and combined with the steady state 
measurements identify the position of the transition state through the alanine mutation 
analysis in the helices 1 and 7. 
 
Attempts at measuring kinetics of GlpT were described in chapter 3. It is possible to 
record the unfolding rate of GlpT WT, however the rich aromatic environment of GlpT 
complicates the fitting of the data to a single exponential fit. A potential improvement to 
this experiment would be substitution of many intrinsic fluorescence reporters with a 
single probe substitute. The single reporter could be used to measure kinetics of the 
unfolding and thus gain insight into the state of the protein during the unfolding. Design 
of a rhodamine marker thought to characterize behaviour of GlpT during unfolding is 




The urea-induced reversibility was shown for all alanine mutants through the regain of 
CD signal measured at 222 nm, as well as the return of the binding constant. Although 
there was a small discrepancy at a few urea concentration points, the general trend of 
the refolding curve suggests that the refolding pathway of GlpT’s alanine mutants is 
similar to the unfolding pathway and the alanine mutations do not seem to affect the 
pathway. Further repeats of the points on the refolding curve would provide greater 
resolution into the refolding curve and confirm the close relationship between unfolding 
and refolding curves.    
 
The comparison of ΔGUH2O and ΔGfH2O calculated from the unfolding and refolding data 
shows similarities between these values. Both the ΔGuH2O and ΔGfH2O were found to be 
within the region of 4.4 kcal.mol-1 and therefore are an indication of the unfolding reaction 
being in a reversible equilibrium. Furthermore, the similarity between the slope of the 
unfolding curve, mUH20, and slope of the folding curve, mFH20, as well as the midpoint Cm 
values suggest that the protein is in equilibrium, changing its state between the folded 
and unfolded phases. The refolding assay, measured by CD spectroscopy, has a higher 
error associated with the calculation of mFH20 and Cm values than the calculation of 
unfolding’s mUH20 and Cm values, resulting in an uncertain final value of ΔGfH2O, 
especially for the mutants L26A and V43A.The reason for such discrepancies could be 
due to the refolding efficiency of mutants being reduced, compared to the WT, thus 
contributing to the larger spread of the refolding values in the repeated experiments. 
Also, the discrepancy in V43A refolding could be linked to its lower stability measured by 
the unfolding assay. 
 
4.3.2 Differences in stability of alanine mutants 
The alanine substitutions along the helix 1 of GlpT were designed to investigate the 
possibility of a stable unit located in the first helix of the membrane protein. As a 
comparison, a residue in a similar environment and position was also mutated to alanine 
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in the opposite helix 7. Both helices are the first helices of their respective domains and 
therefore any difference to the stability of helix 1 of the protein could be attributed to its 
location as the first helix to be translated by the ribosome.  
 
A series of alanine mutants were investigated using urea as a chemical denaturant in 
the unfolding assay. Although, as shown in chapter 3, a stronger denaturant GuHCl 
unfolds up to 45 % of the total protein structure, its use was omitted due to lack of 
refolding upon dilution of the denaturant. Overall, it was found that helix 7 mutants unfold 
less in the 8 M urea compared to the WT. Helix 7 mutations showed an average 11% 
decrease in the total MRE reduction, compared to helix 1 mutations. Helix 1 mutations 
showed a 6% increase in the total MRE reduction. Only the V43A mutation showed less 
unfolding. These results suggest that alanine substitutions in the helix 1 lead to an 
increased degree of unfolding in urea within the structure of GlpT. However, a number 
of mutations that lead to a total MRE change upon unfolding is higher in helix 7. 6 helix 
7 mutations had a significant effect on total MRE change, compared to 4 helix 1 
mutations. The helix 7 has therefore shown to be more sensitive to mutations than helix 
1. 
 
The protocol of GlpT WT reversibility, first established in chapter 3, was used to assess 
whether the alanine substitutions have any influence on the capacity of the protein to 
refold from the urea denatured state. The GlpT unfolding curves were fit to a two-state 
curve and the ΔGuH2O values were calculated. The extrapolation of data from the linear 
fit introduces a larger error into the final analysis. Therefore the calculated values from 
the sigmoidal fits were used to form the final comparison.  
 
The measured effect of alanine substitutions on the GlpT ΔGUH2O values range from 3.9 
± 0.6 to 4.6 ± 0.6 kcal.mol-1. Large errors and spread of data associated with the ΔGUH2O 
values need to be considered when reviewing these results. The spread of these values 
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is the result of measuring small differences in energy caused by the elimination of a few 
individual methyl groups across the length of the helix.  
 
Overall, considering the large error, the majority of the mutations were found to have a 
general stabilising effect on helix 7, while 3 mutations on helix 1 had a destabilising effect 
compared to 1 destabilising mutation on helix 7.  The changes in ΔGUH2O compared to 
the WT are both positive and negative, when comparing different mutations (table 4.3). 
However, when considering the mutation location within the protein structure, the 
mutations placed in the protein core were predominantly destabilising, with only one 
mutation on helix 7 being stabilising. By comparing the mean WT ΔGUH2O value against 
the largest difference in ΔGUH2O of alanine mutants (>0.20 kcal/mol), helix 1 mutations 
showed a higher frequency of destabilising mutations (V43A, L44A and L50A) compared 
to the helix 7 mutation (I258A). The higher occurrence of helix 1 ΔΔGuH2O WT 
destabilising mutations shows the possibility that helix 1 may be slightly more sensitive 
to alanine substitution than helix 7. The comparison between the differences in energy 
within mutation pairs showed little or no difference in the mutations placed on the 
cytoplasmic side of the membrane, such as the L26A-L254A pair, as well as near the 
binding pocket, the Y38A-Y266A pair. Interestingly, the mutations Y38A, Y266A, V43A, 
L44A, L267A and L50A, located in the protein core and facing towards other helices, 
showed a repeated destabilising effect on the ΔGUH2O value. The next mutation pair 
L54A-L279A, located at the very end of the helix, contradicts this statement. This final 
mutation is located at the very end of the helix on the periplasmic side of the membrane 
and could therefore be counted as being influenced by the DDM molecules forming a 
micelle around the protein.  A summary of the ΔGuH2O values from alanine substitutions 























Figure 4.16 Diagram of alanine substitutions and their effect on free energy of unfolding 
in the helices 1 and 7 
Mutation sites that had an effect on free energy of unfolding are presented above with their 
respective ΔΔGuH2O WT, calculated as a ΔGuH2O WT - ΔGuH2O Ala shown below. Helix 1 is 
indicated by purple colour and helix 7 by blue colour. The summary of all of ΔGuH2O values from 
Ala mutants are shown in table 6.1. Structure was rendered in PyMOL software. 
 
Furthermore, the mutations that were located in the vicinity of the protein core have been 
found to be predominately destabilising. Possibly due to alanine substitutions creating 
cavities that increase the access of the denaturants, making the protein core more 
susceptible to the effects of denaturation. Alternatively, the binding of P5P increases 
resistance to denaturation, possibly by reducing the access of the denaturants to the 







Table 4.7 Summary of ΔGuH2O values from Ala mutants from two state curves 
The free energy values for alanine mutants and WT were calculated from sigmoidal fits to CD 
unfolding data, errors are taken from the standard error of the fit.  The ΔΔGuH2O was calculated 
as a ΔGuH2O WT - ΔGuH2O Ala difference. 
 
A higher frequency of destabilising mutations near compact protein centre can be 
explained using the solvation model. Cavity-creating mutations, such as alanine 
substitutions increase the access of the denaturants, making the protein core more 




ΔΔGuH2O WT Effect 
WT 4.3 ± 0.5   
L26A 4.2 ± 0.4 -0.1 Minimally altered 
L254A 4.2 ± 0.8 -0.1 Minimally altered 
I34A 4.4 ± 0.4 0.1 Minimally altered 
I258A 4.1 ± 0.2 -0.2 Destabilising helix 7 
Y38A 4.3 ± 0.3 -0.1 Minimally altered 
Y266A 4.2 ± 0.7 -0.1 Minimally altered 
V43A 3.9 ± 0.5 -0.4 Destabilising helix 1 
L268A 4.6 ± 0.5 0.3 Stabilising helix 7 
L44A 4.1 ± 0.4 -0.2 Destabilising helix 1 
L267 4.2 ± 0.4 -0.1 Minimally altered 
L50A 4.1 ± 0.3 -0.2 Destabilising helix 1 
L273A 4.5 ± 0.9 0.2 Stabilising helix 7 
L54A 4.5 ± 0.5 0.2 Stabilising helix 1 
L279A 4.2 ± 0.8 0.1 Minimally altered 
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disrupted weak intermolecular interactions between helices, thus affecting the packing 
energetics and efficient burial of hydrophobic residues (181). 
 
It is difficult to draw a definitive conclusion due to the error of the ΔGUH2O and the complex 
nature of intermolecular interactions within the protein structure. The errors associated 
with the results make it difficult to fit the data accurately and subsequent data 
manipulations carry a bigger error. As the contribution from different mutation 
environments was reduced, it should be easier to define the differences in stability 
between the helices. A potential improvement to distinguish between the stability of helix 
1 and 7 would be to either use amino acid mutation that is larger than alanine, such as 
valine or isoleucine, or use different method of reporting the unfolding of the protein. 
Furthermore, additional controls which increase protein preparation reproducibility would 
be advantageous in decreasing error seen in CD measurements. Fluorescence can be 
measured very accurately, however it may not necessarily report the loss of structure. A 
combination of fluorescence tags with other methods of measuring the structure change, 
could be used to collect data to supplement the study. The individual tags could be used 
to report on the extent of unfolding in the labelled regions of the protein.  
 
4.3.3 Temperature induced denaturation 
The alanine mutants were subjected to the additional stability assay via means of 
temperature-induced denaturation. Overall, an increase in the thermal stability was 
observed for the mutations located in helix 7, with the exception of the Y38A-Y266A 
mutation pair. Mutations in helix 1 showed marginal or no difference in stability when 
compared against the WT. Although the increase in thermal stability (table 4.6), caused 
by mutations in helix 7, overlaid with the results from the chemical denaturation assay 
(table 4.1), they are not necessarily linked, as the two assays involve different 
mechanisms of unfolding, resulting in two different pathways of obtaining the unfolded 
state. However, the temperature denaturation data provides an additional insight into the 
effects of alanine substitutions. Most mutant Tm values fall within 3.5 °C difference from 
171 
 
the Tm measured for the WT, with the exception of Y266A, L267A and L273A, which is 
an indication that overall the alanine substitutions do not greatly affect the general 
stability of the protein to the temperature denaturation. The Y266A mutant showed a 
flatter gradient compared to the rest of the alanine mutants. The result could indicate that 
the sample of the protein used has a more heterogeneous population of protein species, 
therefore affecting the slope of the transition phase. Overall, the alanine substitution 
mutations did not have big enough effect to change the behaviour of GlpT during 
temperature-induced denaturation. 
 
4.3.4 P5P binding of alanine mutants in the folded and refolded state 
Reversibility of the unfolding reaction was tested via a binding assay, in addition to a 
simpler refolding assay by a method of rapid dilution of urea. The ligand P5P was picked 
as the best ligand to test the return of the binding affinity to GlpT. The binding of P5P 
was followed by the measurement of the CD signal at 222 nm. The large dilution required 
during the process of refolding did not impede data collection, as the P5P binding was 
strong in a magnitude of 0.7 µM, requiring little protein to successfully collect a complete 
saturation binding curve and to avoid protein aggregation issues during the experiment. 
All alanine mutants have shown successful recovery of binding affinity, with the average 
Kd for folded protein equal to 0.81 µM, compared to the 0.82 µM for refolded protein, 
showing return of function. The error in the CD measurements could be attributed to the 
slight differences in the protein concentration between the samples, as the unaccounted 
protein concentration would result in a CD signal difference imitating binding of the P5P. 
Alternatively, binding of P5P ligand, discussed in chapter 3, had a bigger effect on 
temperature and chemical stability of GlpT WT. 
 
The equal recovery of the CD signal, measured in the refolding assay, and recovery of 
the P5P ligand affinity, measured in the binding assay, suggests that both secondary 
and tertiary structure return to their native state upon GlpT refolding. Investigation into 
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the recovery of binding of different ligands bound in other areas of protein would further 
confirm the return of inter-helical interactions making up the tertiary structure.  
 
The substrate assay provides information on the recovery of binding affinity during 
protein refolding, but also informs the effect of alanine mutations on the potential 
changes in the binding pocket affecting that binding affinity. Surprisingly, Y38A and 
Y266A mutations did not significantly affect P5P binding, confirming the claim from the 
previous studies (119) in which these residues are not directly involved in binding, but 
rather act to close the channel on one side when the ligand is transported to the other in 
the rocker-switch-type transport mechanism. A small loss of affinity was noted for the 
V43A mutation. It is unclear why an alanine substitution would affect the binding affinity 
within the protein structure. The residue is located away from the binding pocket and is 
facing towards small hydrophobic residues located on helices 3 and 6. However, it is 
possible that the mutation location affected the protein interaction with the detergent 
molecules within the DDM micelle, in turn causing a minor change in conformation of 
helices and therefore a drop of the binding sensitivity. Further investigation into the 
binding and transportation mechanism of GlpT would clarify the issue and prove or 
disprove the role of the V43 residue. An assay involving G3P-Pi transportation across 
the membrane could be used to show the return of function upon GlpT refolding as well 












4.4 Summary of chapter 
 Alanine mutants show recovery of structure and the return of P5P binding during 
the refolding assay.  
 The effect of alanine mutations on P5P binding shows the lack of Y38 and Y266 
involvement in binding of P5P. 
 Alanine mutants display a range of ΔGuH2O values with mutations located in the 





















































Chapter 5  
Final discussion and future work  
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5.1 Aims of the chapter 
This section is summarising the work in this thesis, highlighting key outcomes and 
discussing their implications, as well as possible improvements in measuring inter-helical 
stability. At the end of this chapter, potential future work is discussed that would expand 
understanding of membrane protein folding. 
 
5.2 Summary of results 
The denaturation assays with urea and GuHCl have shown that GlpT’s structure is 
reduced by approximately 33% and 45%, respectively. The urea unfolded state of GlpT 
has also been shown to be reversible with a complete return of the signal, as measured 
by far-UV CD spectroscopy, upon exclusion of urea. Although the harsher denaturant, 
GuHCl resulted in a greater reduction in of CD signal, it was not possible to recover the 
native structure upon GuHCl removal.  
 
The unfolding of GlpT with urea denaturant is consistent with a two state reaction with 
only folded and unfolded states present in the unfolding reaction. Moreover, the GlpT 
was shown to fully regain both function and structure after refolding from its denatured 
state. Unfolding curves from both fluorescence and CD measurements estimate the 
ΔGuH2O for the GlpT unfolding to be approximately 4.6 and 4.3 kcal.mol-1, respectively. 
Regardless of the method of following the state of the protein, both ΔGuH2O from unfolding 
and refolding reactions are similar in magnitude, supporting the equilibrium state reaction 
model of GlpT folding. Further evidence of the reversibility of urea denaturation was 
provided by the P5P binding assay. The results of the sample before denaturation match 
closely with the sample after refolding reaction. This suggests that the GlpT is able to 
regain its structure as well as tertiary conformation, as the amino acid residues 
responsible for binding have likely returned to their native positions before denaturation, 





The alanine substitutions of amino acid residues along the length of the helices 1 and 7 
of GlpT have been designed to investigate differences in the stability of the two targeted 
helices. All Ala mutants refolded reversibly, similarly to WT. Only the V43A mutation was 
shown to affect the affinity of the chosen substrate, P5P, to its binding site.  Out of 14 
alanine substitutions, four (I258A, V43A, L44A and L50A) have shown a potential 
decrease in ΔGuH2O values, with the remaining alanine substitutions showing a range of 
values. V43A has showed to be most destabilising, possibly due to the effect on helical 
packing of the surrounding helices 3, 4 and 6, thus increasing the accessibility of the 
denaturant. The alanine scan has also shown a higher likelihood of destabilising 
mutations near the protein core and facing other helices, compared to the mutation sites 
facing the protein surface, as these are less likely to cause a destabilising effect. These 
results highlight the effect of cavity-creating mutations on access of denaturant as well 
as destabilising effect of disrupting weak intermolecular interactions between helices, 
thus affecting the packing energetics and efficient burial of hydrophobic residues (181). 
 
5.3 Discussion 
Overall, the GlpT unfolding with urea shows approximately 33 % of protein structure loss. 
Taking into account the resistance of the helical structure to denaturation, it is likely that 
the exposed regions that resemble the unfolded state are aqueous loops, ends of the α-
helices as well as the binding cavity separating the two domains. The remaining structure 
remains mostly folded with only most exposed regions being affected by the 
denaturation. Interestingly, binding of the P5P substrate results in the marked increase 
in resistance to denaturation, possibly due to reduced accessibility of the denaturant to 
the binding site. Moreover, the initial results with the rhodamine conjugated GlpT suggest 
that the unfolding of the unbound protein starts at the interface region; same region is 
also responsible for the binding of the substrate.  The role of the binding cavity in 
facilitating of unfolding may be due to three components:  
- the critical position at the interface of two domains; 
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- the specific chemical composition of hydrophilic amino acids to facilitate      
transport; 
- the enabling of access to the denaturants. 
Out of all the alanine substitution mutations, the V43A-L268A pair showed the greatest 
difference in stability compared to the WT. The pair is located at the interhelical interface 
between the helices 3, 4, 6 and 9, 10, 12 for V43A and L268A, respectively. The 
explanation why these mutations caused a much bigger difference compared to other 
mutations has yet to be resolved, but it could be result of altering interactions and packing 
between the neighbouring helices.  Overall, majority of the mutations were found to have 
a general stabilising effect on helix 7, while 3 mutations on helix 1 had destabilising effect 
compared to 1 destabilising mutation on helix 7.  
Furthermore, the mutations that were located in the vicinity of the protein core have been 
found to be predominately destabilising. This is possibly due to alanine substitutions 
creating cavities that increase the access of the denaturants, making the protein core 
more susceptible to the effects of denaturation. Alternatively, binding of P5P increases 
resistance to denaturation, possibly via reducing the access of the denaturants to the 
binding site.  
 
The differences in behaviour of mutations in helices 1 and 7 were noted. Although it is 
difficult to say how these can be compared to the WT, they did show a range and variety 
of ΔGuH2O values, regardless of their possible gene duplication evolutionary history. 
These findings are in agreement with the previous work on LacY, GalP and bR, where 
the protein unfolds mostly in areas of the hydrophilic cavity or domain interface and 
different areas of the protein may have significantly different stability in vitro. These 
shared attributes could mean that a set of rules governs the protein folding in vitro and 
could be used in future studies on therapeutically relevant targets (162). Moreover, the 
results presented in this thesis show a complex range of amino acid contributions to 
stability of helices in two domains, regardless of two domains pseudo symmetry. 
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Although the alanine scan analysis consists of large errors from CD measurements and 
protein instability, it is a useful inquiry into the behaviour of membrane transporters as 
there are not many folding studies for large multi subunit transporters focusing on the 
relative stability of its components. The development of the rhodamine labelled GlpT 
shows promise and proves its ability to report on fluorescence changes during the 
unfolding without it causing any change to the CD spectra as measured by far-UV CD. It 
could be used therefore, as a reporter of protein changes during the unfolding studies. 
However, the question whether a larger label is influencing protein conformational 
changes during the experimental processes still needs further investigating.  
 
5.4 Comparison with other MFS protein folding studies 
Similarly to other alpha helical membrane proteins such as XylE, GlpT shows a high 
resistance to unfolding by thermal and chaotropic denaturation. The total amount of CD 
signal lost due upon urea denaturation is comparable to studies of MFS transporters 
solubilised in DDM, LacY and GalP. All three MFS transporters remained folded in 2 M 
urea, unfolding starting around 3 M concentration of urea, with midpoint of unfolding 
curve at around 4 M concentrations. Furthermore, GlpT’s full return to the native structure 
after urea-induced unfolding has also been noted in the reversible denaturation reactions 
with other members of the MFS such as, LacY, GalP and XylE. 
 
The determined ΔGUH2O for GlpT is estimated to 4.3 ± 0.5 kcal.mol-1 and is within the 
same magnitude range as its related proteins LacY with the ΔGUH2O of 2.2 ± 0.9  kcal.mol-
1. The higher stability of the GlpT is reflected by its larger size of 52 kDa compared to 
LacY’s 46 kDa. However, GalP with molecular mass, estimated to be 50 kDa, was 
determined to unfold with ΔGUH2O equal 2.5 kcal.mol-1, compared to GlpT’s 4.3 kcal.mol-
1. Unlike GalP and LacY, GlpT has a higher energy of unfolding per residue of 0.10 




The lower unfolding energy values for these MFS transporters compared to GlpT could 
possibly be explained by their proposed mode of transport, differences in flexibility and 
therefore access of denaturant to inter-domain site, rather than differences in size. GlpT 
is an example of antiporter, compared to the LacY’s and GalP’s symporter function. The 
nature of the substrate transporter could have effect on the mechanism of transport and 
flexibility of the structure that accommodates the protein’s function. The differences in 
the domain stability and the importance of the binding cavity as a domain interface have 
been reported as key characteristics of the MFS protein stability in the previous LacY 
work (106). Interestingly, an increase in stability to chemical unfolding has only been 
reported in GlpT and XylE (in process of publication). Both LacY and GalP did not show 
an increased stability when bound to their respective substrates. 
 
Although GlpT shares common fold with GalP and LacY, results presented in this thesis 
also highlight some differences in the behaviour and stability, which need to be 
addressed by further studies on MFS transporters in order to form a set of rules 
governing the stability and folding of these group of membrane proteins. The importance 
of inter-domain interface in mediating interactions and unfolding with denaturant is seen 
in both LacY and GlpT studies. Moreover, studies of these two-domain proteins have 
both highlighted that, although the MFS domains are pseudo-symmetrical, they do not 
share same stability in-vitro. Furthermore, differences in stability between members of 
the MFS family show a complex picture of membrane protein folding. Nevertheless, the 
detail obtained from these studies puts forward the methodology needed to establish 
future studies focused on physiologically this important family of transporters. 
 
5.5 Focus of the future studies 
Although, the alanine mutation analysis is incomplete and it did not show clear 
differences between two helices or domains, it still provided the methodology, as well as 
highlighted potential difficulties and pitfalls that will be useful for the development of 
future studies. This work shows the potential of multi technique experiments in deducing 
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the behaviour of membrane proteins. 
 
The potential improvements could involve the use of less conservative, bulkier mutations, 
rather than alanine substitutions, such as valine or isoleucine, to cause bigger, more 
distinguishable changes to the stability. The bigger differences in stability could be easier 
to compare against the error associated with the measurements. Moreover, the 
combination of fluorescence tags with other methods of measuring structure change, 
could be used to supplement and collect more informative data.  The individual tags 
could be used to report on the extent of unfolding in the labelled regions of the protein. 
Chapter 3 provides the groundwork to expand the alanine scan of helices methodology 
to include fluorescent tags. Once, the system of labelling is optimised and fully 
characterised it could be used to measure time-resolved unfolding data. Furthermore, by 
placing two rhodamine tags at different positions, it would be possible to determine the 
relative stability and behaviour of those protein regions compared to the overall picture 
of GlpT’s unfolding. For example, one of the possible studies would be to characterise 
the flexibility and stability of periplasmic and cytoplasmic regions of GlpT during the 
process of unfolding. The same system could also be used as a sensor of substrate 
binding, as GlpT undergoes extensive conformational changes during the process of 
binding.  
 
The established two state unfolding system of GlpT in urea in micelles could be modified 
to extend the GlpT’s unfolding studies to include other membrane mimetic systems, such 
as liposomes. The native membrane environment differs significantly from the 
experimental in vitro conditions. First, the two state and the reversible equilibrium of 
unfolding need to be shown for liposomes. Then, some of the investigated mutants could 
be tested in the lipid system that is more related to the in vivo conditions. A different 
hydrophobic environment may provide a bigger contrast to the free energy comparisons 
between the pairs of mutants. The combination of fluorescence tags and liposomes could 




One of the key features of the MFS transporters is their interface region, found between 
the two domains. The interface is made up of residues creating a hydrogen bond network 
through the centre of the protein, which restricts the movement of molecules through the 
transporter depending on whether the recognised substrate is bound. The interface is 
also lined with a few charged amino acids that facilitate the binding to the transported 
substrate. Since, the interface region is a key characteristic of the MFS transporters, 
studying its contribution towards the stability of the protein could expand its role in protein 
folding events and its role in the mechanism of substrate transport. This could be 
achieved by selective mutations disrupting the key interactions between the two 





















Appendix A. Primer sequences 
 
Primers used in mutagenesis reactions that led to experiments in chapters 4 and 5 are 
listed below. The ‘fwd’ suffix is used to describe primers directed for the sense, forward 
strand, while primers with ‘rev’ suffix were used to bind to the reverse, antisense sites. 
The matching nucleotides are written as small case, mismatching sequences are 
represented by capital letters. The primer sequence is supplemented with the calculated 
melting temperature (Tm) with and without the mutation site. Calculation of Tm and other 
oligonucleotide properties was performed using oligo property scan tool web service 
found on the primer’s supplier website 
(https://ecom.mwgdna.com/services/webgist/mops.tcl). Table lists primers used in 
alanine scan experiments, all mutations with the exception of L26A, L268A and L44A 
were performed with regular site-directed mutagenesis protocol. Remaining primers 

















Mutation Sequence (5’  3’) Tm (°C) Tm without 
mutation (°C) 
Alanine scan mutations 
L26AHornfwd GCgcgctggcaaattttcctg 63.2 57.5 
L26HornArev tcgacgataagtcggatcgatctc 65.2 65.2 
L254Afwd gccgaacaaaGCgctgtggt 62.5 56.0 
L254Arev accacagcGCtttgttcggc 62.5 56.0 
I34Afwd cgctggcaaGCtttcctg 58.2 51.7 
I34Arev caggaaaGCttgccagcg 58.2 51.7 
I258Afwd tgctgtggtatGCcgccatc 61.4 51.0 
I258Arev gatggcgGCataccacagca 61.4 51.0 
Y38Afwd ctttggcGCTgcggcttactatttg 64.6 60.0 
Y38Arev caaatagtaagccgcAGCgccaaag 64.6 60.1 
Y266Afwd gtgttcgttGCTctgctgcgttac 64.4 55.8 
Y266Arev gtaacgcagcagAGCaacgaacac 64.4 55.8 
V43AHornfwd GCggttgagcagggat 52.8 48.6 
V43AHornrev ataaggcatagcaagcgc 51.6 51.6 
L268AHornfwd Cgcgttacggcatcctc 57.6 54.3 
L268AHornrev Ccagataaacgaacacgttgg 57.9 55.3 
L44Afwd gctatgccttatGCggttgagca 62.5 55.8 
L44Arev tgctcaaccGCataaggcatagc 62.5 55.8 
L267Afwd cgtgttcgtttatGCgctgcgtta 62.7 58.2 
L267Arev taacgcagcGCataaaacgaacacg 62.7 58.2 
L50Afwd gaactttgcgGCtgctatgccttatc 64.8 61.0 
L50Arev gataaggcatagcaGCcgcaaagttc 64.8 61.0 
L273Afwd cgttacggcatcGCcgactggt 67.2 60.4 
L273Arev accagtcgGCgatgccgtaacg 67.2 60.4 
L54Afwd gctatgccttatGCggttgagca 62.4 55.3 
L54Arev tgctcaaccGCataaggcatagc 62.4 55.3 
L279Afwd caccgacttatGCgaaagaggt 57.8 49.8 




M107Wfrw gcggcggcagtgTGGttgtttatg 66.1 62.8 
M107Wrev cataaacaaCCAcactgccgccgc 66.1 62.8 
F148Wfrw gtactatggtgcactGGttctcgcag 66.4 58.8 
F148Wrev ctgcgagaaCCagtgcaccatagtac 66.4 58.8 
V332Wfrw gcaaccggcTGGttctttatgac 62.4 54.8 
V332Wrev gtcataaagaaCCAgccggttgc 62.4 54.8 
Rhodamine label construct mutations 
C215Sfrw cgcaatcctCAggcttgc 58.2 54.3 
C215Srev gcaagccTGaggattgcg 58.2 54.3 
S61Cfwd gcagggattctGTcgcggtgat 64.0 61.4 
S61Crev atcaccgcgACagaatccctgc 63.4 61.3 
V283Cfwd ctgaaagagTGtaagcatttcgcgcta 63.4 61.3 
V283Crev tagcgcgaaatgcttaCActctttcag 63.4 61.3 
 
Table 5 List of all mutagenesis primers used in creating tryptophan, cysteine and alanine 

















Appendix B. Summary of PCR conditions 
 
The full protocols for Quik change mutagenesis and ‘Round the horn are found in chapter 
2 Materials and Methods sections. The optimal conditions for successful PCR 
amplifications for individual mutations are listed below. 
Mutation Tm without 
mutation 
(°C) 
Optimal conditions for PCR amplification 
L26A 57.5 2 mM Mg2+, 55.5 °C for 30 cycles 
L254A 56.0 3 mM Mg2+, 51.0 °C for 35 cycles 
I34A 51.7 3 mM Mg2+, 47.7 °C for 30 cycles 
I258A 51.0 4 mM Mg2+, 57.0 °C for 30 cycles 
Y38A 60.0 1 mM Mg2+,52.0 °C for 5 cycles, 54.0 °C for 5 cycles, 56.0 °C for 
5 cycles, 58.0 °C for 5 cycles, 60.0 °C for 15 cycles, 2% DMSO 
Y266A 55.8 2 mM Mg2+, 50.8 °C for 25 cycles 
V43A 48.6 2 mM Mg2+, 44.6 °C for 35 cycles 
L268A 54.3 2 mM Mg2+, 49.8 °C for 25 cycles 
L44A 55.8 2 mM Mg2+, 50.8 °C for 25 cycles 
L267A 58.2 2 mM Mg2+, 53.2 °C for 25 cycles 
L50A 61.0 2 mM Mg2+,53.0 °C for 5 cycles, 55.0 °C for 5 cycles, 57.0 °C for 
5 cycles, 59.0 °C for 5 cycles, 61.0 °C for 15 cycles, 2% DMSO 
L273A 60.4 2 mM Mg2+,52.4 °C for 5 cycles, 54.4 °C for 5 cycles, 56.4 °C for 
5 cycles, 58.4 °C for 5 cycles, 60.4 °C for 15 cycles, 2% DMSO 
L54A 55.3 3 mM Mg2+, 50.3 °C for 25 cycles 
L279A 49.8 4 mM Mg2+, 45.8 °C for 35 cycles 
M107W 62.8 3 mM Mg2+, 57.8 °C for 30 cycles 
F148W 58.8 2 mM Mg2+, 53.8 °C for 30 cycles 
V332W 54.8 1 mM Mg2+, 49.8 °C for 30 cycles, 2% DMSO 
C215S 54.3 3 mM Mg2+, 49.3 °C for 25 cycles, 2% DMSO 
S61C 61.4 2 mM Mg2+, 46.4 °C for 25 cycles, 2% DMSO 
V283C 61.3 2 mM Mg2+, 46.3 °C for 25 cycles, 2% DMSO 
Table 6 List of optimal conditions for each mutagenesis reaction performed 
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Appendix C. Growth curve for individual mutants 
 
The LB growth media was established to provide highest yield of mutant of interest. 
Terrific broth led to expanded growth and increased bug weight, however it did lead to 
increased protein yield. As part of the growth protocol, media was preheated to 37 °C 
before overnight culture was added. Without the preheating, the lag phase of bacterial 
growth was increased by an additional 30 minutes. The descriptions of mutants and their 
final protein yields, are described below each growth curve. The yields for the gel purified 
proteins are given after spin concentrating approximately 8 ml of the peak elution of the 
gel filtration column, values are shown as mg of protein purified per 1 L bug culture 
grown, and the concentration was calculated by the UV absorbance at 280 nm. For the 














Figure 5 Growth curves for L26A, L254 and I34A alanine mutants 
GlpT WT (open squares) yield of 1.02 mg/L, L26A (filled squares) yield of 1.05 mg/L, L254A (open 
circles) yield of 0.98 mg/L, I34A (filled circles), yield of 0.95 mg/L 
 
Time (min)


































Figure 6 Growth curves for I258A, Y38A and Y266A and V43A alanine mutants 
I258A (open squares) yield of 1.05 mg/L, Y38A (filled squares) yield of 1.01 mg/L, Y266A (open 













Figure 7 Growth curves for L268A, L44A and L267A and L50A alanine mutants 
L268A (open squares) yield of 1.02 mg/L, L44A (filled squares) yield of 1.08 mg/L, L267A (open 






























































Figure 8 Growth curves for L54A, L273A alanine mutants and cysteine mutant 
L54A (open squares) yield of 1.04 mg/L, L273A (filled squares) yield of 0.99 mg/L, (open circles) 













Figure 9 Growth curves for V332, M107W, F148W and Trpless GlpT mutants 
V332W (open squares) yield of 0.08 mg/L, M107W (filled squares) yield of 0.08 mg/L, Trpless 
















































Appendix D. PyMOL alanine mutant pairs 
 
The diagrams below illustrate locations of alanine mutant pairs within the GlpT structure. Helix 1 
and 7 are displayed in purple and blue, respectively. The mutated residues are labelled in yellow. 
The positions and possible interactions of alanine mutants are discussed in chapter 4. All 













Figure 10 Diagrams L26A-L254A, Y38A-Y266A and I34A-I256A alanine pairs located near 
cytoplasmic side of the membrane 
Helix 1 is represented by purple helix, while helix 7 by blue helix. The mutated residues are 
















Figure 11 Diagrams for V43A-L268A, L44A-L267A alanine pairs located near protein core 
Helix 1 is represented by purple helix, while helix 7 by blue helix. The mutated residues are 































Figure 12 Diagrams for L50A-L273A and L54A-L279A alanine pairs located near 
periplasmic side of the membrane 
Helix 1 is represented by purple helix, while helix 7 by blue helix. The mutated residues are 
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